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Cisplatin, cis-[Pt(NH 3 )2C1 2], has been a successful and widely used anticancer drug since 
the discovery of its activity 30 years ago. Up to now the mechanism of action of this drug is 
still not well understood. In this thesis, pH dependent platinum-sulfur interactions, the 
solution structure of a cisplatin DNA GpG intrastrand adduct and the chemistry of a new 
platinum anticancer drug have been investigated. Using ['H, 15N] 2D NMR spectroscopy 
and HPLC, together with 15N-labelled amine ligands, highly pH dependent interconversion 
between 5- and N-bound methionine adducts of {Pt(dien)} 2 (dien = diethylenetriamine) 
via then ring-opened intermediates has been observed. The isolated ring-opened 
intermediate exists as four diastereomers and was surprisingly long-lived. This study 
suggests a possible role for thioether-sulfur in the transfer and activation of platinum drugs. 
The NMR solution structure of a DNA 14mer duplex containing a cisplatin I ,2-GpG 
intrastrand crosslink has been determined by combined NOE measurements, coupling 
constants and restrained molecular dynamics calculations. Platination at GpG site causes 
significant bending and unwinding of the DNA duplex. The 3'-side of the DNA duplex is 
much more bent towards the major groove. Sequence-dependent structural characteristics 
are discussed and compared with the other reported structures of intrastrand platinated 
DNA. The 2-picoline (2-methylpyridine) complex, cis-[PtCl 2(NH3)(2-Pic)] (1), has 
recently entered clinical trials and is highly active against cisplatin resistant cell-lines. The 
crystal structure of 1 shows steric hindrance induced by the 2-CH 3  group towards an axial 
approach to Pt, while its 3-picoline analogue (2) is less sterically hindered. 15N labelling of 
complexes 1 and 2 allowed both the hydrolysis rates and pKa values of the complexes to be 
determined using 2D ['H, 15N] NMR spectroscopy. The steric effect of 2-picoline ligand 
reduces the reactivity of the complex during substitution reactions and the position cis to 2-
picoline is more affected. The rate constants for reactions between 1 and guanosine 5'- 
11 
monophosphate (5-GMP) were determined via 2D NMR studies, and compared with those 
for reactions with 2. The reactivity of 1 with thiol ligand of glutathione (GSH) was greatly 
reduced. Both mono- and bis-GMP adducts were observed in the competitive reactions of 1 
with GSH and GMP. Slow rotation about the Pt-N picoline bond and fast rotation about Pt-
N7 GMP bonds on the NMR time scale were observed for the bis(GMP) adducts of 1. 
These features of 1 may play an important role in its altered spectrum of biological activity 
compared to cisplatin. Complex 1 forms four stereoisomers in reactions with d(GpG) and a 
14mer DNA single strand due to the different orientations of 2-picoline (either towards 5'-
G or 3'-G) and slow rotation of Pt-N(2-Pic) bond. These contrast with reactions of 1 with a 
14mer DNA duplex, in which only one major stereoisomer was observed. 2D NMR 
experiments and molecular modelling suggest that favourable steric interactions, H-
bonding and van der Waals contact provide the structural basis for this unusually high 
stereoselectivity. These results give new insights into the effect of ligand design on the 
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NaCI04, pH 6.0, 9 mlvi phosphate buffer, 90% 1120/10% D20) recorded after (A) 15 
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shown in green. The perfect fit and alignment of the 2-picoline ligand along the 
major groove can be seen. (B) Close-up view of the Pt binding site showing NOE 
connectivities (yellow dashed lines, listed in Table 7.2) between 2-picoline and DNA. 
H-bonding between Pt-NH3 and 06 of G8 is shown as a yellow dotted line. Colour 
code: C (white), H (cyan), N (blue), 0 (red), P (orange), Pt (purple). 
List of Schemes 
Scheme 1.1 Reactions of 5'-GMP and L-Met with carboplatin. 
Scheme 2.1 Basic HSQC (a) and HMQC (b) pulse sequences. The delays A and t are 'AJ 
and ½J respectively, where J is the one-bond HX coupling constant. Other 
modifications are usually needed to improve the suppression and to detect resonances 
close to the water signal including presaturation (+SCUBA) and WATERGATE 
(WATER suppression by GrAdient-Tailored Excitation). 
Scheme 2.2 Pulse sequence for two-dimensional (a) COSY; (b) DQF-COSY and (c) 
NOESY, Tm is the mixing time. 
Scheme 3.1 {Pt(dien)} 2 migration from S-bound to N-bound L-Met and then ring-opening 
via S,N-che]ation of L-Met. 
Scheme 4.1 Hydrolysis pathways of picoline complexes 1 and 2. 
Scheme 4.2. Comparison of half-lives for hydrolysis (310 K) and pKa values (298 K) of 
platinum-picoline complexes (0.1 M NaCl04). 
Schemes 5.1 Pathways for reactions of picoline complexes 1 and 2 with 5 '-GMP. 
Scheme 7.1 Pathways for reactions of anticancer complex 1 with DNA duplex III (only G7 
and G8 are shown). Charges on complexes are not shown. A possible preferred route 
to the major GG adduct with 2-picoline cis to 5'-G is indicated by bold arrows. 
xxi 
List of Tables 
Table 1.1 Major structural parameters for G*G*  platinated DNA structures. 
Table 2.1 195Pt NMR chemical shifts of cis-Pt adducts with different donor atoms. 
Table 3.1 1 H and 15N chemical shifts of {Pt(dien)} 2 and {Pt(dienH-N,ND) 3  complexes. 
The spectra were recorded during the reaction of 15N-labelled complex (1) with ' 5N-
labelled L-methionine at 298 K. 
Table 3.2 1 H and ' 5N chemical shifts of HPLC separated complex (4) [Pt(dienH-
N,N(' 5N-L-Met-S,N)] 2 (pH 4.0, 298 K). 
Table 4.1 X-ray crystal structure data for cis-[PtC1 2(' 5NH3)(2-picoline)] (1) and 
cis-[PtCl 2( 5NH3)(3-picoline)] (2). 
Table 4.2 Selected bond lengths (A) and angles (°) for complexes 1 and 2. 
Table 4.3 Rate and equilibrium constants for the hydrolysis of the platinum-picoline 
complexes! (pH = 4.6) and 2 (pH = 4.4) at 310 K (0.1 M NaCI04). Data reported for 
cisplatin under related conditions (308 K, 0.32 M KNO3) are listed for comparison. 
Table 5.1 'H and 15N NMR Pt-NH3 chemical shifts at 296 K for cis-(Pt(' 5NH3)(2-
picoline) 2' and cis- [ Pt(' 5NH3)(3-picoline) 12+  complexes. 
Table 5.2 Rate constants for reactions of cis-[PtC12(NH3)(picoline)] with 5'-GMP at 296 K 
(0.1 M NaCI04). The errors represent one standard deviation. 
zui 
Table 5.3 'H NMR chemical shifts and coupling constants (Hz) for bis 5'-GMP adducts of 
1 (pH = 6.85) and 2 (pH = 6.55) at 296 K. (Pic = picoline) 
Table 5.4 'H and ' 5N NMR Pt-NH3 chemical shifts at 296 K for the major peaks observed 
during the reactions of 1 and 2 with GSH (1:1 molar ratio, pH 7). 
Table 6.1 1 H chemical shift assignments (ppm) for the DNA 14-mer duplex 
d(ATACATG*G*TACATA).(TATGTACCATGTAT) 111*  in 0.1 M NaC104 at pH 
6.2 and 278 K. 
Table 6.2 RMSD values (A) calculated from structures of rMD-A, rMD-B and rMD-final. 
Table 6.3 Major structural parameters for G*G*  platinated DNA structures. 
Table 7.1 Assignments of key 'H resonances for the G*G*  chelate of duplex III with cis-
Pt(' 5NH3)(2-picoline) 2+ 
Table 7.2 Key NOE signals observed between 2-picoline and DNA protons after 
platination of DNA duplex Ill with the platinum anticancer drug 1. The 
corresponding distances in the four models are listed for comparison. Distances over 
S A are beyond the limit for NOEs, and are labelled (-). 
Xxiii 
Publications: 
[H-i, N-iS] nuclear magnetic resonance studies of [Pt(dien)Cl] 	(dien= 
diethylenetriamine): Hydrolysis and reactions with nucleotides 
Zijian Quo, Yu Chen, Erie Zang, Peter J. Sadler 
J. Chem. Soc., Dalton Trans., 1997, 4107-4111. 
Stereospecific and kinetic control over the hydrolysis of a sterically hindered platinum 
picoline anticancer complex 
Vu Chen, Zijian Quo, Simon Parsons, Peter J. Sadler 
Chem. Ear. J.,  1998, 4, 672-676. 
Interconversion between 5- and N-bound L-methionine adducts of Pt(dien) 2 (dien= 
diethylenetriamine) via then ring-opened intermediates 
Vu Chen, Zijian Guo, Piedad del Socorro Murdoch, Erie Zang, Peter J. Sadler 
J. Chem. Soc., Dalton Trans., 1998, 1503-1508. 
Kinetic control of reactions of a stericaliy-hindered platinum picoline anticancer 
complex with guanosine 5 -monophosphate and glutathione 
Vu Chen, Zijian Quo, John A. Parkinson, Peter J. Sadler 
J. Chem. Soc., Dalton Trans., 1998,3577-3585. 
A new platinum anticancer drug forms a highly stereoseiective adduct with duplex DNA 
Vu Chen, John A. Parkinson, Zijian Guo, Tom Brown, Peter J. Sadler 
Angew. Chem. mt. Ed. 1999, 38, 2060-2063. 
195Pt and 15N NMR spectroscopic studies of cisplatin reactions with biomolecuies 
Vu Chen, Zijian Guo and Peter J. Sadler 
in 'Cisplatin-Chemistry and Biochemistry of a Leading Anticancer Drug', 
Ed. B. Lippert, WILEY-VCH, Basel, 1999, pp.293-318 . 
xxiv 
Abbreviations: 
cis-Pt: cis-[PtC]2(NH3)2], cis-DDP 
COSY: 2D correlation spectroscopy 
dien: Diethylenetriamine 
DQF: Double-quantum filtered 
EXSY: 2D exchange spectroscopy 
Glutathione: y-L-Glu-L-Cys-Gly 
GMP: Guanosine 5'-monophosphate 
GSH: Glutathione 
HMG: High mobility group 
HtvIQC, HSQC: Heteronuclear 	multiple-quantum 	(or 	single 	quantum) 
coherence 
HPLC: High performance liquid chromatography 
hSRY: Sex determining factor in humans 
ICL: Interstrand cross-link 
LEF-1: Lymphoid enhancer binding protein 
L-HMet: L-methionine 
MT: Metallothionein 
NMR: Nuclear magnetic resonance 
NOESY: 2D nuclear Overhauser effect spectroscopy 
NOE: Nuclear Overhauser effect 
Pic: Picoline, methyl-pyridine 
rMD: Restrained molecular dynamics 
RMSD: root-mean-square deviation 
SSRY-1: Structure specific recognition protein 
UV: Ultraviolet spectroscopy 
WATERGATE: 	Water suppression by gradient-tailored excitation 
xxv 
Chapter 1 Introduction 
Chapter 1 
Platinum Anticancer Drugs 
Chapter 1 Introduction 
1.1 Cisplatin 
The compound cis-[PtCl2(NH3)2], clinically known as 'cisplatin' (often abbreviated 
as cis-Pt), was discovered to be cytostatically active and became a very effective 
antitumour drug in the 1960s.1  It is one of the most widely used and successful drug 
in cancer chemotherapy. It is highly effective in the treatment of a number of 
tumours, e.g. testicular and ovarian cancer. In combination therapy with other drugs, 
cisplatin is also used to treat cervical, bladder and head/neck tumours. 2 it has become 
well known that cisplatin reacts with cellular components such as DNA and 
proteins. 3,4  A key reaction step in the mechanism of action appears to be the binding 
of the cis-(Pt(NH3)2 )21  unit to cellular DNA at two neighbouring guanine bases, and 
more specifically at N7 position. 5 
Despite the successful therapeutic use of cis-Pt, it still suffers from serious 
side effects which include: (1) poor solubility in saline, (2) severe toxicity (e.g. 
nausea, ear damage, vomiting, loss of sensation in hands and kidney toxicity), (3) the 
development of resistance. 6,7  Also, the applicability of cis-Pt is still limited to a 
narrow range of tumours. These raise the importance of understanding the 
mechanism of anticancer activity of cisplatin and lead to the search for new 
generations of Pt drugs which can circumvent those problems. 
1.2 Development of New Platinum Drugs 
Derivatives belonging to the cis-[PtX2(amine)2] structural class (X = leaving anionic 
group; amine = any primary or secondary amine), show similar or improved 
biological activity compared with cisplatin. Among them, the second-generation 
platinum drug carboplatin, [Pt(l,l-cyclobutanedicarboxylato)(NH3)2], has been in 
routine clinical use and has less toxic side-effects than cisplatin. Both cisplatin and 
its closely related analogue carboplatin lead to high levels of resistance in various 
tumours. 
2 
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Three major mechanisms have been proposed for cisplatin resistance in vivo. 8 
First, the reduced intracellular concentrations of the drug due to either blocking 
uptake or increasing efflux. Second, the increased inactivation of the drug through 
reaction with intracellular ligands such as glutathione and metallothionein. Finally, 
the increased removal of drug-DNA adducts by cell-based repair systems including 
nucleotide excision repair. 
In order to reduce the spontaneous drug resistance developed in certain 
tumours and at the same time achieve a similar level of effectiveness, a third-
generation serious of drugs containing different amines has evolved during the last 
decade. They include platinum(IV) pro-drugs (e.g. JM216, Fig. 1.1) that have 
potential to be administered orally. 9 It is still not very clear whether or not such 
compounds are reduced before binding to the DNA, although most evidence suggest 
that the formation of Pt(IV)-DNA adducts is too slow to account for the activity. 10 
One strategy to overcome cisplatin resistance has been to use sterically 
hindered carbocyclic amines, these include DWA21 14R, oxaliplatin and most 
recently ZD0473 (or AMD473), shown in Fig. 1.1. The bulky ligands in these 
complexes may prevent recognition and inhibit nucleotide excision repair even 
though they form similar adducts to those of cisplatin." 2 DWA2114R is currently in 
phase ifi clinical trials. The chiral ligand used in this compound provides the 
interesting observation that the R-isomer is not toxic while the S-isomer is. The 
activity of a chiral platinum drug may provide insight into the stereo requirements of 
adduct formation or possibly the intermolecular interactions that occur following 
DNA binding. Oxaliplatin has been in clinical trials since 1986, both in combination 
therapy and as a single agent drug for the treatment of colorectal cancer. 
12,13  It is 
active in cisplatin resistant ovarian cancer, and was the first cisplatin derivative to be 
approved in France for the treatment of advanced colorectal cancer. ZD0473 is a 
newly reported anticancer active drug, which is now in phase I clinical trials in UK. 14 
3 
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Compared with cisplatin, this new drug is both oral and i. v. active and shows 
diminished cross-resistance to cisplatin in three different cell lines with acquired 
cisplatin resistance. 15  It also lacks nephrotoxicity. The steric hindrance of the 2-
methyl pyridine ligand appears to play an important role during the substitution 
reactions,' 6,17  and highly stereoselective formation of G*G*  adduct with DNA duplex 
may be recognised differently by excision repair system. is 
Until now, most of the potential drugs have two amines in a cis geometry 
(symmetric, asymmetric, chelating or not), and the presence of at least one N-H 
group on the amine, as well as leaving groups with a weaker trans effect than the 
amine. These characters were found to be necessary in structure-activity relationships 
for platinum compounds. By applying careful variations in: (a) the chosen amine 
ligand on platinum (chelating or not, hydrogen-bond donor, steric effects, bioactive 
carrier groups, possible side arms for secondary DNA interactions), and (b) the 
selected leaving groups at platinum (non-toxic, optimal ligand-exchange kinetics, 
possibility of acting as a pro-drug), more new drugs can be expected. 19 
Besides the 'classical' platinum compounds, completely different structural 
classes of platinum antitumour drugs have also been reported. The recently reported 
dinuclear and trinuclear platinum-amine compounds (e.g. BBR3464, Fig. 1.1) appear 
to be able to form very different types of DNA lesions to those of cisplatin. 2° The 
activity of these compounds depends on the chain length of backbone. 21 The elevated 
activity level in cisplatin-resistant cells and in some cases the different activity 
spectrum, suggest that these compounds have a potentially different mechanism to 
that proposed for mononuclear cisplatin derivatives. The trinuclear platinum complex 
is now in phase I clinical trials in the USA. Trans-[PtC12(E-imino ether)2] complex 
(trans-EE) (imino ether = HN=C(OCH3)CH3) is another reported anticancer active 
complex. 22  Compared with its cis isomer (cis-EE), the trans-EE is not only more 
cytotoxic but also endowed with significant antitumor activity, which implies a new 
rd 
Chapter 1 Introduction 
0 











254-S 	 oxaliplatin 
J M-2 16 NK 121 
[CINH3 
	 4+ 
'NNH2(CH2)6H2N. 	NH3 	1`13N 	""Cl j 
BBR-3464 
H3NCI 
 C1 a H3 
DWA2114R ZD0473 
Figure 1.1 Some clinically used Pt drugs and some compounds which are in different 
stages of clinical trials. 
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mechanism for the activity of trans platinum complexes. 
From the platination complexes which have been investigated so far, it is 
clear that the relationship between structure and activity is extremely complex. Many 
factors that can influence activity have to be taken into account, for instance, 
reactions prior to cell uptake, the rate and mechanism of cell uptake, deactivation 
prior to DNA binding, the rate of DNA binding, the adduct profile that results, and 
the repair and removal of the DNA adducts. Those factors all have the potential to 
profoundly influence the activity of the complex, and each factor can also differ 
substantially between one tumour type to another. Simple unifying structure-activity 
rules are only likely to be indicative of classes of compounds that act by similar 
mechanisms. However, it is still generally true that compounds adhering to the 
structure-activity rules can be expected to be active. 23 
Overall, new structures (to increase activity, overcome the above-mentioned 
problems of resistance and reduce toxicity) and improved sequence selectivity (to 
avoid mutagenic side effects) of platinum drugs may result in better treatment of 
tumours that are not sensitive enough to cisplatin. Some of the first, second and third 
generation of platinum compounds clinically used or on trial are shown in Fig. 1.1. 
1.3 Mechanism of Action of Cisplatin 
After administration, either by injection or infusion, cis-Pt circulates in the 
blood. Because of the relatively high concentration of chloride ions in blood (100 
mM), the hydrolysis of cis-Pt is inhibited and it remains almost unchanged before 
entering both normal and tumour cells. The mechanism of how cisplatin enters cells 
still remains under-defined. Existing data suggest that cisplatin enters cells via 
transmembrane channels, though these data are also consistent with high-capacity 
facilitated transport .24  Once inside the cell, cis-Pt hydrolyses to give active forms of 
aqua-species such as cis-[PtCI(NH3)2(H2O)1 and cis-[Pt(NH3)2(H2O)2I 2 because of 
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the much lower chloride ion concentration (about 4 mM). Hydrolysis is known to be 
the rate-limiting step in the binding of cisplatin to DNA 
.25 
In theory, a large variety of biological molecules could be the potential targets 
for platinum compounds, including DNA, RNA and proteins. From the Hard-Soft 
Acid-Base theory, S-donor ligands in proteins would bind strongly and generate the 
most stable bonds. Binding to lone pairs of nitrogen atoms can also be very strong. 
These types of binding would involve amino acid side chains of proteins from 
cysteine, methionine, histidine and the solvent-exposed N7 atoms of adenine and 
guanine in double-stranded DNA. Usually, interactions of platinum antitumor 
complexes with S-containing biomolecules are thought to have an overall negative 
effect on antitumor activity. Such interactions can be responsible for the inactivation 
of Pt(111) species, development of resistance and toxic side effects such as 
nephrotoxicity. But recent studies have shown that sulfur ligands, especially thioether 
from methionine or perhaps oxidised glutathione, could also play a key role in the 
transfer of Pt to the nucleic acids. 26,27 
The antitumour activity of cisplatin depends on its ability to modify the 
structure of the DNA of cancer cells. Approximately 1% of the intracellular cisplatin 
reacts with genomic DNA and yields a variety of mono-adducts and intra- and inter-
strand crosslinks. The most electron-donating sites in duplex DNA are known to be 
guanine residues located adjacent to a second guanine residue. 11,29  For all third-
generation platinum anticancer agents, guanine-N7 position appears to be the 
preferred binding site. Therefore it is not surprising that the major DNA lesions both 
in vitro and in vivo are intrastrand d(GpG) crosslinks, Besides GG intrastrand 
crosslinks (70%), the other major DNA adducts of cisplatin are intrastrand AG (but 
not GA) crosslinks (15%), the remainder being minor 1,3-intrastrand and interstrand 
crosslinks involving two non-neighbouring guanines. 30  Platination of DNA by trans-
DDP was found to give the following adducts after digestion: dG-Pt-dC (50%), dG- 
7 
Chapter 1 Introduction 
Pt-dG (40%), dG-Pt-dA (10%).3 1  As expected, trans-DDP does not form intrastrand 
chelates between adjacent nucleotides. From the genetic effects of DNA adducts 
formed by cis-DDP, the G*G*  adduct is the most genotoxic of the three major cis-
{Pt(NH 3 ) 2 } 2 intrastrand crosslinks, which collectively account for --95% of the 
adducts formed by cis-DDP. Although highly toxic, the G*G*  adduct is -4-5 fold 
less mutagenic than the A*G*  adduct. Since the mutagenic properties are important 
factors which may lead to the development of second tumours, drugs with a high 
ratio of toxicity to mutagenicity are desirable. Therefore platinum drugs should be 
designed to maximize the occurrence of the G*G*  adduct and minimize the 
frequency of the more mutagenic A*G*  adduct. 32 
- Platinum in cells  
I apoptosis ,' 
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The fate of cells following cisplatin exposure depends on both the extent of 
damage induced and on the cellular response to damage. One potentially important 
way in which cisplatin may kill cells is by induction of apoptosis. Apoptosis is a 
ubiquitous, genetically regulated mechanism of active cell death that is conserved in 
multicellular organisms. Considerable evidence indicates that cisplatin can kill cells 
by apoptosis. 34 ' 35 Proteins that specifically recognise cisplatin induced DNA damage 
have been found, such as HMG proteins. Through binding to cisplatin-DNA adducts, 
HMG proteins could either protect cisplatin adducts from recognition by DNA repair 
enzymes or trigger apoptosis. 36 A schematic and somewhat hypothetical picture for 
the multi-step transport and reaction of cis-Pt in cell is illustrated in Fig. 1.2. 
1.4 Reactions with Amino Acids and Nucleotides. 
Pt(IT) being a "soft" metal ion is known to have a very high affinity for "soft" 
ligand atoms such as sulfur. Sulfur-containing ligands, e.g. glutathione (GSH), N-
acetyl-L-cysteine, have been investigated as rescue agents for the removal of Pt from 
the body. The thioether L-methionine (L-HMet) is thought to play an important role 
in the metabolism of cisplatin, and one of the few characterised metabolites of 
cisplatin is [Pt(L-Me0 2] which has been isolated from urine. 
37  [Pt(L-Met)2] exists as 




Cis 	 Trans 
a mixture of cis and trans isomers in aqueous solution. 
38,39  At neutral pH, the isomers 
interconvert extremely slowly (half-lives of 22.4 h and 3.2 h for the cis and trans 
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isomers, respectively, at 310 K) with the cis isomer predominating at equilibrium 
(10:1, K=7.0). 
The S-containing tripeptide glutathione (y-Glu-Cys-Gly) is present in cells at 
millimolar concentrations. The formation of Pt:GSH complexes may play an 





important role in the biological activity of platinum complexes. GS-Pt complexes can 
be pumped out of cells through an ATP-dependent process. 40 During the reaction of 
cis- [PtC] 2 (' 5NH 3) 2 j with OSH, the mono-substituted complex cis- [PtC1(SG)( ' 5NH 3 ) 2 } 
is formed first, but several other species containing a 15NH3-Pt-S linkages are present 
within a few minutes . 4 ' Release of 15NH3 ligands has been observed and no 
coordinated 15NH3 is contained in the final product, which is consistent with a high- 
molecular mass polymer with a 1:2 Pt:GSH stoichiometry. A product containing a 
dinuclear Pt 2S 2 four-membered ring has been observed from reactions of cis- 
[Pt(NH 3 ) 2(H 20)2] 2  with GSH.42 Glutathione can also affect macrochelate ring 
closure of cis- and trans-DDP monofunctional adducts on DNA. 43 Compared with 
cisplatin, the reaction between GSH and trans-DDP monofunctional adducts more 
rapidly leads to the formation of sulfur-bound, glutathione-trapped monofunctional 
adducts. Glutathione does not appear to react with cis- or trans-DDP bifunctional 
adducts. These results are consistent with proposals that the biological inactivity of 
FE 
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trans-DDP may arise from selective trapping of monofunctional adducts before they 
ring-close to form bifunctional lesions. 
MT is a low-molecular weight protein rich in cysteine (-30%) and thought to 
be responsible for cisplatin detoxification. The tetrapeptide Boc-Cys(SMe)-Ser-Ala-
Cys(SMe)-CONH2 (CSAC) has been used as a model for metallothionein (MT) for 
reactions of MT with cis-DDP and trans-DDP.' The reaction with cisplatin forms a 
mixture of different diastereoisomers and polymeric species, with NH3 liberation due 
to the strong trans-effect of sulfur. Trans-DDP, on the other hand, forms a 2:1 
complex coordinated to the -S-CH3 groups and no ammonia release is observed. 
Therapeutic nucleophilic agents for cisplatin, such as Na(ddtc) (sodium 
di ethyl dithiocarbamate) and thiourea, can help to remove Pt from certain proteins so 
as to relieve toxicity.  45  The mechanism may be based on the relatively easy reversal 
of Pt binding to methionine side chains. In contrast, nephrotoxicity, thought to be 
caused by formation of Pt-cysteine adducts (Pt(ll) thiolate bonds), cannot be reversed 
by Na(ddtc) and thiourea. 
The pH-dependent S,O- versus S,N-chelation in the reaction of cis-
[Pt(NH 3 ) 2(H20) 2 ] 2 with S-methyl-L-cysteine (mecysH) and L-methionine has been 
studied by Appleton et al.46 The chelate products [Pt(NH3)2(mecys-S,N)] and 
[Pt(NH 3)2(met-S,IV)] were observed at pH values near 5. In strongly acidic 
conditions (pH !~ 0.5), the initial product from the reaction with mecysH is 
[Pt(NH 3 ) 2(mecysH-S,O)] which slowly converts to the S,N-chelate. A similar 
reaction sequence occurs with methionine, but cis- [Pt(NH 3 ) 2(metH-S)2] 2  is also 
formed in competition with the S, 0- chelate. 
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Intramolecular migration of the model fragment {Pt(dien)} 2 from sulfur to 
imidazole-N' in histidylmethionine (his-metH) has been investigated by HPLC and 
NMR methods.47 Under acidic conditions, the dominant Pt complex is [Pt(dien)(his-
metH-S)] 2 , while the imidazole NI-bound complex, [Pt(dien)(his-metH-N])} 2 
becomes the major species at pH values higher than 6.1. The dinuclear intermediate 
[Pt(dien)(his-metH-N],S)I 2  was observed during the slow isomerization. 
Although the kinetic reactivity of sulfur is high, the Pt-thioether bond is labile 
in the presence of other nucleophiles. 48 This could provide a novel pathway for DNA 
platination. The competitive binding of Met, His, 5'-GMP, 5'-AMP, 5'-TMP and 5'-
CMP to {Pt(dien)Cl} in aqueous solution show that 5'-GMP selectively displaces 5-
bound Met. Initially only L-Met coordinates to Pt with little GMP coordination, but 
in the later stages of the reaction coordinated L-Met is displaced by N7 of GMP. 48 ' 49 
It is notable that thioethers such as L-Met react with Pt(H) amines faster than thiols 
such as GSH, and reactions of thiols tend to be irreversible. 50  Intramolecular 
migration of {Pt(dien)} 2 from S to guanosine-N7 in S-guanosyl-L-homocysteine has 
been observed by van Boom et al.51 Novel intermediates including cis-[Pt(GMP-
N7)(Met-S)(' 5NH3)2] 2 and cis- [Pt(GMP-N7)(Met-S,N)(' 5NH3)1 (N7 trans to 5) 
have been detected and characterised in the reaction of cisplatin with 5'-GMP in the 
presence of L-Met. 52 Ammonia release was observed during the formation of 
intermediates. Monodentate S-bound L-HMet can coordinate to Pt reversibly, 
whereas S,N-cheiated L-Met is much more inert. Interestingly the reaction of 5'-
OMP with cisplatin is faster in the presence of L-Met than in the absence. 
12 
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Highly stable monofunctional adducts are formed during reactions of 
monodentate S-bound N-acetyl-L-methionine complexes Pt(en)(MeCO-Met-S)C11' 
and [Pt(en)(MeCO-Met-S)2]
21  (MeCO-Met = N-acetyl-L-methionine) with 5'-GMP 
and GpG. 53 Such adducts formed by methionine and its derivatives could play a role 
in the trapping of monofunctional adducts of platinum anticancer drugs with DNA in 
vivo. 
The lower side-effects and toxicity of carboplatin [Pt(NH3)2(CBDCA-0,01 
(H2CBDCA: cyclobutane-1,1-dicarboxylic acid) compared with cisplatin, can be 
attributed to its lower reactivity caused by the presence of the chelating CBDCA 
ligand. It could be a pro-drug for cisplatin but the rate of hydrolysis is very slow 
(half-life in water > 4.4 years). A ring-opened carboplatin adduct containing 
monodentate CBDCA can be detected during reactions of carboplatin with 5'-GMP. 54 
The fast reactions of carboplatin with 5'-GMP compared with nitrate, phosphate and 
Cl - suggest that direct attack of nucleotides on carboplatin may be of importance in 
the mechanism of action of this drug. 54 Ring-opened adducts of carboplatin can form 
not only from reactions with nucleotides, but also by the attack of sulfur amino 
acids. 55 Reactions with thioether ligands are much more rapid compared with thiols. 
Surprisingly very stable ring-opened species such as [Pt(CBDCA-0)(NH3)2(L-HMet-
S)I are formed, which has a half-life for Met-S. N closure of 28 It at 310 K. A similar 
species was detected as a major metabolite in the urine of animals treated with 
carboplatin. 56 Such an intermediate could also play a role in the biological activity of 
this drug. 
13 






11 3N" "N7—GMP 
H3N 	 H 3N 
Chelation 	Pt 
H 3V \—Met 	H 3V 
Scheme 1.1 Reactions of 5'-GMP and L-Met with carboplatin. 
1.5. Kinetic Studies of Reactions of Cisplatfn with GG Single Strand and Duplex 
DNA 
Recently there has been much interest in investigating the mechanism of 
formation of d(GpG) intra- or inter-strand crosslinks on either DNA single strands or 
duplexes. Such interest is important because the lifetimes of the various species 
along the pathways may determine their biological significance. For example, 
intermediates may live long enough to be recognised by repair systems, and 
monofunctional adducts en route to d(GpG) chelates may themselves distort the 
structure of DNA . 57 '58  Chottard et al. have identified individual monofunctional 
adducts during reactions of cis-[Pt(NH3)2(H2O)2] 2  with single and double-stranded 
DNA at pH 4•4•59.60  They found that the 5'-G is platinated fasted than 3'-G, but the 
3'-G monofunctional adduct chelates faster. The differences were increased in 
duplexes compared to single strands and were sequence-dependent. By observing Ill 
and 15N NMR resonances of Pt- ' 5NH3 groups,61  Sadler et al. reported the first direct 
comparison of the kinetics of platination of defined single- and double-stranded DNA 
with cisplatin. 62  The rate of platination of one of the GG residues was faster by a 
14 
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factor of Ca. 4 for both the single GO strand and duplex, and the monofunctional 
adduct that formed faster on the duplex (probably 3'G) also ring-closed faster by 
about an order of magnitude. One of the monofunctional adducts on the duplex (5'G) 
had a surprisingly long life-time (5 days at 298K). 63 In contrast, there was little 
difference between the rates of ring closure of the two monofunctional adducts on the 
OG single strand. GG platination gave rise to an equilibrium between two major 
forms (kinked or bent) of the GO chelate. Double platination on adjacent nucleobases 
has been reported to occur at high-salt conditions. 64  The intrastrand cross-link could 
compete with the second metal coordination. 
Using 2D ['H, ' 5N1 HSQC NMR spectroscopy, rates of platination of AG and 
GA containing double-stranded DNA have been compared .65  It was concluded that 
the bifunctional intrastrand adduct profile observed when cisplatin binds to DNA is 
substantially controlled by the rate of formation of monofunctional adducts at the 
different X-purine-purine-X sequences. Monofunctional binding of cisplatin to the 
GpA sequence is approximately an order of magnitude slower than binding to either 
GpG or ApG sequences. A slow rate of closure also contributes to the nonformation 
of the bifunctional OpA adduct. Kinetic studies of GG versus AG platination on 
hairpin-stabilised duplex oligonucleotides were also carried out using HPLC 
methods. 66 
1.6 Structural Studies of Platinated DNA Duplexes 
Significant distortion of the DNA structure upon platination was indicated in 
the early studies of cisplatin binding to nucleobases and nucleotides. The crystal 
structures of [Pt(NH3)2{d(pGpG)}] 67 '68 and [Pt(NH3)2{d(CpGpG)1] 69 gave evidence 
of the structural changes upon cisplatin adduct formation. The cis-diammine-
platinum(ll) moiety binds to the N7 atoms of the two guanine rings, which are 
orientated in a head-to-head manner and destacked, the dihedral angle between the 
15 
Chapter] Introduction 
purine base planes being 810.67  Using two-dimensional NMR methods, Den Flartog et 
al. reported the first solution structure of cisplatin chelated to two neighbouring 
guanines. 70 
Recently a number of high-resolution structure determinations have been 
obtained for the major cisplatin adduct on duplex DNA 71-76  as well as minor 
adducts. 11,71,79  The high resolution (2.6 A) X-ray crystal structure of an intrastrand 
G*pG* platinated DNA duplex d(CCUCTG*G*TCTCC).(GGAGACCAGAGG) 
has been reported '72  where UBr  is a 5-bromo-U heavy atom derivative of the native 
DNA sequence used for phasing. The triclinic unit cell contained two independent 
molecules which allowed two different but very similar structures of the platinated 
duplex (molecules A and B) to be obtained. There are several interesting features 
revealed from the analysis of this X-ray structure of the cisplatin-modified 
dodecamer duplex. The duplexes are bent towards the major groove with the bend 
locus near the site of platination. Two different bending angles were observed: one is 
—39° similar to that reported from gel electrophoresis studies, and the other is —55°. 
The bend is due in large part to a very shallow roll of 26° towards the major groove 
of the platinated G*G*;which  results in considerable strain at the Pt-N7 bonds. The 
Pt atom lies 1 A out of the plane of the guanine rings. Duplex formation and crystal 
packing preclude more complete destacking of the bases, and base pairing is retained 
throughout much of the helix. The duplex contains an A-form/B-form junction 
situated just to the 3' side of the platinum adduct, with the first 8 base pairs (bp) to 
the 5'-side of the platinum site exhibiting A-form DNA parameters. This A-B fusion, 
which is only observed in the crystal structure of the platinated duplex, is thought 
most likely to be due to crystal packing. A projection of the DNA structure, based on 
the X-ray coordinates, is shown in Fig. 1.3. 
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40 
Figure 1.3 The structure of the GpG platinated DNA duplex 
d(CCTCTG*G*TCTCC)Id(GGAGACCAGAGG) as determined by X-ray 
diffraction." Colour code: C (green), N (blue), 0 (red), P (purple), Pt (yellow). 
The solution structure of the cisplatin-modified DNA dodecamer was also 
determined by high-resolution 2D NMR spectroscopy and restrained Molecular 
Dynamics (rMD) refinement by the same group, in order to find out the effect of 
crystal packing on the structural features. 74  The sequence of the DNA dodecamer 
d(CCTCTG*G*TCTCC).d(GGAGACCAGAGG) is the same as the one used in 
crystal structural studies. There is a significant bend of 78° toward the major groove 
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resulting largely from the 49° guanine-guanine roll at the site of platination. These 
features are much more exaggerated than those observed in the X-ray crystal 
structure, probably due to the absence of the crystal packing forces. The larger roll 
between guanine bases relieves the strain imposed on the Pt-N7 guanine bonds, but 
still the Pt atom is displaced from each base plane by -0.8 A. A common property of 
the solution and crystal structures is the widening and flattening of the minor groove 
opposite the platinum adduct, affording geometric parameters resembling those found 
in A-form DNA. The unwinding of the helix at the site of the platination is 25°. 
Although considerably distorted from B-form DNA, the solution structure of the 
platinated duplex has predominately B-type sugar puckers (S conformation). Only the 
5'-platinated guanosine (G6*)  has its deoxyribose ring in the C3'-endo conformation, 
and the remaining 23 ring sugar puckers exist in the C2'-endo or closely related C3'-
exo conformation. 
With the normal NMR NOESY methods, usually it is possible only to observe 
NOE connectivities between protons c 5 A apart. This small distance limitation 
presents difficulties for determination of the global features of DNA duplexes, for 
example bend angles or long range unwinding, although the local geometry of DNA 
helices can be resolved to high resolution. Recently a spin-labelled platinum 
compound cis-[Pt(NH 3)(4-amino-TEMPO)ClI] has been used in studies of the 
solution structure of a platinated-DNA . 75 This compound binds to the GpG site of 
DNA in a similar manner to cisplatin, with the label nestling rigidly in the major 
groove of the duplex. The use of this spin-labelled platinum compound allows the 
detection of long-range electron-proton distances for use in restrained molecular 
dynamics. The structure of the reduced diamagnetic duplex d(CTCTCGGTCTC) 
.d(GAGACCGAGAG) was determined by using conventional 2D NMR methods and 
distance-restrained molecular dynamics, and then further refined by applying 99 
additional long-range (<20 A) electron-proton distance constraints. Refinements of 
ii;i 
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Table 1.1 Major structural parameters for G*G*  platinated DNA structures 
Complex dodecamer72 dodecamer74 octamer73 undecamer75 
method X-ray' NMR" NMR" NMRb 
crystal solution solution solution 
DNA form AIB junction primarily B primarily B primarily B 
Minor groove width(A) 9.5-11.0 9.4-12.5 4.5-7.8 9.0-12.0 
depth (A) 3.0 1.4 3.2 2.1 
P-P distance (A) 5.5 6.9 6.8 6.8 
Roll at G*G*  bases (°) 26 49 42 59 
Pt atom displacement 1.3 A, 5' 0.8 A, 5' 1.0 A, 3' 0.5 A, 5' 
from guanine ring 0.8 A, 3' 0.8 A, 3' 0.8 A, 3' 0.65 A, 3' 
Average helix twist (°) 32 25 25 26 
DNA bend (°) 39 and 55' 78 58 -81 
a  cis-[Pt(NH3)2C12] was used in the study. 
b Spin-labelled compound cis-[Pt(NH3)(4-amino-TEMPO)Cl1] was used in this 
study, which provided long-distance constraints for rMD. 
Two independent molecules. 
the structure with either conventional interproton or a combination of the electron-
proton and interproton restraints afforded the same local but different global 
structures. The final refined structure has a bend angle of -81°, even larger than that 
observed for the dodecamer in solution. From the result of this study, it appears that 
the use of paramagnetic constraints is especially important in defining the ends of a 
duplex structure. These are usually poorly determined by NMR because of the 
intermolecular motion and a lack of the full complement of interproton NOEs for 
these base pairs. 
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The solution structure of another cis-[Pt(NH3)2] 2 platinated duplex DNA 
d(CCTG*G*TCC).d(GGACCAGG) containing the G*G*  intrastrand cross-link was 
also reported .73  Interestingly, the G*G*  intrastrand crosslink adduct slowly converted 
into a more stable interstrand didentate adduct (between G4 and G9) promoted by the 
presence of the nucleophilic chloride ion. This phenomenon is not observed in the 
other structural studies with longer sequences and may be due to its strained Pt-N7 
bonds in this very short length and less stable platinated DNA structure. 
Structural studies of cisplatin-DNA adducts are not only focused on the major 
intrastrand G*G*  adduct, but also on the other minor adducts which can also play an 
important role in the anticancer activity of this drug. The intrastrand AG crosslink is 
the second major adduct formed by cisplatin with DNA, which accounts for —20% of 
the total adducts. For cancer patients, a correlation exists between the level of 
intrastrand GG and AG crosslinks in leukocyte DNA and their response to cisplatin 
therapy. 80 The solution structure of a nonanucleotide duplex crosslinked by cisplatin 
at an ApG sequence has been solved recently by means of NMR and molecular 
modeling.79 It showed that the nucleotide was kinked towards the major groove in a 
way similar to the G*G*  adduct. The major difference was at the position of the 
thymine complementary to the platinated adenine A*.  It remained stacked on its 5-
neighbour, corresponding to the "E-model", whereas in the G*G*  adduct, the 
cytosine facing the 5'-G was found to oscillate between the 5-branch ("model E", 
stacking on 5' side) and 3'-branch ("model C", stacking on 3' side). 
An early study of the minor adduct 1 ,3-intrastrand GTG cross-link by gel 
electrophoresis experiments revealed that the DNA duplex is bent by —35° and 
unwound by 230.81  The solutional structure of a 13-mer duplex was determined 
recently by NMR spectroscopy and rMD. 82 The 1,3-intrastrand cross-link does not 
distort the global helical structure to the extent observed in the 1 ,2-intrastrand 
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adducts but significantly disrupts local base pairing and stacking at the 5'-side of the 
adduct. 
The interstrand cross-link JCL) represents a small fraction (-5%) of the 
adducts formed by cisplatin on duplex DNA. Formation of a cisplatin ICL is usually 
easy at a GpC step 83  and is expected to cause significant distortion of B-form DNA 
due to the long (>7 A) distance between the two bind sites of G-N7. The structures of 
two different duplexes containing the cisplatin interstrand cross-link have been 
determined by NMR and rMD. 77 ' 78 In both models, the double-helix is bent and 
unwound but with significantly different angle values. Extensive unwinding caused 
by the ICL adduct produces a local left-handed helix geometry about the platinum 
atom resembling that of Z-DNA. In both cases, some of the forces which may be 
necessary for stabilizing unusual platinum-DNA structures have been observed: base 
stacking, unconventional hydrogen bonding, and electrostatic interactions. The X-ray 
crystal structure of a DNA duplex containing a cisplatin interstrand cross-link has 
been solved at 1.63 A resolution. 84 The double-helix is bent by 47° and unwound by 
700. The crystals are stabilized by intermolecular contacts involving two cytosines 
extruded from the double-helix, one of which makes a triplet with a terminal GC 
pair. The platinum residue is embedded into a cage of nine water molecules linked to 
the cross-linked guanines, to the two ammine groups, and to the phosphate backbone 
through other water molecules. The presence of the cage of water molecules around 
the lesion could interfere with the lability of the cross-link under physiological 
conditions, 85  and might be relevant for the mechanism of recognition of the ICL by 
proteins. 
Structural analogues of cis-DDP do not show a greatly altered spectrum of 
clinical efficacy in comparison to the parent drug. 86  With respect to DNA binding, 
they are also very similar. The alteration of the DNA binding mode in comparison to 
cis-DDP could possibly give alternative antitumour activity. On the basis of this 
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hypothesis, a new class of dinuclear platinum complexes has been developed. These 
compounds are of special interest because they show high activity in vitro and in vivo 
against tumour cell lines which are resistant to cis-DDP. 87 ' 88 The DNA-binding 
properties of dinuclear platinum complexes are affected by changing the diamine 
chain length and the coordination spheres. 89,90  Structures with dinuclear platinum 
compounds coordinated to dinucleotides have been reported, 9 ' and it has been shown 
that intrastrand chelation to neighbouring guanines is still possible. But with a self-
complementary octanucleotide, 92 it was found that only a 1 ,2-interstrand adduct 
formed. The dinuclear platinum-amine unit lies in the minor groove of the dumbell 
DNA. 
1.7 Recognition of Platinated DNA by Cellular Proteins. 
The specific mechanisms that trigger apoptosis in response to cisplatin have 
not been defined. Such mechanisms logically must include ways to detect damage as 
well as to determine whether damage is sufficiently severe to be lethal. Much 
attention has recently focused on identification and characterisation of proteins that 
recognise cisplatin induced DNA damage. 93  At least two such types of proteins have 
now been identified: mismatch repair proteins and high mobility group (HMG) 
proteins. 36 
Mismatch repair is a post-replication repair system that corrects unpaired or 
mispaired nucleotides. Mismatch repair deficiency predisposes cells to genomic 
instability and also confers tolerance to damage induced by certain alkylating agents 
in some model systems. 94,95  In one of these model systems, loss of mismatch repair 
was accompanied by loss of p53 function, which could disrupt cell cycle and 
apoptosis regulation and contribute to further genomic instability. 
96  One recent 
preliminary report shows that some cell lines with mismatch repair defects may also 
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be less proficient at nucleotide excision repair, which is the primary mechanism by 
which Pt-DNA adducts are repaired 
.97 
Mismatch repair proteins recognise but do not remove cisplatin-DNA adducts. 
It is hypothesised that mismatch repair proteins attempt to insert the 'correct' base on 
the non-damaged strand opposite to the adduct. Establishment of such a 'futile' repair 
cycle might then generate a signal triggering apoptosis. According to this hypothesis, 
loss of mismatch repair proteins confers resistance through failure to recognise and 
initiate apoptosis in the response to DNA damage. Resistant cells thus acquire the 
ability to tolerate damage that would otherwise be lethal. 
Figure 1.4 Structure of HMGI domain B as determined by 2D NMIR 
spectroscopy. 103,104  
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The HMG domain is a DNA-binding motif composed of approximately 80 
amino acids. It was first identified in the high mobility group protein 1 (HMG1), so 
named because of its rapid mobility on polyacrylamide electrophoresis gels. The 
HMG1 domain (box) is shared in most of the DNA-binding proteins. The HMG 
domain proteins are divided into two subfamilies based upon their ability to bind 
DNA in a structure-specific versus a sequence-specific manner. This includes the 
structure-specific HMGI and HMG2 proteins and the sequence-specific HMG-
domain proteins LEF-1 and hSRY. The HMG proteins are a multifunctional family 
of small non-histone chromatin-associated proteins, which recognise distorted DNA 
structure. 98101 These chromosomal proteins found in higher eukaryotes are believed 
to play a role in transcription, cell differentiation, and assembly of chromatin 
structure. 102  HMG1 is a 25-kDa protein with two FIMU domains (A and B) and an 
acidic tail. Both HMG1-A and B domains specifically recognise locally bent and 
unwound DNA, with similar binding affinities (Kd - lO- M). The solution structures 
for the two HMG1 domains show similar secondary structures which consist of three 
a-helices arranged in a distorted L-shape providing a concave surface for DNA 
binding, as shown in Fig. l.4.' ° " ° Other HMG family proteins include human 
structure specific recognition protein (SSRP-l) and the ribosomal RNA (rRNA) 
transcription factor hUBF. 
Lymphoid enhancer binding protein 1, LEF-1, contains one HMG domain. It 
contacts AT base pairs primarily in the minor groove; replacement of AT with IC 
base pairs, which are identical in the minor groove but differ in the major groove, has 
no effect on binding.' 05  LEF-1 activates transcription both by bending DNA, a 
property of its HMG domain, and by interacting with other proteins. 106 Another 
HMG-domain protein is hSRY, the sex determining factor in humans. HSRY binds 
to four-way junctions as well as to AACAAAG and related sequences. 107,108 Much 
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like LEF-1, SRY binds to DNA in the minor groove, bends it, and activates 
transcription. 
The HMG proteins bind to the most abundant DNA adducts of the anticancer 
drug cisplatin, especially the 1,2-d(GpG) and 1,2-d(ApG) intrastrand cross-links but 
not the 1,3-d(GpTpG) intrastrand cross-links or adducts made by trans-DDP or 
[Pt(dien)Cl]t The kinked, unwound, platinated DNA provides a basis for recognition 
and binding, but these processes are hindered if the formation of the platinum-
induced DNA lesion is accompanied by a local denaturation or an increased 
flexibility of the duplex around the adduct. 109 It is interesting to note that the DNA 
interstrand cross-links induced by cisplatin are efficiently bound to HIvIG1 protein or 
cleaved by T4 endonuclease VII, but that the same type of lesion made by transpiatin 
is not. 33'1 10,111  A recent study of HMG-1 binding to cisplatin GG adducts has shown 
that the DNA sequence around the platinated site is an important factor in 
determining the binding strength.' 12  DNA having AlT flanking G*G*  sequences is 
bound preferentially by both proteins. HMG-1A bound more tightly than HMG- lB to 
any of the platinated DNAs, with typically a 10- to 100-fold lower Kd values. SSRPI 
binds specifically to cisplatin-DNA intrastrand adducts. 113 A recently reported study 
showed that hUBF binds cisplatin d(GpG) intrastrand adduct with extraordinarily 
high binding affinity (Kd - 60 pM), which is likely due to additive contributions from 
multiple HMG domains participating in the binding. 114 
Not only do HMG-domain proteins recognise and bind pre-bent DNA, but 
they can further bend and distort the helix on binding.' 15 This study indicated that the 
role of the HMG1 may be one of structural distortion, bending DNA for nucleosome 
packaging, or for transcription mediation, facilitating binding of transcription factors 
to pre-bent DNA. The molecular basis for sequence-specific DNA recognition by the 
HMG domains of LEF-1 and SRY has been determined by NMR. 
116-118  The unwound 
and bent DNA duplex conformation in both of these complexes resembles very 
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closely the structure of DNA containing a cis-DDP d(GpG) intrastrand adduct. The 
sequence-specific interaction between DNA and the HMG box of LEF-1 or SRY 












Figure 1.5 The X-ray structure of the complex between the non-sequence-specific 
domain A of HMG and cisplatin-modified DNA." 9 The protein backbone is shown in 
yellow, the intercalating Phe37 residue as van der Waals spheres, and the DNA in red 
and blue with the cis-[Pt(NH 3)2 { d(GpG)-N7(Gs)-N7(G9) }] intrastrand adduct in 
green. Numbers indicate the first (N terminus) and last (C terminus) ordered residues 
of the protein in the crystal structure. 
An X-ray crystal structure of HMG I domain A bound to a 16-base pair DNA 
fragment containing the major cisplatin-DNA I ,2-d(GpG) intrastrand cross-link was 
solved to 2.5 A resolution The HMG-1A protein binds to the widened 
minor groove of DNA duplex with its concave surface. The DNA is strongly kinked 
at a hydrophobic notch created at the Pt-DNA crosslink and protein binding extends 
exclusively to the 3' side of the platinated strand, covers five basepair steps. Residue 
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Phe37 is intercalated into this hydrophobic crevice and stacked onto the platinated 
G9 base at a distance of 3.5 A. Binding of the domain is dramatically reduced in a 
mutant in which alanine is substituted for phenylalanine at this position. The binding 
site observed in this crystal structure differs from that in the structures of sequence-
specific HMG domains, which bind to the bend locus near the centre of the protein-
binding site.' 7h18  A further examination of sequence alignments reveals nearly all 
chromatin-associated HMG-domain proteins (structure-specific) have a hydrophobic 
residue at position 37 that can serve as a bending wedge, while those sequence-
specific HMG domains found in transcription factors have a polar residue at the same 
position which would allow sequence-specific hydrogen-bond formation. 
There are several ways in which the binding of HMG proteins to cisplatin-
DNA adducts might affect the biological activity of cisplatin.' 20" 21 One of the 
hypotheses is that the HMG-domain proteins may block the cisplatin-DNA adducts 
from recognition by the repair apparatus, thereby enhancing the cytotoxic properties 
of the drug. The blocking of excision-repair of cisplatin-DNA adducts has been 
observed both in human cell extracts and in yeast cells. By repairing the damage on 
DNA caused by cisplatin binding, the cell might increase the probability of its 
survival. The second possibility is that the HMG-domain proteins may themselves be 
part of the excision repair apparatus of the cell, by recognising the damage created by 
the cisplatin adducts. The third possibility is that the cisplatin titrates or "hijacks" the 
protein away from its natural binding sites. Assuming that the hijacked protein is in 
some manner vital to the tumour cell, its diversion could sensitise the cells to 
cisplatin.' 22 
One critical regulator of apoptosis is the tumour suppressor protein p53.' 23 It 
plays a central role in the regulation of cellular growth and is a potent transcription 
factor activated in response to a variety of DNA damaging agents including 
irradiation or anticancer drugs, leading to cell cycle arrest at the GUS phase 
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checkpoint or to induction of apoptosis) 24 Disruption of this pathway occurs in a 
wide variety of human cancers and correlates with the development of the 
tumorogenic mutants that are defective in DNA binding and consequently cannot 
activate transcription. Sequence-specific DNA binding and transactivation are the 
key activities that control the biological function of p53. One crystallographic 
structure of a p53 DNA binding domain binding to target DNA has been reported. 125 
Wild-type p53 binds to DNA as a tetramer on the outside of the DNA loop, and 
causes DNA bending - and twisting. 126  Recent experiments provide evidence that 
inactivation of the p53 DNA binding domain GSEs (genetic suppressor elements) can 
confer resistance to cisplatin. 127 
There are about 200 to 300 human genes transcriptionally activated by p53. 
The effects of p53 are complex and difficult to study in isolation. Much more work 
needs to be done in order to clarify the precise role of p53 as a determinant of 
cisplatin sensitivity. 
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2.1 NMR Spectroscopy 
2.1.1 195 Pt and 15N NMR Spectroscopy 
A) 195  Pt NMR1'2'3 	195  Pt is a reasonably sensitive nucleus for NMR detection, with 
natural abundance of 33.8%, nuclear spin quantum number I = ½, and a receptivity 
relative to 1 H of 3.4 x 10-3  . The limit of detection (ca. 10 mm) precludes detection of 
natural abundance 1 95p signals in physiological fluids. The receptivity can be 
improved by a factor of three by isotopic enrichment of 195Pt (> 95%). The spin-
lattice relaxation time (T1 ) for 195  Pt is usually in the range of 0.3 to 1.3 s. 
The 195Pt chemical shift range is very large, about 15,000 ppm (usually in the 
range from -600 to 9000 ppm relative to [PtC16] 2 ), and often allows easy 
differentiation between Pt(111) and Pt(IV), which tend to have chemical shifts at the 
high-field and low-field ends of the range, respectively. The 195Pt chemical shift in 
monomeric complexes is sensitive primarily to the set of bound donor atoms, see 
Table 2.1. Some caution is required in searching for peaks, because the shifts of 
Pt(IV) halides alone span 12000 ppm. Also, usually there are 195Pt chemical shift 
differences between geometrical isomers and between diastereomers (chiral ligands). 
For ' 5N-enriched ligands, the splitting pattern in the 195Pt spectrum indicates the 
number of non-equivalent ' 5N atoms coordinated. These characteristics of the 195Pt 
chemical shift can be utilized in the detection of different intermediates formed 
during the reactions of platinum complexes with biomolecules. Sometimes even 
isotopomers are distinguishable: the 195Pt isotope shift difference for 195Pt-35137C1 is 
0.17 ppm and for ' 95Pt-79"8 'Br is 0.03 ppm.4 Therefore in principle it is possible to 
count the number of Cl and Br ligands bonded to Pt via the isotope splitting pattern. 
In practice it is difficult to resolve because of line broadening, which is usually due to 
either relaxation mechanisms or poor temperature control of the sample. The latter is 
a problem because of strong temperature dependence of 195Pt NMR resonances (0.5 
to 1.1 ppmK'). 
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Table 2.1 "'Pt NMR chemical shifts of cis-Pt adducts with different donor atoms. 
Cis-Pt Complexes 	 8(195 Pt) range (PPM)  a 	 Ref. 
cis-[PtC]2(NH3)2] 	 -2149 	 5 
cis-[Pt(NH3)2(0)2] 	 -1460 to -1598 	 6,7 
cis-[PtC1(NH3)2(0)] 	 -1806 to -1841 	 6 
cis-[Pt(NH3)2(N)(0)] 	 -2067 to -2147 	 7 
cis-[PtC1(NH3)2(N)] 	 -2297 to -2369 	 5, 8, 	9 
cis-[Pt(NH3)2(N)2] 	 -2434 to -2660 	 5, 6, 7 
cis-[Pt(NH3)2(S)(0)] 	 -2618 to -2800 	 10,11 
cis-[Pt(NH3)2(S)(N)] 	 -2800 to -3218 	 10,11 
cis-[Pt(NH3)2(S)2] 	 -3200 to -3685 	 10,11 
a Relative to Na2PtC15. 
The quadrupolar effects of natural abundance ' 4N (i.e. 99.6% ' 4N, I = 1) from 
ammines which coordinate to Pt can broaden the 195  Pt resonances. Such quadrupolar 
effects ofN have the beneficial effects of shortening the 195Pt relaxation times and 
allowing rapid pulsing without saturation effects. 195Pt- 14N couplings in 195Pt NMR 
spectra are usually better resolved at higher temperature, because of the decreased 
quadrupolar relaxation rate of ' 4N due to the decrease in correlation time. Even in the 
absence of ' 4N ligands, 195  Pt resonances can still be very broad owing to chemical 
shift anisotropy (CSA) relaxation, which can be the dominant relaxation mechanism 
for platinum complexes at high magnetic field strength. Similarly, 195Pt satellites in 
' 5N and 'H spectra of Pt(H) complexes are often broadened beyond detection owing 
to CSA relaxation of ' 95Pt.' 2 The linewidths of 195Pt satellites of 'H NMR resonances 
are dependent on the spin-lattice relaxation time of 195Pt: 
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Av112(H) = [11T2*(H)]A + [2mTj(Pt)] - ' 
where [7ET2 t(H)] - ' is the natural linewidth plus the contribution from magnetic 
inhomogeneity broadening (measurable from the linewidth of the centre peak). The 
contribution to 195Pt T1 relaxation from CSA is given by: 
[T1 (Pt)f 1 (CSA) = (6/7)x[T2(Pt)] - ' (CSA) = (2/1 5)Xyp t2xBo 2xA&x'r c 
In general, 195Pt satellites (and 195  Pt resonances) are sharper in Pt(W) complexes 
which are six coordinate and hence more symmetrical (smaller anisotropy A) and 
are broader at higher fields of measurement (B 0) and in larger molecules (longer 
correlation time ;). 
B) 15N NMR 
' 4N NMR spectroscopy can be useful for ammine and amine complexes, but 
' 4N is a quadrupolar nucleus, and quadrupolar relaxation is dominant when the 
environment of ' 4N has a low symmetry. This can lead to very broad lines and a 
consequent reduction in sensitivity. On the other hand, short relaxation times also 
have the advantage of allowing rapid pulsing so that a large number of transients can 
be acquired. Thus it is possible to follow reactions of cisplatin in blood plasma and 
cell culture media at millimolar drug concentrations and to detect ammine release. 13 
By using 15N-substituted ammine complexes, the broadening of 195Pt signals 
caused by the quadrupolar effects of ' 4N can be avoided. Both ' 5N NMR chemical 
shifts and 1 J( 195Pt 5N) coupling constants are sensitive to the nature of the trans 
ligand in Pt ammine and amine complexes, which can provide useful information for 
identifying the ligands in the coordination spheres of both Pt(111) and Pt(IV) 
complexes. Typical ' 5N and 1 H shift ranges for Pt 11-NH, Pt"-NH, and Pt"-NH, and 
'J(' 95Pt-' 5N) values are shown in Figure 2.1 and Figure 2.2, respectively. In genera], 
ligands with high trans influences give rise to smaller ' 95 Pt-' 5N coupling constants (S 
cf c Br c Cl cH2O) and cause a low-field shift of the 15N resonance. The dominant 
BC 
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Figure 2.1 Variation of 1 H and ' 5N NMR chemical shifts with the trans ligand in 
Pt"-NH, Pt"-NH 2 and Pt"-NH3 complexes.' 42° The ' 5N chemical shifts of NH2-Pt and 
NH-Pt are mainly based on ring-closed {Pt(en)} 2 and {Pt(dien)} 2 complexes. 
contribution to one-bond coupling constants between 195  Pt and 15N is 	usually 
interpreted in terms of the Fermi contact interaction involving Pt 6s and N 2s 
orbitals. 21 The usefulness of 'J('95Pt-'5N) values is limited by the difficulty in 
determining them for larger molecules especially at high observation frequencies on 
account of the dominance of relaxation via chemical shift anisotropy. The 'J('95Pt-
15N) values for Pt(1V) are smaller by a factor of about 1.5 (in theory based on the 
change in hybridization from dsp 2 to d2sp) to 1.2 (in practice) and are 1.4 
(y' 5N/y14N) larger than 'J('95Pt-14N) values. 
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Figure 2.2 Plot of 'J(' 95Pt-' 5N) versus 3( 15N) for Pt-NH 3 , Pt-NH2 and Pt-NH, 
showing a similar dependence on the trans ligand. Data are taken from literature. 
2259-62 
The low receptivity of ' 5N (3.85x10 6 relative to 'H) limits to some extent its 
usefulness for directly-detected 15N NMR studies of Pt amrnine and amine 
complexes. However, the sensitivity of detection can be improved by ' 5N isotopic 
enrichment combined with enhancement by polarization transfer from 1 H (e.g. ' 5N- 
'H} DEPT and INEPT pulse sequences). The maximum enhancement in 15N signal 
intensity achievable via polarization transfer is only 9.8 (yHIyN), which means that 
42 
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inverse ('H-detected) 15N methods are usually preferred due to the superior 
enhancement for ' 5N-detection (vide infra). The repetition time of the pulse sequence 
is governed by the 1 H rather than the longer 15N spin-lattice relaxation time (T,), 
which is an additional advantage because it allows more rapid pulsing. For example, 
' 5N-{ 'HJ DEPT sequences enable detection of rapidly-changing intermediates in the 
reaction of 15N-cisplatin with glutathione, 23 and also ammine release following 
reaction of 15N-cisplatin with intracellular components in intact red blood cells at 
concentrations as low as 1 mM. 2' Direct 15  N-('HI DEPT/INEPT methods can be of 
value in situations where 1 14 NMR resonances are very broad. 
C) Inverse Detection Methods 
The sensitivity of ' 5N can be greatly improved by the use of inverse detection 
methods ('H-detected 15N) , by a theoretical maximum of 306 {( I yH I I I yN I )5/2} 
with respect to directly detected 15N, such that signals can be detected in aqueous 
solutions at concentrations of physiological relevance (5 jiM), Figure 2.3. 'H-
detected inverse methods are applicable to any system which contains a ' 5N atom 
with a measurable spin-spin coupling to 'H (i.e. 'J(' 5N, 'H) in ammine, primary and 
secondary amines, but not tertiary amines although a longer range coupling can 
sometimes be utilised). In practice the best applications are for those systems with 
large one-bond couplings (e.g. Ca. 73 Hz for 15NH3). Besides the high sensitivity, 
inverse detection also brings a simplification of complicated spectra because it 
detects only those protons directly attached to the labelled ' 5N atoms in the sample. 
This is very important for investigations of 'H NMR spectra of body fluids or cell 
culture media which consist of thousands of overlapping resonances. 
Although 'H NMR resonances can be detected from NH protons with ' 4N 
present in natural abundance (99.6%), they are often broad because of the 
43 
Chapter 2 Experimental Methods 
quadrupolar relaxation of ' 4N (I = 1). It is also necessary to work in H20 (as opposed 
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Figure 2.3 The theoretical increase in receptivity (abundance x sensitivity) 
obtainable by isotope enrichment and inverse 'H detection of 13 C, ' 5N and "'Pt. In 
practice inverse 'H-{ ' 95Pt} detection is limited by the broad linewidths of the 195Pt 
satellites. 
exchange with deuterium within minutes. The exchange of NH protons with solvent 
is much faster for Pt(W) than for Pt(H) complexes at neutral pH, since, for example, 
NH3 ligands on Pt(IV) have lower pKa  values. Introduction of 15N by synthetic 
labelling usually gives rise to a sharp 'H NMR doublet for a Pt- 15NH group in H20 
together with (CSA-broadened) 195Pt satellites. The resonances move progressively to 
lower field on changing from Pt-NH3 to Pt-NH2 and to Pt-NH, see Figure 2.1. Both 
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' 5N and 'H NMR resonances for Pt(IV)- 15NH are to lower field than those for Pt(ll). 
Pt(IV) anticancer complexes can be studied by the 'H-{' 5N} NMR if NH exchange is 
slowed down by lowering the pH or by other means. 
2.1.2 Heteronuclear Multiple (single)-quantum Correlation 
In biological NMR, the heteronuclear experiments of interest are those which 
identify the chemical shifts of protons and X-nuclei that are directly coupled. One 
obvious use of this correction information is to allow assignments already made for 
one nuclear species to be transferred to the other. A more important but less obvious 
use is in overcoming problems caused by overlap in the proton spectrum: in the 
heteronuclear 2D spectrum the proton resonances are spread out according to the 
shifts of the heteronuclei to which they are coupled. 
The heteronuclear multiple-quantum (and single quantum) coherence (HMQC 
and HSQC) technique belongs to the family of indirect (or inverse) detection 
techniques. An important feature of the experiment is that the proton magnetisation 
which is detected during t2 originated as proton magnetisation at the start of the 
sequence. The main advantage of this technique is the enhanced sensitivity, a 
theoretical maximum of [IyHu/'yxI] 512 (306 for ' 5N) with respect to direct detection, and 
relatively short repetition time according to the T, of the protons and not of the X-
nuclei. 24 Therefore it is possible to detect species at concentrations of physiological 
relevance (mlvi or even jiM) in D20 or aqueous solution (90% 1120/10% D20) where 
labile NH protons can be observed. By means of selective labelling ' 5N, this 
technique can also simplify a complicated spectrum in which only those protons 
directly attached to ' 5N atoms are detected. The basic HIvIQC and HSQC pulse 
sequences are shown in Scheme 2.1. 
The Pt- 15NH protons can be detected selectively by the use of ['H, ' 5N] single 
(or multiple) quantum coherence (HSQC and HMQC) pulse sequences. A ID 'H 
45 
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spectrum containing only resonances from Pt- 15NH species is obtained by acquiring 
only the first increment in a two-dimensional experiment; resonances for CH and OH 
(including water) are eliminated. This is particularly useful in studies of body fluids 
x 	 Il tj 	I 	I IIGARP(dec.) 
it/2 	 it 
 
1H 	 I 
itI2 
X 	 I I 	ti 	I I 	I GARP(dec.) 
Scheme 2.1 Basic HSQC (a) and HMQC (b) pulse sequences. The delays A and 'r are 
'/&T and '/iJ respectively, where J is the one-bond FIX coupling constant. Other 
modifications are usually needed to improve the suppression and to detect resonances 
close to the water signal including presaturation (+SCUBA) and WATERGATE 
(WATER suppression by GrAdient-Tailored Excitation). 
or cell culture media, where only the signals from platinum complexes are detected 
and thousands of other overlapping 'H resonances are filtered out. If ' 5N decoupling 
is employed during acquisition (e.g. the GARP method), then each type of Pt-NH 
resonance appears as a singlet, sometimes together with broadened 1 95p satellites. In 
practice the water resonance is so intense that it is usually necessary to use additional 
solvent suppression techniques (e.g. presaturation). The addition of an H20 T2 
acq. 
I 
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relaxation agent (e.g. 0.5 M (NH4)2SO4) can also be helpful to detect NH peaks very 





2J(1 H, 195Pt) 
Figure 2.4 General appearance of a 2D ['H, ' 5N] HMQC or HSQC spectrum. The 
195Pt satellites are usually more intense for symmetrical Pt species (Pt(IV) rather than 
Pt(ll)). 
use of pulsed field gradients for coherence selection, for example, by use of the 
HSQC sequences of Stonehouse et al. 25 We have been able to detect NH peaks 
within a few Hz of the water resonance at concentrations as low as about 10 PM 
without the need for additional solvent suppression techniques. 
The combined detection of 'H and ' 5N in a 2D inverse NMR experiment is 
especially powerful, since both the ' 5N NMR chemical shift (Figure 2.1) and the one-
bond coupling constant 1 J('H-' 5N) (Figure 2.2) are diagnostic of the trans ligand. As 
shown in Figure 2.4, the 195Pt satellites (when not broadened beyond detection by the 
effects of CSA relaxation) in a 2D ['H, 15N] spectrum appear as diagonal peaks 
which correspond to the 2J('95Pt-'H) coupling constant in the F2('H) dimension and 
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to the 1 J(' 95Pt-' 5N) coupling in the F1( 15N) dimension. Pt(H) and Pt(IV) ammine and 
amine complexes can be distinguished by the combination of 'H and 15N chemical 
shifts. 
2.1.3 2D DQF-COSY and NOESY Spectrum 
COSY (correlated spectroscopy) is a two-dimensional homonuclear (H, H)-
correlated NMR experiment which yields NMR spectra in which 'H chemical shifts 
along both frequency axes are correlated with each other. 21,21  It is the standard 2D 
experiment that can be used to identify pairs of protons that have a scalar spin-spin 
coupling connectivities. There are two inherent drawbacks that limit its usefulness 
with macromolecules: one is that the fine-structure components that make up each 
cross-peak appear in antiphase; the other is that the diagonal peaks and the cross-
peaks are 900  out of phase in both dimensions. These gives poor sensitivity and 
extremely harsh weighting functions must be used to give spectra with usable 
lineshapes which in turn gives a further reduction in sensitivity. 
More favourable lineshapes can be obtained by using the double-quantum 
filtered COSY sequence (DQF-COSY), 28 shown in Scheme 2.2a. In this experiment 
the diagonal peaks and the cross-peaks all show the same antiphase absorption mode 
fine-structure. Although the double-quantum filtering attenuates the signals to some 
extent this is more than offset by the gain resulting from not having to use resolution 
enhancement to impose acceptable lineshapes on the peaks, this experiment still 
suffers from poor sensitivity. 
The NOESY experiment 29,30  is often used to identify pairs of protons that are 
undergoing cross-relaxation, i.e. protons that would show an NOE in 1D 
experiments. The characteristic feature of the NOESY pulse sequence (shown in 
Scheme 2.2b) is the mixing time 'r. The cross-peaks are generated by magnetisation 
transfer that takes place during the mixing time so the length of this delay must be 
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chosen according to the rate of the transfer process. In contrast to the COSY 
experiment, both cross-peaks and diagonal peaks in NOESY spectra can be obtained 
with absorption-mode lineshapes. The experiments are therefore eminently suitable 
for studying macromolecules. if presaturation is used in a NOESY experiment it is 
usually also necessary to irradiate the solvent during the mixing time. A complicated 
factor is that the NOESY pulse sequence cannot distinguish between magnetisation 
transfer caused by cross-relaxation and magnetisation transfer by chemical exchange. 
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Scheme 2.2 Pulse sequence for two-dimensional (a) COSY; (b) DQF-COSY and (c) 
NOESY, 'tin is the mixing time. 
2.1.4 Dynamic NMR Spectroscopy 
Dynamic NMR spectroscopy is very useful in studying reactions with rate 
constants in the range 101  to 103 51, which is too slow for optical spectroscopic 
methods but too fast for investigation by classical methods. From the temperature 
10 
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dependence of the resonance lines, the rate constants and activation parameters can 
be obtained . 3 ' A complete line-shape analysis can allow determination of the precise 
rate constants of the exchange process, but in studying an exchange process it is often 
not necessary to go through a complete line-shape analysis to obtain the information 
needed. 
If the coalescence temperature T at which the two signals just coalesce was 
detected, the rate constant k is given by: 
lc = 2.22 LW 
Here Ày is the separation in Hz between the two signals in the absence of exchange. 
It is determined experimentally from spectra recorded at temperatures which are as 
far below the coalescence temperature as possible. This equation is only valid 
provided that: 1) the dynamic process occuring is first-order kinetically, 2) the two 
singlets have equal intensities, 3) the exchanging nuclei are not coupled to each 
other. An important fact of kc is that it is determined by the magnitude of LW, which 
is in turn proportional to the resonance frequency. Thus Tc is not a constant, but 
depends on the observing frequency. 
From the Eyring equation, the free enthalpy of activation AGC+ at T can be 
determined: 
AG+ = 19.14 T (10.32 + log fi)  j mol' 
The NOESY pulse sequence used to investigate dynamic processes such as 
chemical exchange is called 2D EXSY NMR spectroscopy. 32,33  The two experiments 
are both formally and practically identical. This technique has several advantages 
over conventional ID techniques (e.g. saturation transfer, selective excitation and 
lineshape analysis etc.). The first is the ability to study exchange networks involving 
n sites, thus all the dynamic data can be determined by a single 2D EXSY 
experiment. The second advantage is the ability to study partially overlapped spectra, 
where ID selective excitation (saturation transfer) experiment is not possible. Finally 
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a 2D spectrum becomes clear (for multi-site exchange) if the dynamic processes are 
monitored as a function of mixing time (Tm). 
For quantitative analysis, a 2D EXSY spectrum can be treated according to 
the Bloch-McConnell equations: 
M = M°exp(Rt) 	(Eq. 2.1) 
where M is the matrix comprising the peak volumes of the 2D spectrum, R is a 
matrix of dimensions equal to the number of sites between which exchange is 
occurring, containing all the exchange rate constants and spin-lattice relaxation rates, 
and tm is the mixing time. The integral intensity I ij of the 2D absorption peak at w1, w, 
is given by: 
I,j(t,n) = M°exp(-Rt,,)jj 	(Eq. 2.2) 
For the simplest case of first-order two-site exchange with equal populations (MA = 
MB = M, k+ 1 = k1 = k) and equal relation rates (RA = RB = R), then: 
Diagonal peaks: 	'AA = 'BB = /2[ H  + exp(-2ktm)]exp(-tmR)j 	(Eq. 2.3) 
Cross-peaks: 	'AB = 'BA = /21 P  - exp(-2ktm)]exp(-tmR)} 	(Eq. 2.4) 
In this simple two-site exchange system, the exchange rate can be determined from 
the initial rate of build-up of cross-peak intensity at short mixing times 
(8Ip 5I8tm)j = M°k 	(Eq. 2.5) 
or directly from the ratio of the cross and diagonal peak intensities at short mixing 
times: 
hA 1 +. exp(-2kt) - (1— kt.) 
(Eq. 2.6) 
JAB - 1 - exp(-2kt,) - kt 
Equation (2.6) can also be extended to N-site exchange, and a dynamic matrix is 
needed to extract the dynamic data. 34,35 
2.1.5 The Process of Generating an NMR Structure. 36 
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Four stages are necessary to generate an NMR-based structure for a double-
helical nucleic acid fragment. These stages are intricately overlapped with each other. 
The first phase includes the generation of proton homonuclear 2D NMR spectra 
sufficient to provide spectral assignments for as many of the exchangeable and non-
exchangeable protons as possible. In most cases, it includes several 2D NOESY 
spectra with different mixing times in H20 and D20, DQF-COSY and TOCSY 
experiments. 
The second stage of the process is to extract accurate intensities of 2D NOE 
cross-peaks and convert them into distances via computational tools using iterative 
Complete Relaxation Matrix Analysis, which can simulate spin-diffusion effects. 
The programme MARDIGRAS 37 was used in my work. It is important here to 
determine realistic error bounds consistent with the quality of the experimental data. 
Deoxyribose coupling constants can be extracted from DQF-COSY directly or 
indirectly and subsequently utilised to generate torsion angles to define the sugar 
pucker. By comparing the computer simulated and the experimental fine-structure of 
cross-peaks in 2D DQF-COSY spectra, individual J-couplings can be deduced and 
subsequently the conformation analysis of sugar pucker (C2 or C3'-endo) can be 
carried out. The computer programmes used to do this are called SPHINX and 
LINSHA. 38 SPHINX generates a data file from the simulation, and LINSHA 
calculates the shape of the peaks resulting from SPHINX. It takes into account line-
widths, digital resolution in both dimensions and other acquisition and processing 
parameters. 
In the next stage, the NMR-derived restraint information is used to search 
conformational space for a single structure that is most compatible with all restraints. 
Various computing tools are available for determining the nucleic acid structures 
from NMR constraints. In this work, the restrained Molecular Dynamics (rMD) 
approach was used. Molecular motion is simulated starting from an initial model 
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structure (both A- and B-form DNA). The search for the final structure is guided 
through minimisation of a composite energy function that comprises the empirical 
force-field parameters to maintain proper stereochemistry and a penalty term for 
noncompliance with the NMR-derived restraints. Fine tuning parameters of the rMD 
is needed for the convergence of final structures calculated from different starting 
models such as A- and B-forms of DNA. Sometimes a theoretical 2D NOESY 
spectrum calculated from the final structure is needed to compare with the 
experimental data. 
A detailed structural analysis constitutes the final stage of the refinement 
process. For this the programme CURVES 39 was used. It is important to understand 
that typical rMD structures depend on both the restraints and the force field, which 
means that some structural features are sensitive to the balance of those two major 
features. Analysis and validation of NMR-based rMD structures and their properties 
should be rigorously in accord with all experimental data. 
2.2 High Performance Liquid Chromatography (HPLC) 40 
HPLC is one of the fastest developing analytical techniques. It has arisen 
from the theories of liquid chromatography (LC) and instrumentation that were 
originally developed for gas chromatography(GC). The mixture to be analysed is 
dissolved in a suitable solvent, introduced ("injected") at one end of the column, and 
carried through the column by a continuous flow of the same solvent ("mobile 
phase"). The separation takes place in the column, which contains "sorptive" 
particles of large surface area. These particles are referred to as the "stationary 
phase". Injected sample components interact reversibly with the stationary phase in a 
continuous manner. If a component of the mixture (a solute) is absorbed weakly onto 
the surface of the solid stationary phase it will travel down the column faster than 
another solute that is more strongly absorbed. The mobile phase (also called the 
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eluant) is pumped through the column bed of the tightly packed chromatographic 
particles using a solvent delivery system ("pump"). With the selection of the proper 
mobile phase and column packing material, a separation of different components can 
be achieved. As the sample components emerge from the column, a suitable detector 
is used to monitor and transmit a signal to a recording device. The chromatogram is a 
record of the detector response as a function of time and indicates the presence of the 
components as "peaks". 
Besides the classical liquid-solid chromatography mentioned above, there are 
other sorption mechanisms that can be used for separation, depending on whether a 
liquid or a solid is chosen as the stationary phase, or the kind of solid used. Liquid-
Liquid chromatography uses a liquid stationary phase coated on to a finely divided 
inert solid support. Separation is due to differences in the partition coefficients of 
solutes between the stationary liquid and the liquid mobile phase. In normal phase 
LC, the stationary phase is polar while the mobile phase is composed of nonpolar 
solvents. The situation is opposite for reverse-phase LC, in which the mobile phase is 
more polar than the stationary phase. Solutes are eluted according to polarity with 
both techniques. With reverse phase, most polar first and with normal phase least 
polar first, and the retention times of solutes can be changed by changing the polarity 
of the stationary phase or (more easily) the mobile phase. In ion-exchange 
chromatography, the stationary phase is an ion exchange resin, and separations are 
based on attractive ionic forces between solute ions and the exchange sites on the 
resin. Separations are made using a polar mobile phase, usually water containing salts 
or small amount of alcohol, and a stationary phase containing either acidic or basic 
fixed sites. And finally in size-exclusion chromatography, the separation depends on 
differences in size and shape, more precisely the hydrodynamic volume, of the 
molecules in a sample. The larger molecules do not enter the pores of the column 
particles and are excluded more quickly. 
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In analytical HPLC, the mobile phase is normally pumped through the 
column at a flow rate of 1-5 ml/min. If the composition of the mobile phase is 
constant, the method is called "isocratic" elution. The composition of the mobile 
phase can be a binary, ternary or quaternary solvent mixture. Alternatively, the 
composition of the mobile phase can be made to change in a predetermined way 
during the separation, a technique called "gradient" elution. Modem solvent delivery 
systems allow the selection of a wide range of gradient profiles and variation of the 
time over which the gradient is delivered. Besides the shape and time of the gradient, 
other factors including compatibility of the two solvents with the detector, and 
miscibility with the sample solution, have to be considered. 
Some of the important concepts defining the quality of a chromatographic 
separation are listed below. 
Capacity factor k', where 
1<'-
- amount of solute in the stationary phase - ( ti - to) - (VR - Vo) 
	
 amount of solute in the mobile 	phase - 	to 	- 	Vo 
tR and to are the retention time of solute retained on the column and unretained which 
travelling as the mobile phase. k' can also be simply described as the ratio of the 
elution volume of the component, VR, to the void volume of the column, V0. 
Selectivity of the column is the ability to discriminate between the two components. It 
is expressed in terms of a "separation factor" a: 
V2 tR2-tO 	(V2–Vo) 
a
- 	- 	-
k'i Mi - to (Vi – Vo) 
Efficiency of the column, which can be measured using quantities of plate number 
(N) and plate height (H): 
(tR '\ 	L 
N=161 — I,H= —  
\wj N 
tR is the retention time of the component, w is the peak width, L and N are the length 
and plate number of the column, and H is the plate height. 
The resolution of the separation can be defined as 
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where k is the average capacity factor for the two peaks, and Nis the average plate 
number. 
2.3. UV Absorption Spectroscopy ' 
The combination of purine and pyrimidine bases in nucleic acids results in 
strong ultraviolet absorption in the range of 240-280 run. It is modulated by the 
stereochemistry and conformational influences of the ribose-phosphate backbone 
which is essentially transparent to light of that wavelength. 
The absorbance at a wavelength X (A),) is a measure of the relative intensity of 
a beam of light before (Ix°)  and after ('h)  it passes through a solution containing the 
absorbing molecule: A = log(Ix°/I),) = cxci, where c is the concentration (M), I is the 
pathlength of the cell (cm), and Ex is the extinction coefficient (cm -I
M -1
) 
Oligonucleotides exhibit a strong UV absorption maximum, %m, at about 260 nm 
and a molar extinction coefficient, e, of the order of io (M'cm'). The absorption 
arises almost entirely from it-its electronic transitions in the purine and pyrimidine 
components. The intensity and exact position of the Xm is a function of both the 
base composition of the nucleic acid and the state of the base-pairing interactions 
present, the salt concentration of the solution, and its pH. Most importantly, base-
base stacking results in decrease in e known as hypochromicity. This arises from 
dipole-dipole interactions that depend on the three-dimensional structure of an 
oligonucleotide and ranges in magnitude from 1-11% for deoxyribonucleoside 
phosphates to 30% for most helical polynucleotides. 
UV absorption is a sensitive and convenient way to monitor the 'melting 
behaviour' of DNA and RNA. The method depends on the difference in extinction 
coefficient between double stranded and single stranded DNA. When the UV 
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absorption of a nucleic acid sample is measured as a function of temperature, the 
resulting plot is known as a melting curve. The midpoint of the increase in 
absorbance with increasing temperature is known as the melting temperature, Tm. 
This is dependent on the base-composition of the sample, the salt concentration of its 
solution, and even the types of counter-ion present. The melting temperature is 
reduced at lower salt concentration because cations can stabilise the DNA duplex. 
Divalent cations such as Mg2 are much more effect in stabilising duplexes. 4 ' Such 
melting is a co-operative phenomenon and the observed melting curves become 
progressively steeper with increasing length of the oligonucleotides. 
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3.1 Abstract 
The reaction between [Pt(' 5N-dien)Cl] (1) and L-methionine (L-MetH, H3N-
CH(CH2CH2SCH3)-000) has been studied using [ 1 H, 15N1 2D NMR spectroscopy 
and HPLC, together with ' 5N-labelled amine ligands. The complex [Pt(dien)(L-
MetH-S)] 2  (2) was dominant at neutral pH and converted partially and reversibly to 
[Pt(dien)(L-Met-N)1 +  (3) at pH > 8. When the pH was lowered from 8 to 3, the then 
ring-opened intermediate [Pt(dienH-N,N')(L-Met-S,N)] 2 (4) was formed which 
converted slowly into complex (2). Complex (4) was separated by HPLC and 
characterized by NMR spectroscopy as a mixture of 4 diastereomers (due to chiral 
centres at S and NH) present in a 2:2:1:1 molar ratio. This isolated intermediate had a 
surprisingly long lifetime (days) in 0.55 M (NH4)H2PO4 (pH 4.0). 
3.2 Introduction 
Sulfur-containing biomolecules may react in vivo with platinum antitumor 
compounds. Possible such reactive biomolecules are cysteine, methionine, 
glutathione, and metallothionein and other proteins. These reactions could be 
responsible for inactivation, resistance and toxicity of platinum drugs. 1 
Methionine (L-MetH) is an important amino acid which is involved in the 
metabolism of platinum drugs, and platinum bis-methionine complexes have been 
identified as metabolites in the urine of patients undergoing cisplatin cis-
[Pt(NH3)2C12] therapy. 2 The complex [Pt(L-Met-S,N)2] exists in aqueous solution as a 
mixture of cis and trans-isomers which undergo slow interconversion, with the cis 
isomer predominating at equilibrium (K: 7.0), but these are unreactive species which 
can be considered to be a detoxified form of Pt. However, a recent in vivo experiment 
has demonstrated that cisplatin incubated with methionine has reduced 
nephrotoxicity while the cytotoxicity against cancer cells is maintained .4  Methionine 
and its derivatives can form stable ring-opened complexes with carboplatin and its 
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analogues. 5  Since carboplatin itself reacts with nucleobases very slowly, it is 
conceivable that a methionine-containing peptide or protein may play an important 
role in transport or activation of carboplatin and in the transfer of Pt onto DNA. 5-
bound methionine can be displaced by N7 of the DNA base guanine, 63  and L-
methionine can increase the rate of reaction of guanosine 5'-monophosphate with 
cisplatin at pH 78 
Methionine is able to coordinate to Pt(II) in a very versatile manner in aqueous 
solution. A simple system of L-methionine and K2 [PtC14] in molar ratio 2:1 generates 
over 10 platinum species. 9  Thioether sulfur, amino nitrogen and carboxylate oxygen' ° 
are all capable of binding to Pt(ll). The favored binding site is sulfur, and S,N-
chelation is a common binding mode. In methionine-containing peptides, 
coordination of the amide N is also possible." 12 
Hfl\ 




Platinum-dien chelate rings are considered to be both thermodynamically more 
stable and kinetically more inert compared with cisplatin, and reactions of 
[Pt(dien)CI]' are often studied as models of the first binding step of cisplatin.' 3"4 The 
binding of [Pt(dien)CI]' is capable of distorting DNA structure 15  and inducing local 
DNA denaturation. 16  It has been shown that [Pt(dien)Cl] binds to homocysteine or 
methionine through the thioether sulfur, 17  and S-bound thioethers can be displaced 
from Pt(H) intra- 7 ' 11 or inter-molecularly 6 by nitrogen (N7) from guanine at 
physiological pH. 18  Guanine is known to be a major target for DNA platination by 
anticancer drugs.' An intramolecular migration of {[Pt(dien)]} 2 from sulfur to 
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imidazole-N1 in the dipeptide histidylmethionine at pH > 6 has also been reported 
recently. 19 
In this work, I have sought to gain further insight into sulfur-nitrogen migration 
by 2D ['H,' 5N] HSQC NMR spectroscopic and HPLC studies of reactions of 
[Pt(dien)Cl] with L-methionine via the use of 15N-labelled then and L-MetH. 
3.3 Experimental 
Materials and Methods 
L-Methionine (L-MetH) and 15N-labelled L-MetH (99% ' 5N) were purchased from 
Sigma. ' 5N-labelled diethylenetriamine ( 15N-dien) and [Pt(15N-dien)Cl]Cl  were 
prepared according to the reported procedures. 20,21  All other chemicals were 
purchased from Aldrich. 
NMR spectroscopy 
NMR spectra were recorded at 298 K on Bruker DMX500 ( 1 H 500.13 MHz; 
15N 50.7 MHz), using 5-mm NMR tubes. The chemical shift references were as 
follows: 1 H, dioxane (internal, 3.743 ppm), ' 5N (external, 1 M 15NH4C1 in 1.5 M 
HQ. For 1 H NMR, typical acquisition conditions for ID spectra were as follows: 
45-600  pulses, 16-32 K data points, 2-3 s relaxation delay, collection of 32-128 
transients, final digital resolution of 0.2-1 Hz/pt. 2D [ 1 H, 15N] HSQC NMR spectra 
(optimized for 'AN,  H) = 72 Hz) were recorded using the sequence of Stonehouse et 
al .22  The 15N-spins were decoupled by irradiation with the GARP-1 sequence during 
acquisition. Water suppression was achieved by pulsed-field gradients. Typically, 8 
scans were acquired for each of 128 increments of tj and the final resolution was 4 
Hz/point for the F2 dimension and 8 Hz/point for the Fl dimension. For the HPLC 
separated sample, 256 acquisitions were used per t1 period and the final resolution 
was 2 Hz/point for the F2 dimension and 1 Hz/point for the Fl dimension. 
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HPLC 
The following equipment was used: Gilson 305 pumps, Gilson 806 manometric 
module, LKB 2141 variable wavelength monitor, and Rheodyne sample injector. 
Analytical separations were carried out at 298 K on a Nucleosil (100-5SA) cation-
exchange column by injecting aliquots of the reaction mixture at various pH and time 
intervals with detection at 210 nm. A solution of (NH4)H2PO4 solution (0.55 M, pH 
4.0) was used as eluent. The data were analyzed using Dynamax Method Manager 
Software. The HPLC separation was carried out with the help of Dr. P. del S. 
Murdoch. 
pH measurements 
The pH values of the solutions were adjusted with HC104 0  M) or NaOH (1 M) and 
determined using a Corning 240 pH meter equipped with an Aldrich micro 
combination electrode, calibrated with Aldrich buffer solutions at pH 4, 7 and 10. 
NMR sample preparation 
All the NMR samples (except that separated by HPLC) were in 90%H20/10%D20 
(0.6 ml), and contained 0.1 M NaC104 to maintain a constant ionic strength. Buffer 
was not used in order to avoid possible interference with the reactions. The reactions 
of [Pt( 15N-dien)Cl]Cl (5 mM) with L-MetH (' 5N or ' 4N) were conducted at a 1: 
molar ratio at constant temperature. 
3.4 Results 
First the substitution of the chloride ligand of [Pt(' 5N-dien)Cl] (1) by the S of L- 
MetH at pH 6 was studied. The effect on the product of increasing the pH to 8 was 
then investigated, followed by lowering the pH to 3. All of the reactions were studied 
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by both NMR and ITIPLC. For 2D ['H,' 5N] NMR, both ' 5N-labelled or unlabelled 
then and L-MetH were used, and some HPLC-separated fractions of ' 5N-labelled L-
MetH were examined by 2D ['H, 15N] NMR. As summarized recently, the ' 5N 
chemical shifts of Pt-NH of Pt- 15N-dien complexes are usually diagnostic of the trans 
ligands. 23 For an Pt-NH trans to an oxygen donor, the ' 5N chemical shift is ca -10 
ppm, for an Pt-NH trans to nitrogen or chloride, the ' 5N shift is ca 10 ppm, and trans 
to sulfur about 30 ppm. For Pt-NH2 of amine, the 15N chemical shifts are as follows: 
trans to 0, -40 to -50 ppm; trans to N, Cl, -25 to -35 ppm; trans to S, -5 to -15 ppm. 
In this study, the above information has been used to assign the ligands trans to the 
amine groups. 
1) NMR spectroscopy 
Reaction of [Pt(dien)Cl] with L-MetH at pH 6 followed by pH adjustment to 
8.5 
The reaction of 15N-labelled complex (1) (5 mM) with ' 5N-L-MetH in a 1:1 molar 
ratio at pH 6.0 and 298 K was followed by 2D ['H,' 5N] NMR for a period of 12 h. 
After 30 minutes of incubation, three new cross-peaks at 5.75, 5.581-30.29 ppm 
(peaks 2a and 2b, Fig 3.1) and 6.97/26.36 ppm (peak 2c, Fig 3.1) were present in the 
spectrum in addition to three cross-peaks of the starting complex (1). The new cross: 
peaks increased in intensity with time, while the cross-peaks for complex (1) 
decreased in intensity. After 10 h, only peaks 2a, 2b and 2c were observable. Fig. 3.1 
shows a 2D ['H, 15N] NMR spectrum recorded 12 h after incubation. Peaks 2a and 2b 
have ' 5N chemical shifts similar to those for Pt-NH2 of complex (1), in which two 
pairs of non-equivalent 1 H were observed, and can be assigned to the protons of the 
two trans Pt-NH2 groups. Peak 2c has a ' 5N-chemical shift in the region expected for 
Pt-NH trans to a sulfur. Therefore the cross-peaks 2a, 2b and 2c can be assigned to 
the S-bound L-MetH adduct [Pt(' 5N-dien)( 15N-L-MetH-S)] 2 (2). The 2D NMR 
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Figure 3.1. Formation of [Pt( 15N-dien)(' 5N-L-Met-S)j 2 (2) by reaction of [Pt(' 5N-
dien)Cl]' (1) (5 mM) with ' 5N-L-MetH in 1:1 molar ratio at 298 K, pH 6.0. The 2D 
['H, ' 5N] HSQC NMR spectrum was recorded after 12 h of reaction. The peaks 
labeled 2a and 2b are assigned to protons on each of the two NH 2 groups, and 2c to 
the NH group. 195Pt satellites are labeled with 'K• 
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Table 3.1 1 H and ' 5 N chemical shifts of {Pt(dien)} 2 and (Pt(dienH-NN) } 3  complexes. The spectra were recorded during the reaction 
of 15N-labelled complex (1) with ' 5N-labelled L-methionine at 298 K. 
Compound 	 pH 	 '5N-dien('H115N) 
a 	
15N-L-Met ('H115N) a 
NH (trans to) 	 NH2 (trans to) 	 (NH2 trans to N) 
[Pt( 15N-dien)ClI[ (1) 	 6.0 	6.69/7.68 (Cl) 	5.29, 5.081-34.20 (N) 
	
[Pt(' 5N-dien)( 5N-L-MetH-S)] 2+  (2) 6.0 	6.97/26.36 (S) 	5.75, 5.581-30.29 (N) 
[Pt( 15N-dien)(' 5N-L-Met-N)] (3) 	8.5 	6.46/6.76 (N) 	5.421-32.40 (N) 	 4.891-36.76 
5.02/-32.40 (N) 
5.25/-32.83 (N) 
[Pt( 5N-dienH-N,N )(' 5N-L-Met- 	3.3 
(b) (4) 
R, R- 6.71/-13.18 (N) 5.391-10.17; 5.741-10.17 (S) 5.001-46.01; 5.811-46.01 
d 
R, S- 6.591-12.48 (N) 5.331-9.32; 5.621-9.32 	(5) 4.941-46.37; 5.85/-46.37 
d 
S. R- 6.661-14.06 (N) 5.481-9.82; 5.781-9.82 (5) 5.181-46.59; 5.82146.59 
d 
S' S- 6.57/-12.80 (N) 5.59/-10.10 
C  (S) 5.111-46.77; 5.97/-46.77 d 
a Some cross-peaks are multiplets but no detailed analysis was attempted due to the resolution limitation of the 2D spectra (4 Hz per data 
point in 'H dimension). b  The assignment of peaks to individual diastereoisomers is arbitrary, and the pairing of the cross-peaks is based 
on the peak intensities. C  Overlapped. d  These cross-peaks are better resolved in the HPLC purified (4), as shown in Fig. 5, and the minor 
differences in 8('H) (ca 0.1 ppm) and 8(' 5N) (ca 0.3 ppm) compared to the values in Table 2 may be due to the different ionic strengths 
and pH values of the samples. 
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spectrum of the solution was recorded again after 7 d at 298 K, and peaks for 
complex (2) were unchanged. 
The pH of the above solution was raised from 6.0 to 8.5, and the time 
dependence of the resultant ['H, ' 5N1 2D NMR spectrum investigated for a period of 
24 h. The cross-peaks assigned to complex (2) gradually decreased in intensity, 
whilst five new cross-peaks appeared with 'H, 15N chemical shifts of 5.421-32.40 
(peak 3a in Figure 3.2A) 5.251-32.83 (3b), 5.021-32.40 (3a), 4.891-36.76 (3d) and 
6.46/6.76 (3c) ppm. Figure 3.2A shows the spectrum recorded 12 h after the pH 
adjustment, by which time equilibrium had been reached. Each peak contained fine 
structure which can be assigned to NHAHB and NH-CH2 coupling (7 to 11 Hz) but 
this was not further analyzed. Cross-peaks 3a, 3a and 3b have ' 5N chemical shifts in 
the region expected for Pt-NH2 groups trans to N or Cl, and peak 3c has a 
15  N 
chemical shift characteristic of Pt-NH trans to N or Cl. The new peaks have 'H, 15N 
chemical shifts different from complex (1), Table 3. 1, and Cl - can be ruled out as the 
ligand trans to Pt-NH. Peaks 3a and 3a have the same 15N-chemical shifts, and the 
relative areas of peaks 3a : 3b : 3a' are 1:2:1, therefore 3a and 3a can reasonably be 
assigned to two non-equivalent protons on one NH2 group of dien, and peak 3b to the 
other NH2 group with coincident 1 H shifts. 
Peak 3d also has a ' 5N chemical shift in the region of Pt-NH2 groups trans to 
N or Cl, and when the above reaction was repeated using complex (1) 
but unlabelled L-MetH, peak 3d disappeared (Figure 3.2B) showing that this arises 
from a coordinated NH2 group of L-Met. Therefore peaks 3a - 3c can be assigned to 
the Pt-NH2 and Pt-NH groups of a then ligand and the observed peaks are consistent 
with the formation of [Pt(' 5N-dien)(' 5N-L-Met-N)1 (3) at pH 8.5, Table 3.1. 
Curiously cross-peak 2c (Fig. 3. 1), assigned to Pt-NH group of the S-bound L-MetH 
complex (2), became broader with time and disappeared from the 2D spectrum 5 h 
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Figure 3.2 A 2D ['H, 15N] HSQC NMR spectrum recorded 12 h after increasing the pH of a solution containing complex (2) as [Pt(' 5N-
dien)(' 5 N-L-Met-S)] 2 (A) or [Pt(5N-dien)('4N-L-Met-S)]2  (B) from 6.0 to 8.5. Peak assignments: 2a and 2b, N14 2 (trans to N) of 
complex (2); 3a, 3b and 3a, NH2 (trans to N) and 3c, NH (trans to N) of [Pt( 15N-dien)(L-Met-P} (3); 3d, NH2 (trans to N) of NT 
bound 15N-L-Met in complex (3). The cross-peak for NH (trans to S) of complex (2) is not observed because of fast exchange with 
C 
solvent protons on NMR timescale at this pH. Cross-peaks (3a - 3d) exhibit further coupling in the 'H dimension. 
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Effect of pH decrease from 8.5 to 3.3 
The pH of the above solution containing an equilibrium mixture of complexes 
(2) and (3) (labelled with both 15N-dien and 15N-L-MetH) was lowered from 8.5 to 
3.3 and the time dependence of the 2D spectrum was followed for 24 h at 298 K. 
During the first hour, peak 2c reappeared (Pt-Nil of complex (2), slowing down of 
NH exchange rate at low pH) and new cross-peaks appeared in the 'HI 15N regions 
from 5.99 to 4.91146.01 to -46.77 ppm, 6.71 to 6.571-13.18 to -12.80 ppm, and 5.80 
to 5.321-10.22 to -9.32 ppm (boxes e, g, and h, respectively, in Figure 33A), and 
peaks for complexes (2) and (3) (2a, 2b, and 3a to 3d) were still observable, with the 
same 'H and ' 5N chemical shifts as at the higher pH (Fig. 3.2A). The cross-peaks in 
boxes e, g, and h each corresponded to a total of four different ' 5N chemical shifts 
(Table 3.1) with intensity ratio of ca 2:2:1:1. All these new cross-peaks decreased in 
intensity with time and eventually disappeared after 10 h, whereas the cross-peaks for 
complex (2) increased in intensity with time, whilst those for complex (3) decreased 
in intensity but were still just visible after 24 h. A cross-peak at 7.81/17.68 ppm, 
which has similar 'H and ' 5N chemical shifts to those of the NH3 group for free 15N-
L-MetH, was initially observed, but disappeared within 1 h after the pH adjustment. 
This reaction was reinvestigated using ' 5N-labelled complex (1) but 
unlabelled L-MetH. In this case, cross-peak 3d and those in box e of Fig. 33A were 
not observed, Figure 3.313. Therefore these cross-peaks must be due to the 
coordination of 15NH2 of L-methionine. 
No new 2D cross-peaks were observed when the pH of a solution containing 
complex (2) (' 5N-dien and ' 5N-labelled L-Met) was adjusted directly from 6 to 3, 





A 	i - B 
3d 
* * 3a3b3a't 	 * * 3a3b3a' 
0' m • C 
2ae0 2b 
to 0
* *\ 	 * 
0 0-p-I 	-------- I 
9 9 
Ii 	 ii 
3c 	 •3c 







7.0 	6.0 	5.0 	7.0 	6.0 	5.0 o( 1 H) 
Figure 3.3 The 2D ['H, ' 5N] HSQC NMR spectra recorded I h after lowering the pH of solutions containing complexes (2) and (3) (see 
Fig. 3.2) containing 15N-labelled L-Met (A) or unlabelled L-Met (B) from 8.5 to 3.3. The boxed cross-peaks are assignable to the dien-
ring-opened intermediate [Pt( 5N-dienH-N,NYL-Met-S,N)] 2  (4). Note the absence of the peaks in box e and peak 3d in Fig. 33B ( 14N-
L-MetH used). Peak assignments: 2a and 2b, NH 2 trans to N with 195Pt satellites (*) and 2c, NH trans to S of complex (2); 3a, 3b and 
3a', NH2 (trans to N) and 3c, NH (trans to N) of complex (3); 3d, NH 2 (trans to N) of N-bound 15N-L-Met in complex (3); boxes g and 
h can be tentatively assigned to Pt-NH (trans to N) and Pt-NH2 (trans to S) groups of then in ring-opened intermediate (4); box e, NH2 
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Figure 3.4 The HPLC chromatograms for the reaction of [Pt(dien)C1f (1) with L-
MetH (5 mM, 1:1, 298 K, pH 6.0, 24 h). (A) 12 h after pH adjustment from 6.0 to 
8.5; (B) 0.5 h after lowering pH from pH 8.5 to 3.3; (C) 2 h after pH adjustment from 
8.5 to 3.3; (D) 24 h after pH adjustment from 8.5 to 3.3. Peak assignments: a, 
[Pt(dien)(L-Met-S)] (2); b, [Pt(dien)(L-Met-A')f (3); c, then ring-opened 
intermediate [Pt(dienH-N,N(L-Met-S,N)1 2 (4); d and * are from free L-MetH and 
the solvent front respectively. 
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HPLC 
Reactions of unlabelled [Pt(dien)C]] (1) with ' 5N-L-MetH were also followed by 
HPLC at different pH values. Several eluents were tested and 0.55 M (NH4)H2PO4, 
pH 4.0 was found to provide the optimum separation of reactants and products 
present in the solutions and was used in all the HPLC work. 
The HPLC chromatogram from the reaction of complex (1) with 15N-L-MetH 
(5 mM, 1:1) pH 6.0, 298 K for 24 h, showed only one major peak with retention time 
of ca 12.0 mm. After the pH of the solution was raised to 8.5 and left for 12 h, the 
HPLC chromatogram showed a new broad peak with elution time of ca 20.0 min 
(peak b) as well as a strong peak with retention time of ca 12.0 mm (peak a, Figure 
3.4A). The pH of the solution was then lowered from 8.5 to 3.3 and the HPLC 
chromatogram was followed with time for a period of 24 h. Within the first hour, a 
new peak (c) with retention time of 8.2 min appeared and reached its maximum 
intensity (Fig. 3.413), and then decreased in intensity along with peak b (Fig. 3.4C). 
After 24 h peaks b and c had almost disappeared (Fig. 3.4D). 
The fraction corresponding to peak b (Fig. 3.4) from the reaction at pH 8.5 
was collected. When this was re-chromatographed after standing for 3 days at 298 K, 
the chromatogram showed only peaks c and a (3:1 ratio). This change can be 
explained by the decrease in the pH of the collected fraction to 4.0 (that of the 0.55 
M (NH4)H2PO4 eluent). Under these conditions peak c was very long-lived, and even 
detectable after several weeks. 
Characterization of intermediate detected during pH adjustment from 8.5 to 
3.3 
Attempts were made to separate the intermediate and characterize it further by NMR 
methods. Unlabelled complex (1) and 15N-L-MetH (10 mM, 1:1) were incubated for 
24 h at pH 6 to allow formation of complex (2). The pH of the solution was then 
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adjusted to 8.5, and after 12 It was lowered to 3.3. The fraction corresponding to the 
intermediate of peak c in the HPLC chromatogram of Fig. 3.4 was collected 30 mm 
after pH adjustment, and lyophilized. The lyophilized sample was re-dissolved in 0.6 
ml of 90%H20-10%D20, which gave rise to a solution of pH ca 4.0 because of the 
presence of (NH4)H2PO4. The resulting 2D ['H, ' 5N] HSQC NMR spectrum is shown 
in Fig. 3.5, and appears to contain 6 doublets (a', d', c, d, and b' overlapped with c'), 
and 2 triplets (a and b) corresponding to four ' 5N chemical shifts, Table 3.2. The 
splittings (13-14 Hz) can be assigned to 2J(NHa,NHb) and 3J((xCH,NH) couplings 
involving coordinated 15N-L-Met. The relative intensities of cross-peaks c:d and a:b 
is ca. 2:1. The chemical shifts and relative intensities of these cross-peaks in Fig. 3.5 
are nearly the same as those in box e of Fig. 3.3 (6 15N between -46 to -47 ppm, 
Table 3.2). The peaks in boxes g and h (Fig. 3.3A) for complex (4) are not observed 
in this experiment because the then ligand is not 15N-labelled. The 'H NMR spectrum 
of this sample contained four singlets with shifts of 2.641, 2.635, 2.579, 2.567 ppm 
assignable to coordinated SCH3 groups of L-Met ligands (Fig. 3.6). These had 
relative areas of 2:2:1:1. The 1 H NMR spectrum of the solution was recorded again 
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Figure 3.5 The 2D I'H,' 5N] HSQC NMR spectrum of the HPLC-isolated then ring-opened complex (4) (peak c in Fig. 3.4B) at pH 4.0. 
Only the NH2 group of L-MetH was ' 5N-labelled, and the four sets of cross-peaks (peaks a, a' to d, d') can be assigned to the 
nonequivalent Pt-NH 2 groups in the four diastereoisomers of [Pt(dienH-N,N9(' 5 N-L-Met -S,N)I 2 . All peaks have 2J(NH8,NI-Ib) of ca 12 
-. Hz, while only peaks a and b have an additional 3J((tCH,NH) of ca 13 Hz. 
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Table 3.2 'H and 15N chemical shifts of HPLC separated complex (4) [Pt(dienH-
N,N(' 5N-L-Met-S,IV)] 2 (pH 4.0, 298 K). 
Diastereomer a 	SCH3 	Peak 	6 ('HI15N) 
6( ' R) 	 (NH2 trans to N) 
R, R 	2.641 	a 	5.08/46.32 (t) 
a' 	5.86146.32 (d) 
S 	2.579 	b 	5.03/46.70 (t) 
5.861-46.70 (d) 
R 	2.635 	c 	5.31/46.68 (d) 
5.841-46.68 (d) 
S' S 	2.567 	d 	5.26/46.92 (d) 
5.97146.92 (d) 
a The assignment of peaks to individual diastereomers is arbitrary, and the pairing of 
the SCH3 signals with 15NH2 cross-peaks is based on the peak intensities. The upfield 
cross-peaks for R, R- and R, S-diastereomers appeared as triplets due to 3J(aCH,NH) 
(ca 13 Hz) as well as 2J(NHa,NHb) (ca 12 Hz) , whilst only 2J(NHa,NHb) splittings 
(ca 12 Hz) were observable for all other signals. 
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S-CH 3 
E] 
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Figure 3.6 Part of the 500 MHz 'H NMR spectrum of HPLC isolated then ring-
opened complex (4) at pH 4.0 (peak c, Fig. 3.413), showing four singlets from S-CH 3 
of diasteroisomers of SI N-chelated L-Met. 
3.5 Discussion 
Competition between sulfur and nitrogen ligands in coordination to platinum(II) is 
currently attracting attention because this could provide new routes for DNA 
platination via a protein fragment. Thioether S can bind reversibly to Pt(ll), and at 
physiological pH, it can be replaced by a N donor from N7 of guanine. 6,7,17  It can also 
be replaced by NI of imidazole from His at pH > 6.' In this work, the mode of 
binding of L-MetH to { Pt(dien) 2+  at a variety of pH values has been investigated. 
Im 
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S- and N-bound [Pt(dien)(L-Met)] complexes 
The NMR data show unambiguously that at pH 6, initial binding of L-MetH to 
[Pt(dien)ClI (1) takes place via Cl-  displacement with S which has a high affinity for 
Pt(ll). Correspondingly, in the HPLC experiment at this pH, only one major peak 
(peak a, Fig. 3.4) was observed for the product. When the pH of [Pt(dien)(L-Met-S)1 
(2) was adjusted to 8.5, the deprotonated amino group (pKa 9.28 for free L-MetH 24 ) 
from L-Met slowly displaces S to form the thermodynamically-favored product 
[Pt(dien)(L-Met-N)] 2+  (3). 
The two Pt-NH2 groups of complex (3) have different ' 5N chemical shifts and 
the two 1 H NMR peaks for one of the two Pt-NH2 groups are well separated (ca 0.4 
ppm), which may be a consequence of H-bonding with the carboxylate group of N-
bound L-methionine at both pH 8.5 and 3.3 (Scheme 3.1). Since methionine is 
asymmetric, they in theory will all have different chemical shifts. 
2) Identification of Intermediate (complex 4) 
Lowering the pH of a solution containing the N-bound complex (3) from pH 8.5 to 
3.3 gave rise to peaks for intermediates both in 2D ['H, ' 5N] NMR spectra and in 
HPLC chromatograms. By using ' 5N-labelled L-MetH in comparison with unlabelled 
L-MetH (Fig. 3.3A, B), the coordination of NH2 of L-Met in the intermediate was 
confirmed and 15N-chemical shifts of the cross-peaks (box e, Fig. 3.3A) are 
comparable to those of trans- [Pt(' 5N-L-Met-S,N)21 (for which the NH2-Pt-NH2 
groups gave rise to cross-peaks at -41 to -43 ppm). 3 Cross-peaks in box h (NH2 trans 
to 5) in Fig. 3.3 can be assigned to Pt-NH2 ( 15N-dien) groups of the intermediate. 
Therefore, it seems likely that a major intermediate observed after pH adjustment 
from 8.5 to 3.3 is a complex with S,N-chelated L-Met and a chelate-ring-opened then 
ligand, [Pt(' 5N-dienH-NN(' 5N-L-Met-S,IV)} 2t Cross-peaks in box g (Fig. 3.3) can 
be tentatively assigned to NH trans to a nitrogen ligand for the Pt-NH of [Pt(' 5N- 
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dienH-N,NC 5N-L-Met-S, Nfl 21  . For bis-chelated then ligand, a Pt-NH group trans to 
N would be expected to have an ' 5N chemical shift of ca 10 ppm,23 in the present 
case the "NH shifts of [Pt( 5N-dienH-N,ND( 5N-L-Met-S,N)] 2 appears to be shifted 
to high field by 20 ppm, an effect which is presumably caused by the ring-opening. 
The appearance and disappearance of peak c observed in HPLC chromatogram after 
pH adjustment from 8.5 to 3.3 are consistent with those cross-peaks observed in the 
NMR experiments (Fig. 3.3), and therefore can be assigned to the same ring-opened 
species. 
Due to the presence of chiral NH and S centers in [Pt(dienH-N,N(L-Met-
S,JV)1 2 (4), four diastereomers would be expected: R,R; R,S; SR; SS (omitting S 
centre at ctC for L-methionine) . The R, S inversion at the chiral Sd3 center in S,N-
chelated L-Met is usually slow on the NMR time scale; for example the energy 
barrier of such inversion in [Pt(L-Met-S,N)C12] has been estimated to be of 74.6 kJ 
mol*9 Therefore as shown in Fig. 3.3, the four sets of cross-peaks in box e, g and h 
can be assigned to the four diastereomers. Similarly, four SCH3 singlets were 
observed in the 'H NMR spectrum of HPLC purified intermediate (Fig. 3.6). The 
relative area of the four sets of cross-peaks in boxes e, g and h, and the four SCH3 
singlets, is about 2:2:1:1. This can be attributed to the predominance of one of the 
two configurations at chiral S. A 2:1 ratio has been observed previously for R, S 
diastereomers of NS-chelated methionine 1° and methionine-containing dipeptide' 2 
complexes of Pt(ll). 
The four different ' 5N chemical shifts of cross-peaks in the 2D ['H,' 5N] 
spectrum of the HPLC-purified intermediate (Fig. 3.5) are also consistent with the 
presence of four diastereoisomers. Each pair of cross-peaks has the same 
chemical shift, but very different 'H chemical shifts (Aö, 0.5-0.8 ppm). This suggests 
that one of the two NH2 protons of chelated 15N-L-Met in complex (4) is strongly 
involved in H-bonding, perhaps with the deprotonated carboxylate group, which 
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forms a strained five-membered ring. Alternatively, the ring conformation may allow 
the then NH3 group to interact with the CO2 group of coordinated L-Met, and, in so 
doing, may influence the 'H chemical shifts of the NH2 groups. For comparison the 
'H chemical shift differences for the 'H resonances of the NH2 in trans-[Pt('5N-L-
Met-S,Pv)2] are only ca 0.3-0.4 ppm. 3 
The 2J(NHa,NFIb) values for cross-peaks observed in the 2D ['H,' 5N] HSQC 
NMR spectrum (Fig. 3.5) are comparable to those values reported for trans-[Pt(15N-
L-Met-S,N)2] (ca 12 Hz). 3 'J(ctCH,NH) (ca 13 Hz) splittings were also observed for 
cross-peaks (a and b), which implies that envelope conformations may be adopted 
for the six-membered-ring in two of the four isomers. The other two isomers may 
adopt flattened boat conformations for which 3J(uCH,NH) tends to be small, and 
therefore perhaps not observable. This is the case for trans- [Pt(' 5N-L-Met-S,/V)2]: 
several Pt-NH2 peaks have 3J(czCH,NH) values of 9-14 Hz, whilst other peaks have 
no detectable couplings. 3 
After pH adjustment from 8.5 to 3.3, the free nucleophilic S atom of (3) could 
attack the apical position of platinum, leading to labilization of Pt-NH2 bond and the 
formation of then ring-opened 5, N-chelate [Pt(dienH-N,N(L-Met-S,N)] 2 (4) with 
S trans to NH2 of dien. Complex (4) may convert to (2) either via isomerization to 
(5) (S trans to NH of dien) or involving pseudorotation of a five-coordinate 
intermediate by an associative mechanism. 25  The unassigned cross-peaks which are 
in very low intensity in Fig. 3.3 could possibly be due to complex (5). Proton transfer 
from the free NH3 group of ring-opened then in complex (5) to the more basic 
methionine amino group could rapidly give complex (2). The fact that no then ring-
opened intermediate was observed when the pH of complex (2) was adjusted directly 
from 6 to 3, shows that then chelate ring-opening requires displacement of then NH2 
by S. 
11 
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Very few examples of chelate ring-opened then platinum complexes have been 
reported in the literature. The only crystal structure of a ring-opened then complex is 
that for [Pt(dienH-N,NCl1Cl2, obtained from a strongly acidic solution (1 M FIG ). 26 
Ring-opening of Pt-dien ring has been reported in the presence of excess of 
diethyldithiocarbamate and thiourea, 27,28 and the complex [Pt(dienH-N,N)(Guo-
N7)(thiourea-S)j 2 has been isolated by HPLC at pH < 2 . 0. 28  Ring-opened 
ethylenediamine Pt complexes with the di- and tripeptide Gly-HMet and Gly-Met-
HGly have been detected at pH 2.4, and such a ring-opened complex containing Met-
HHis has also been identified at pH 9.6.i229 
The present work appears to provide the first example of an HPLC-isolated and 
NMR-characterized Pt-dien ring-opened complex. Complex (4) is very long-lived 
(weeks) in the presence of high concentrations of (N114H2PO4, which suggests that 
the phosphate group may form strong H-bonds with the dangling NH3 of then and 
stabilize the then ring-opened form. 
Reedijk et al. 30  have observed a pH dependent Pt migration from S to N while 
studying the reaction between (1) and S-adenosyl-L-homocysteine. When they 
adjusted the pH from 11 to 4, the N-bound Pt complex gave rise to ca 20% of 'side 
products' which could not be characterized. These could also be due to the formation 
of then ring-opened adducts. 
Taken together, these results show that significant migration of {Pt(dien)} from 
S-bound to N-bound L-Met occurs at pH values above 8, while N-bound L-Met 
transfers to S-bound L-Met at pH 3 via then ring-opening intermediates, long-lived 
isomers in which L-Met S is trans to coordinated then NH2. The process is 
summarized in Scheme 3.1. 
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Scheme 3.1 {Pt(dien)} 2  migration from S-bound to N-bound L-Met and then ring-
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3.6 Conclusion 
This work has shown that at neutral pH [Pt(dien)C]] (1) forms predominantly an 
bound L-Met complex (2). Complex (2) reversibly converted to the N-bound 
complex (3) at pH 8.5. The adjustment of pH from 8.5 to 3.3 gave rise to formation 
of the then ring-opened intermediate [Pt(dienH-N,ND(L-Met-S,N)] 2 (4) with NH 
trans to L-Met NH2, which converted slowly into complex (2), the only stable adduct 
at pH 3.3. Complex (4) exists as a mixture of four diastereomers with molar ratio of 
2:2:1:1 due to the chiral S centre of L-Met and chiral NH of dien. The two NH2 
protons of L-Met in each of the four diasteromers of complex (4) exhibit remarkably 
different 1 H NMR shifts. 
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4.1 Abstract 
cis-[PtC12(NH3)(2-picoline)] (1) (ZD0473) is a recently reported anticancer active 
complex. Hydrolysis may be an important step in its intracellular activation and 
interaction with DNA. In this chapter, [ 1 H, ' 5Nj 2D NMR spectroscopy is used to 
determine the hydrolysis rates for each chloride ligand of this complex and its 3-
picoline analogue 2. The P1(a  values of the aqua and diaqua ligands as well as the X-
ray crystal structures of 1 and 2 are reported. For the 3-picoline complex 2 the rate of 
hydrolysis of CF trans to NH3 (kit, = 1.0 x l0 sfl', I = 0.1 M, 310 K) is similar to that 
of cisplatin, but slower for CF trans to 3-picoline (ki a = 4.5 x 10 s'). Both of the 
first hydrolysis rates for the 2-picoline complex 1 are slower than those of 2, but in 
contrast to 2, the hydrolysis of Cl - trans to NH3 (cis to 2-picoline) is slower (klb = 2.2 
X 10 1)  than for CF trans to 2-picoline (ki a = 3.2 x 10 5 s'). The crystal structure of 
2 revealed that the pyridine ring is tilted by 49° with respect to the Pt square plane, 
whereas in 1 the ring is almost perpendicular (103°). This introduces steric hindrance 
by the CH3 group towards an axial approach to Pt from above, leading to a 
destabilisation of the expected trigonal-bipyramidal transition state, an effect well-
known in substitution reaction of Pt(II) complexes. The piCa  values for the monoaqua 
adducts of 1 (6.13 and 6.49) and 2(5.98 and 6.26 for H20 trans to picoline and NH3, 
respectively) and for the diaqua adducts (5.22, 7.16 for 1 and 5.07, 6.94 for 2) are 
>0.3 units lower than for cisplatin. The slowness of the hydrolysis, combined with 
the dominance of (inert) hydroxo species, is expected to contribute to a greatly 
reduced reactivity of the sterically-hindered 2-picoline complex under intracellular 
conditions. 
4.2 Introduction 
Cisplatin is one of the most widely used anticancer drug in the world. It is 
extraordinarily effective against certain cancers, for example, testicular and ovarian 
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cancer and is increasingly used against cervical, bladder and head/neck tumours. Due 
to the acquired drug resistance in treatment of certain cancers and severe normal 
tissue toxicity of cisplatin, there is a need for new agents which do not exhibit cross-
resistance and are less toxic.' Most active platinum compounds have the general 
formula cis-[PtAm 2X 2], where Am is an am(m)ine ligand with at least one NH group 
and X is a moderately strongly-bound anionic leaving group such as chloride. 2 
Derivatives belonging to this structural class show similar or slightly improved 
biological activity. Recently there has been interest in pyridine complexes. 3,4,5  The 
presence of planar pyridine ligands, as in cis or trans-[PtC1 2(pyridine) 2] complexes, 
can reduce the rates of DNA binding compared with cis and trans-DDP,6 and by 
changing the nature or position of substituents on the pyridine ligands, different 
binding affinities for DNA can be achieved .4 
The 2-picoline (2-methylpyridine) complex cis-[PtC12(NH3)(2-picoline)] (1) 
(ZD0473, former name A1v1D473), is a newly-reported anticancer complex which is 
now in phase I clinical trials in UK .7,8  It has been developed at the Institute of Cancer 
Research, in collaboration with Johnson Matthey Technology Centre/AnorMED. 
ZD0473 is reported to possess activity against cisplatin-resistant cell lines, and 
against an acquired cisplatin-resistant subline of a human ovarian carcinoma 
xenograph, by injection and oral administration. 9 It showed significantly reduced 
cross-resistance to cisplatin in a panel of three cell lines with known acquired 
platinum drug resistance mechanisms: reduced accumulation, increased cytoplasmic 
detoxification by cellular thiols or increased DNA repair/tolerance of platinum-DNA 
adducts. 10 The toxicity of ZD0473 is also greatly reduced, with no renal toxicity 
observed. 
Once dissolved in water, the labile chloride ions of cisplatin are slowly 
replaced by water molecules in a stepwise manner: first forming monoaqua species 
and then further hydrolysis to form diaqua species. The relative amounts of all these 
Lit 
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hydrolysis species vary as a function of pH and (externally added) chloride 
concentration. The mechanism of action of cisplatin is believed to involve activation 
via hydrolysis inside cells where the Cl - concentration is much lower (ca. 4 MM) than 
outside cells (ca. 100 mM). Hydrolysis is the rate limiting step in the reaction of cis-
Pt with DNA. Since water is a far better leaving group than chloride and hydroxide, it 
is very important to determine the hydrolysis rates and pK a values of the hydrolysis 
adducts. 
Various methods have been used before to determine the hydrolysis rates and 
pKa values of Pt(H) complexes, those include conductivity, spectrophotometry, 
HPLc, Cl - ion titration, Cl' ion specific electrode, H ion titration and capillary 
electrophoresis ."' 3  Detailed kinetic studies of the hydrolysis of cisplatin have been 
carried out by Miller and House.' 3 Using ' 5N and "'Pt NMR spectroscopy, accurate 
pKa values for hydrolysis species of cisplatin were reported. 14,15  2D ['H, 15N] HSQC 
spectroscopy is a very powerful tool in accurate and rapid measurement of hydrolysis 
rates and pKa values at low concentrations (mM), if the ammine groups of platinum 
complex are ' 5N labelled. 14 
Few chemical studies of ZD0473 have been reported although it appears to 
hydrolyse, form interstrand DNA cross-links and bind to plasma proteins much more 
slowly than cisplatin. 8" 6 In this work, complex 1 has been labelled with ' 5N and 2D 
['H, ' 5N] HSQC spectroscopy were used to compare its hydrolysis behaviour with 
that of the isomeric 3-picoline derivative 2, since hydrolysis is likely to be an 
important initial activation step for this drug. The pKa values for the mono- and 
diaqua complexes have also been determined since hydroxo ligands on Pt(H) are 
usually inert compared to aqua ligands. The data reveal notable differences between 
the chemistry of the sterically-hindered picoline complex and that of cisplatin. 
4.3 Experimental 
Of 
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Chemicals and preparation of complexes: 2- and 3-Picoline were purchased from 
Aldrich. Cis-[PtC12( 15NH3)2] was prepared according to a reported procedure. 7 
Complexes 1 and 2 were prepared by a similar procedure to that described in the 
literature for natural abundance, mixed ligand ammine/amine Pt(II) complexes. 18 
pH Measurements: These were performed using a Coming 145 pH meter equipped 
with an Aldrich micro combination electrode calibrated with Aldrich buffer solutions 
of pH 4, 7 and 10. The values of pH were adjusted with 1 M HCI04 or NaOH as 
appropriate. 
X-ray Crystallography: Crystals of complexes 1 ( 15NH3) and 2 ( 14NH3) were 
obtained by the slow evaporation of aqueous solutions containing excess KCI. Data 
for 1 and 2 were collected on Stadi-4 diffractometers equipped with an Oxford 
Cryosystems low-temperature device. Scan models were both 0)-6. Complex 2 
crystallised as fine, delicate needles, which tended to form co-axially aligned clumps 
and exhibited broad diffraction profiles. For these reasons, CuKU radiation was used 
for its intensity advantage over MOKa  radiation. The structures were refined by full-
matrix least-squares against F2 (SHELXL1). H-atoms were placed in calculated 
positions: the CH3 and NH3 were modelled as rotating rigid groups. All non-H atoms 
were refined anisotropically. Data collection and structure determination were carried 
out by Dr. S. Parsons. 
Crystal data for the two structures are listed in Table 4.1, and selected bond 
lengths and angles are given in Table 4.2. Crystallographic data (excluding structure 
factors) for the structures reported in this paper have been deposited with the 
Cambridge Crystallographic Data Centre as supplementary publication no. CCDC-
100573. 
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Table 4.1 X-ray crystal structure data for complexes 1 and 2. 
1 	 2 
Empirical formula C6H10Cl2N 15NPt C6H10Cl2N2Pt 
Mr 377.1 376.1 
color yellow yellow 
crystal size (mm) 0.47 x 0.39 x 0.25 0.43 x 0.08 x 0.08 
crystal shape block needle 
crystal system monoclinic orthorhombic 
space group P211c Pbca 
a (A) 9.859(2) 12.287(8) 
b (A) 8.910(2) 7.318(8) 
c(A) 11.197(2) 20.801(14) 
$ (°) 102.684 (15) 90 
V(A 3) 959.6(3) 1871(3) 
Z 4 8 
2, A) 0.71073 1.54178 
T (K) 220(2) 220(2) 
Pcalcd (g CM-3) 2.604 2.420 
/lcalcd(mm) 15.119 (M0KU) 30.166 (CuKa) 
F(000) 688 1240 
20 range (°) 5.9-50 8.5-140 
abs. Correction (Tminimax) y,-scans (0.0033/0.0175) Shelxa (0.0263/0.4036) 
refl. Collected 3725 4662 
unique refl. 1688 (R1=0.0358) 1672 (R1=0.0560) 
refl. Used 1684 1670 
parameters 102 101 
R 	(F0>4(Y(Fo)) ['I 0.0355 0.0437 
wR2 (all data) 	b, 0.0903 0.1183 
gl.; g2 0.0596; 0.0000 0.0746; 0.0000 
resid. Elec. Density (eA 3 ) +1.521-1.16 +1.561-2.72 
[a] R I = E(I I F0 I - I F 1)/I F0 1 . [b] wR2 = { E[w(Fo2-F2)2]/Z[w(Fo2)2] 1'2 
[c} w = 1/[o2(F02)+(glxP)2+g2xP]; P = (F(,2+2F 2)/3. 
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Table 4.2 Selected bond lengths (A) and angles (°) for complexes 1 and 2. 
1 	 2 
Pt-N(l) 	 2.017(8) 	 2.008(8) 
Pt-N(2) 	 2.030(8) 	 2.039(9) 
Pt-CI(l) 	 2.299(2) 	 2.296(3) 
Pt-CI(2) 	 2.322(2) 	 2.309(3) 
N(1)-Pt-N(2) 	 90.5(3) 	 90.5(4) 
N(1)-Pt-Cl(1) 	 177.6(2) 	 177.3(3) 
N(2)-Pt-CI(l) 	 87.3(2) 	 86.8(3) 
N(l)-Pt-Cl(2) 	 89.5(2) 	 90.9(2) 
N(2)-Pt-CI(2) 176.1(3) 178.6(3) 
Cl(1)-Pt-Cl(2) 92.70(8) 91.72(10) 
NMR Spectroscopy: NMR spectra were recorded on a Bruker DMX500 instrument 
using 5 mm tubes. All the samples were recorded in 90% H20/10% D20 (0.6 ml), 
and containing 0.1 M NaC104 to maintain a constant ionic strength. The chemical 
shifts are reported relative to sodium trimethylsilyl-[d4]propanoate (through internal 
dioxane at 3.743 ppm) for 'H, and 1 M ' 5NH4C1 in 1.5 M HC1 for 15N (external). 
Typical acquisition conditions for 'H spectra were: 45-60 ° pulses, 2.5 s relaxation 
delay, 64-256 transients, final digital resolution 0.2 Hz per point. When necessary the 
water resonance was suppressed by presaturation, or by means of the WATERGATE 
pulsed-field-gradient sequence. 19 
Both 1D 15N-edited 1 1-1 NMR spectra and 2D ['H, ' 5N1 HSQC spectra 
(optimized for 1 J(N,H) = 72 Hz) were recorded by using the sequence of Stonehouse 
et. al.20 The 15N-spins were decoupled by irradiating with the GARP-1 sequence 
during acquisition. 
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Data Analysis: For the kinetic analysis of NMR data, the appropriate differential 
equations were integrated numerically, and the rate constants were determined by a 
nonlinear optimisation procedure using the programme SCIENTIST (Version 2.01, 
MicroMath Inc.). The errors represent one standard deviation. Equilibrium constants 
were calculated from the equilibrium concentrations of species determined by 
integration of the 2D NMR spectra. The analysis was carried out with the help of Dr. 
Zijian Goo. 
For first-order rate reactions: A - B + C. Let the initial concentration of A be 
a mol•dm 3 . if after a time t, x mol•dm 3 of A has reacted, the remaining concentration 
of A is a - x, and x mol•dm 3 of B or C has been formed. The rate of formation of B or 
C is thus dx/dt. For a first-order reaction this rate is proportional to the instantaneous 




For second-order rate equations: A + B -* C + D. Let the initial concentrations 
at t = 0 be a moldm 3 of A and b mo1dm 3 of B. After a time t, x moldm 3 of A, and 
of B, will have reacted, forming x moldm 3 of C and of D. if a second-order rate is 
followed, then 
dt 
For the hydrolysis reaction: 
[Pt(NH3)(Picoline)Cl21 + H20 	[Pt(NH3)(Picoline)(H20)Cl] 1 + Cl 
The forward reaction is considered as first order because of the large excess of water, 
while the back reaction is a second order reaction. For the hydrolysis reaction 
(scheme 4. 1), if at time t, the concentrations of species a, b, c and d are A, B, C and 
D, respectively, then the corresponding reaction rates are: 
A' = ki a A k,bA + k'ia B(B+C+D) + k',uC(B+C+D) 
B'= kiaA 42a B + k'2a D(B+C+D) - k'iaB(B+C+D) 
Scheme 4.1 
(a) 
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C= k1,•A -k2b•C + k'2bD•(B+C+D) - k'lbC•(B+C+D) 
D'= k2a B +k2bC - k'2a D(B+C+D) - k2bD(B+C+D) 
The above model equations were used in least squares fitting of the NMR data (the 
change of concentration of each species with time), with a set of initial parameters 











Titration curves were fitted to the Henderson-Hasselbalch equation using the 
KaleidaGraph numerical analysis programme (Synergy Software, Reading, PA, USA) 
on a Macintosh computer. The equation is as follows: 
6obs = 	+ 8oKa'}/t [H] + Ka } 
where 8ob, = observed chemical shift; 8+ and 50 = limiting chemical shift of fully 
protonated and deprotonated chemical shift, respectively; n = Hill coefficient and K = 
dissociation constant. 
4.4 Results and Discussion 
Synthesis of 15N labelled complexes 1 and 2: A solution of cis-[Pt(15NH3)2C12] (100 
mg, 0.33 mmol) and tetraethylammoniumchloridexH20 (0.065 mg) in 
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dimethylacetamide (20 ml) was heated to 100 ± 2°C for 6 h. A slow stream of 
nitrogen was bubbled through the reaction mixture during this period. After the 
reaction, the orange solution was cooled to room temperature. Ethyl acetate/hexane 
(90 ml, 1:1 v/v) was added and the cloudy reaction mixture was left in the freezer 
over night at -10°C. A clear, colourless solution and a thick, orange oil was produced 
after this procedure. The clear solution was discarded and the oil was dissolved in 




To the solution of amminetrichloroplatinate, KI (166 mg, 0.99 mmol) was added. 
The reaction mixture was stirred at room temperature for about 10 min to give 
[Pt(' 5NH3)13 1 -, then 32 pJ of 2-picoline was added. The reaction mixture was stirred 
at room temperature for two hours and the yellow precipitate cis-[Pt12(' 5NH3)(2-
picoline)], was collected, washed with cold water and air-dried. Yield: 70.5 mg 
(37.8%). 
IC 
Cis-[Pt12( 15NH3)(2-picoline)] (70.5 mg, 1.26x10 4 mmol) was suspended in water (10 
ml) with AgNO3 (41.8 mg) and stirred in the dark for about 20 hours. The 
yellow/green precipitate was removed by filtration and the remaining cis-
[Pt(' 5NH3)(2-picoline)(H20)2] 2 was stirred with an excess KCI for about 2 hours. 
we 
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The yellow precipitate cis-[PtC1 2(' 5NH3 )(2-picoline)] was collected by filtration and 
washed with cold water. Yield: 35 mg (27%). 
HN15 	CI 
Element analysis calculated for C 6H, 0 C12N' 5NPt: C, 19.1%; H, 2.65%; N, 7.69%. 
Found: C, 19.28%; H, 2.97%; N, 7.57%. 'H NMR: S = 8.87 (d, J = 8Hz, 11-1, H-6), 
7.81 (in, 1H, H-4), 7.49 (d, J = 8 Hz, 1H, H-3), 7.32 (m, IH, H-5), 3.13 (s, 3H, 
CH3). 
Complex 2, cis- [PtCl2(' 5NH3 )(3-picoline)], was prepared in the same way. The 
result of element analysis was: C, 18.82%; H, 2.70%; N, 7.3 1%. 'H NMR: S = 8.62 
(s, 1H, 1-1-2), 8.54 (d, .J 6Hz, IH, H-6) 1 7.77 (d, J= 9Hz, 111, H-4), 7.37 (m, 1H, 




Figure 4.1 X-ray crystal structures of complexes I and 2 showing the steric hindrance 
caused by the 2-methyl group in complex 1. Colour code: H (white), C (pale green), 
N (blue), Cl (bright green), Pt (yellow). 
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X-ray crystal structures: Both ' 5N-labeled and unlabelled complexes 1 and 2 were 
prepared, and pale yellow crystals for X-ray analysis were obtained after slowly 
cooling the filtrate. As can be seen in Figure 4.1, both complexes have a square-
planar configuration with angles close to the ideal values of 900  and 180°. In 
complex 1, the Pt-CI(2) bond trans to NH3 is slightly longer (2.322(2) A) than 
normal, while the Pt-Cl(1) bond distance (2.299(2) A) is within the normal range. In 
complex 2 both Pt-Cl bond lengths (2.296(3) A, 2.309(3) A) are close to the expected 
values. The Pt-N(l) bond lengths in both complexes 1 (2.017(8) A) and 2 (2.008(8) 
A) are comparable to those of cis-[Pt(Py)2C12] (2.01 and 2.04 A). 22 The most notable 
feature of the structures is the orientation of the picoline ring with respect to the Pt 
square-plane. The 3-picoline ligand is tilted by 48.9°, whereas the 2-picoline ligand is 
almost perpendicular (102.7 0) to the plane, so that the 2-methyl group lies directly 
over the square-plane (113CPt: 3.224 A). The space-filling model (Figure 4.1) 
demonstrates that this introduces steric hindrance to an axial approach to Pt from 
above. The steric effect leads to a slight twisting of the [PtN2Cl2] square plane, with a 
mean deviation of the atoms from the plane of 0.0406 A, which is an order of 
magnitude higher than that for complex 2. 
There are strong intermolecular hydrogen-bonds involved in the crystal packing 
of both complexes (Figure 4.2). For complex 1, the three H atoms of the NH3 ligand 
are H-bonded to four Cl ligands from two neighbouring molecules, while for 
complex 2, H-bonds of similar strength are formed only to three of the four Cl 
ligands. Such intermolecular H-bonds are common in chloro Pt(fl) am(m)ine 
complexes. 23,24  A very weak graphitic-type of interaction between the picoline groups 
of neighbouring molecules of 1 may also be present. In complex 1, layers containing 
ClH-N H-bonding interactions alternate with layers containing picoline groups. In 
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2 
Figure 4.2 Intermolecular hydrogen bonding in crystals of (A) complex 1, and (B) 
complex 2; N-H• • •CI distances for complex 1 range from 2.55 A to 2.74 A and for 
complex 2 from 2.62 A to 2.81 A. 
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complex 2, the molecules themselves form layers, with H-bonds both within and 
between layers. 
Hydrolysis: The ['H, 15N] 2D NMR spectra of 15NH3-labelled 1 and 2 in aqueous 
solutions containing 0.1 M NaC104 were each monitored for a period of over 20 h at 
310 K. Initially a single cross-peak was observed at 4.151-66.52 ppm assignable to 
the dichloro complex 1. After I h, two additional cross-peaks with similar intensities 
were detected at 4.40/-64.41 ppm and 4.32/-87.25 ppm. The former peak is consistent 
with an assignment to complex 3a, with an ' 5N shift diagnostic of ' 5 N trans to N or 
C1, 25 and the latter to 3b with 15N trans to 0, Scheme 4.2. Both peaks increased in 
intensity for several hours, while the peak for 1 decreased in intensity. After about 
2.5 h, a fourth cross-peak appeared at 4.41/-82.91 ppm. This was assigned to the 
diaqua complex 5 (Figure 4.3A); however, even after 20 h, this accounted for only 
<10% of the total 15NH3-Pt species present. 
For the 3-picoline complex 2, the time-dependence of the [ 1 H, ' 5N] 2D NMR 
spectrum was similar to that of complex 1, except that the cross-peak c (Figure 4.3B) 
assignable to one of the two monoaqua complexes was more intense than the other. 
The ' 5N chemical shifts for the peaks of the 3-picoline complexes are shifted slightly 
to lower field with respect to those of the 2-picoline adducts. However, the 'H 
chemical shifts are very similar. The time-dependence of the concentrations of 
species detected during hydrolysis of complexes 1 and 2 is shown in Figures 43C 
and 3D. The assignments of the peaks for the aqua complexes were confirmed by pH 
titrations, Figure 4.4, and these allowed the determination of PK a value for each 
monoaqua complex as well as two pK a values for each diaqua complex, Scheme 4.2. 
The NMR data allow the determination of the hydrolysis rates for each 
individual chloride ligand in the initial complexes 1 and 2, and in the monoaqua 
complexes 3a, b and 4a, b (Table 4.3). It is notable that the hydrolysis rates of the 
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Figure 4.3 2D [ 1 H, 15N] HSQC NMR spectra of 2 mM aqueous solutions of (A) cis-
[PtC1 2 ( 15NH3 )(2-picoline)] (1), and (B) cis-[PtC12('5NH3)(3-picoline)]  (2) after 3 h at 
310 K. Peak a is assigned to the starting complex, peaks b, c to the two monoaqua 
complexes (H20 cis to NH 3 and H70 trans to NH3 , respectively), and peak d to the 
diaqua complex. Time dependence of the concentrations of the dichioro complexes 
and aqua adducts are shown in (C) of 1 and (D) of 2, respectively. Labels: 1 and 2 
(•), monoaqua complexes 3a and 4a (A), monoaqua complexes 3b and 4b (•), 
diaqua complexes S and 6 (+). The curves are the computer best fits calculated with 
the rate constants shown in Table 4.3. 
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Table 4.3 Rate and equilibrium constants for the hydrolysis of the platinum-picoline 
complexes 1 (pH = 4.6) and 2 (pH = 4.4) at 310 K (0.1 M NaC10 4). Data reported for 
cisplatin under related conditions (308 K, 0.32 M KNO 3) are listed for comparison. 
Compounds Rate constants [a] Equilibrium constants thl 
(x 10.6  s') (x 10-4 M) 
1 kia: 31.9± 1.5 K, a: 12.1 
2-picoline klb: 22.1 ± 1.4 KIb: 21.4 
k2a: 73 ± 14 K2 a: 4.8 
k2b: 3.5+2.5 K2b: 2.7 
2 ki a : 44.7 ± 1.9 Ki a: 23.2 
3-picoline kib: 103 ± 4 KIb: 28.0 
k2 a : 35.0± 1.7 K2a: 2.8 
k2b:78±60 K2b:2.3 
c i splati nki k,: 75.9 K 1 : 43.7 
The errors in the rates for the second hydrolysis step are large because the fitting 
process is relatively insensitive to the rate of the back reaction. Hence these 
constants are not discussed in the text. 
Constants correspond to kinetic steps indicated, i.e., Ki a to equilibrium between 
1 (or 2) and 3a (or 4a), etc. 
Ref 18. 
two Cl - ligands of complex 1 are both slower than those for complex 2 (Table 4.3). 
The Cl - ligand trans to NH3 in complex 1 hydrolyses about four times more slowly 
than that in the unhindered complex 2. In complex 2, the Cl ligand trans to NH3 
hydrolyses about twice as fast as that trans to 3-picoline. This might be expected 
from the higher trans influence of NH3 (pK a=9.29) versus 3-picoline (pK a=6.0). 26 
However, for complex 1, the situation is reversed: hydrolysis is faster for the Ci 
ligand trans to 2-picoline (pKa=6. 1).26  All the first step hydrolysis rates determined 
here are slower than that of cisplatin 41,2: 1.75 hat 310 K).' 3 
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Figure 4.4 pH dependence of the 'H NMR chemical shifts of NH3 in the monoaqua 
complexes and diaqua complexes: (A) complex 1, and (B) complex 2. The curves 
represent the computer best fits using the pK a values listed in Scheme 4.2. Labels: 
monoaqua complexes 3a and 4a (A), monoaqua complexes 3b and 4b (•), diaqua 
complexes 5 and 6 (0). 
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Axial steric interactions have long been known to decrease the rate of 
substitution reactions of square-planar complexes. 27,28  For example, the rate of 
reaction of 2-picoline with [AuC141 -  is about 9 times slower than with 3-picoline, but 
10 times faster than with 2,6-dimethylpyridine which blocks both axial sites. In the 
complexes cis- [Pt(PEt 3 ) 2(R)Br], the rate of displacement of Br by MeOH decreases 
dramatically as the steric hindrance by the aryl ligand R, which is cis to the leaving 
group, increases: Ph = p-MeC 61­14 >> o-MeC6H4 > o-EtC6H4 > 2,4,6-Me3C6H2 . 29 In an 
associative mechanism with a trigonal-bipyramidal transition state, the ligands cis to 
the leaving group become axial to the trigonal plane in the 5-coordinate transition 
state, and interact with the entering and leaving groups at a 90 °, so that the steric 
effect is more prominent on the ligand in the position cis to the bulky ligand. 
PK a values: A change of the methyl group from the 2- to the 3-position only has a 
small effect on the pKa values of the aqua ligands, lowering them by Ca. 0.2 units 
(Scheme 4.2). The pKa values for both the monoaqua and diaqua adducts of the 2-
picoline and 3-picoline complexes are >0.3 units lower than that of cisplatin. This 
means that although the sterically-hindered 2-picoline complex 1 will exist 
predominately (about 70%) as a dichloro adduct under extracellular conditions (0.1 
M CL, pH 7.4), under intracellular conditions (4 mM Cl - , pH 7.4), the hydroxo/chioro 
and dihydi'oxo adducts of 1 will predominate (>70%), whereas for cisplatin the 
dichloro, chloro/aqua and chioro/hydroxo are present in about equal proportions 
(about 30% each) . 30 The slowness of the hydrolysis steps of complex 1 (Table 43) 
coupled with the dominance of (inert) hydroxo species would both be expected to 
contribute to its greatly reduced reactivity under intracellular conditions. 
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4.5 Conclusions 
The Cl - ligand cis to 2-picoline (trans to NH3) in the complex cis-[PtCl 2(NH 3 )(2-
picoline)] (1) hydrolyses about 4 times more slowly than that in cisplatin (t112: 8.7 h 
at 310 K, compared with 1.8 h for cisplatin), and both Cl - ligands of 1 hydrolyse 
more slowly than the 3-picoline analogue 2. X-ray crystallography has confirmed the 
steric hindrance introduced by the 2-methyl group of the picoline ligand in 1, which 
has the effect of destabilising the expected trigonal-bipyramidal transition state, an 
effect well-known in substitution reaction of square planar Pt(ll) complexes. 1211  The 
pKa values of the monoaqua and diaqua adducts of both 1 and 2 are >0.3 units lower 
than those similar cisplatin adducts. This, combined with slower hydrolysis (Table 
4.3), is likely to result in a reduced intracellular activity of complex 1 compared to 
cisplatin and may contribute to its high activity against cisplatin-resistant cell lines. 
Studies of reactions of complexes 1 and 2 with guanosine 5'-monophosphate (5'-
GMP) were also made, which is reported in the next chapter, and have established 
that hydrolysis is the rate-limiting step for both complexes 1 and 2. The formation of 
the bis-GMP adduct of complex 1 is about twice as slow as that for complex 2, which 
is consistent with the brief report that complex 1 forms DNA cross-links extremely 
slowly. 8 Further NMR studies should allow a detailed insight to be gained into the 
effect of steric hindrance on the formation of DNA adducts. 
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Chapter 5 
Kinetic Control of Reactions of a Sterically-hindered 
Platinum Picoline Anticancer Complex with 
Guanosine 5'-monophosphate and Glutathione 
Chapter 5 Reactions with GMP and GSH 
5.1 Abstract 
Kinetic studies (296 K, 0.1 M NaC104, pH 6-7) of reactions of the anticancer 
complex cis-[PtC12(NH3)( 2-picoline)] (1) (ZD0473) with guanosine 5'-
monophosphate (5'-GMP) and the tripeptide glutathione (GSH) using 2D ['H, ' 5N] 
HSQC NMR spectroscopy are reported, and compared to reactions of the isomeric 
complex cis-[PtC1 2(NH3)(3-picoline)] (2). Reactions with 5'-GMP followed two 
pathways with either hydrolysis trans to NH3 or picoline as the first step, with 
subsequent formation of Cl/GMP and H 20/GMP intermediates, and cis-
[Pt( 15NH3 )(pico]ine)(5-GMP-N7)2] 2 as the final product. Eight rate constants were 
determined for each starting Pt complex 1 and 2. The rates of ligand substitution (CV 
by H20 and H20 by 5'-GMP) cis to 2-picoline were 2-12 times slower than the same 
ligand substitution cis to 3-picoline. This was also the case for ligand substitution 
trans to 2-picoline (2-3 times slower), except that when 5 '-GMP was present as the 
cis ligand (second stage of substitution) the rate of substitution was enhanced for the 
2-picoline complex. Slow rotation about the Pt-N picoline bond (0.62 s') and fast 
rotation about Pt-N7 GMP bonds on the NMR time scale were observed at 296 K for 
the bisGMP adduct of complex 1, while these were both fast for the analogous adduct 
of complex 2. Reactions of GSH with 1 were ca 3 times slower than those with 2, 
and appeared to proceed via aquated intermediates with initial substitution trans to 2-
picoline for 1 and trans to NH3 for 2, but no kinetic analyses were attempted due to 
the complexity of the reactions. Both mono- and bis-GMP adducts were observed 
during competitive reactions of GSH and 5-GMP with complex 1 (molar ratio: 
2:2: 1) at pH 7, 296 K. These features of the chemistry of 1 may play an important 
role in its altered spectrum of biological activity compared to cisplatin. 
5.2 Introduction 
Chapter  Reactions with GMP and GSH 
Cisplatin, cis-[PtCl2(NH3)2], is a widely-used anticancer drug. Because of its serious 
toxic side-effects and the spontaneous development of drug resistance in tumours, 
there is a need for new drugs which circumvent these drawbacks. Investigations have 
been made of the activity of many other platinum complexes, most of which belong 
to the structural class cis-[PtAm2X2] (X = anionic leaving group; Am = ammonia, 
primary or secondary amine).' An exception is the 2-picoline (2-methylpyridine) 
complex cis-[PtCl2(NH3)(2-picoline)} (1) (ZD0473), which is currently in phase I 
clinical trials. 2,3  It possesses activity against cisplatin-resistant cell lines and against 
an acquired cisplatin-resistant subline of a human ovarian carcinoma xenograph both 
by injection and by oral administration. 2 It appears to circumvent thiol-mediated 
resistance mechanisms whilst still maintaining the ability to form cytotoxic lesions 











In order to gain an understanding of the chemical reactivity of this complex, 
investigation has been made with its X-ray crystal structure and hydrolysis behaviour 
in comparison with the isomeric 3-picoline complex cis-[PtCl2(NH3)(3-picoline)] 
(2). The most notable feature of the structures is the orientation of the picoline ring 
with respect to the Pt square-plane. The 2-picoline ligand is almost perpendicular 
(103°) such that the 2-methyl group lies directly over the square-plane, while the 3-
picoline ligand is tilted by 49°. This steric effect plays an important role in 
determining the hydrolysis rates of the Cl - ligands. For complex 2, the rate of 
hydrolysis of Cl' trans to NH3 is similar to that of cisplatin 4112 = 1.75 h, 310 K), 6 
while for complex 1 the rate of hydrolysis for the CF ligand trans to NH3 (cis to 2-
picoline) is about 5 times slower 0112 = 8.7 h). The slow hydrolysis of 1 can be 
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attributed to the axial steric hindrance provided by the 2-methyl group. Complex 1 
appears to form interstrand DNA cross-links and to bind to plasma proteins much 
more slowly than cisplatin. 7 
Besides steric effects, electronic factors may also play a role in determining 
the reactivity of pyridine complexes. For example the presence of planar pyridine 
ligands in cis- or trans-[PtCl2(pyridine)2] complexes can reduce the rates of DNA 
binding compared to ammine complexes. 8 DNA platination is a key event in the 
mechanism of action of platinum anticancer drugs, and the major adduct formed by 
attack of cisplatin on DNA is the intrastrand cross-link between N7 atoms of two 
adjacent guanine (G) residues.' In a DNA duplex helix, GN(7) is not involved in 
Watson-Crick base pairing and is exposed in the major groove. 
5'-GMP 
Guanosine 5'-monophosphate has been widely used to model Pt-DNA 
interactions. There are several possible metal-binding sites on 5 '-GMP, which 
include: the five nitrogen atoms (each of which has a formal lone pair of electrons) 
and the carbonyl oxygen atom (in the case of guanine). However N(7) is the preferred 
binding site because it has a 'directed', sp 2-hybridized lone pair and the site is less 
sterically crowded. In typical cis-PtA2G2 adducts, the appearance of one time-
averaged set of signals in the 'H-NMR spectrum indicates that rotation about the Pt-
N(7) bond is fast on the NMR time scale. 9 However, bulky ligands (A2) can slow the 
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rotation about the Pt-N(7) bond, permitting the observation of rotamers which are 
evident from the appearance of multiple sets of 'H-NMR signals.' ° ' 1 ' 
Besides nucleotides, platinum can also interact with many other biomolecules, 
especially those containing methionine and cysteine residues. Glutathione (GSH), a 
cysteine-containing tripeptide (y-L-Glu-L-Cys-Gly), is the predominant intracellular 
OOC 	 OH 	OH 
"cH_(cH2)24—rti-_ci-i_&_LcH_coo - 
Glutathione (GSH) 
thiol with concentrations typically ranging from 0.5 to 10 MM. It has a variety of 
physiologically important functions in cellular defence and metabolism, and also 
interacts with a wide range of drugs. GSH can quench DNA-platinum monoadducts 
before their conversion to cytotoxic DNA cross-links, 12  or it may form complexes 
with cisplatin, thereby reducing the amount of intracellular cisplatin available for 
interaction with DNA. 13  Reactions of thiols with Pt complexes are considered to be 
responsible for drug inactivation and the development of drug resistance. 14 The 
cytotoxicity of cisplatin has been shown to be enhanced by depletion of cellular GSH 
in some tumour cells. GSH is over-expressed in cisplatin-resistant cells and the Pt-
GS adducts can be pumped out of cells through a novel ATP dependent GS-X 
pump. 5" 6 At physiological pH, Pt(II) complexes usually show a kinetic preference 
for the thiols cysteine and glutathione over 5'-GMP, even in the presence of excess 
nucleotide. 17 
In this work, the reactions of complex 1 and the less-hindered isomeric 
complex 2 with 5'-GMP and glutathione (GSH) have been investigated by both 1D 
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'H and 2D ['H, ' 5N] HSQC NMR spectroscopy, in order to study the influence of 
both steric and electronic effects on reactions of potential biological importance. 
5.3 Experimental 
Materials 
2-, 3-Picoline and GSH were purchased from Aldrich. The sodium salt of 5'-GMP 
was obtained from Sigma. Cis-[PtC12( 15NH3)21  was prepared according to the 
reported procedure. 18 N labelled complexes 1 and 2 were prepared from cis-
[PtC12( 5NH3)21 as described in Chapter 4. The cis-[Pt(NH3)(2picoline)(H20)2j 2 
was prepared in situ by addition of slightly less than 2 mol equiv of AgNO, to an 
aqueous solution of complex 1. The solution was stirred in dark for 24 hours and 
followed by removal of the AgCI precipitate using centrifuge. 
NMR spectroscopy 
NMR spectra were recorded on a Bruker DMX500 NMR spectrometer operating at 
500.13 MHz using a TBT probehead. All data processing, including the integration 
routines described below, was carried out using XWIN-NMR version 1.3 (Bruker 
Spectrospin Ltd.). The chemical shift references were as follows: dioxane (internal, 
3.767 ppm) for 'H, and 1 M ' 5NH4CI in 1.5 M HCI for 15N (external). All spectra 
were recorded at 296 K unless otherwise stated. Typical acquisition conditions for 1 H 
spectra were: 45-60 ° pulses, 2.5 s relaxation delay, 64-256 transients, final digital 
resolution 0.2 Hz per point. The water resonance was suppressed by presaturation, or 
via the WATERGATE pulsed-field-gradient sequence. 19 2D [ 1H, ' 5N] HSQC NMR 
spectra (optimised for 'J(NH) = 72 Hz) were recorded by using the sequence of 
Stonehouse a. al.20 The 15N-spins were decoupled by irradiating with the GARP-I 
decoupling sequence during acquisition. The 2D exchange experiment was 
performed using phase-sensitive nuclear Overhauser effect spectroscopy (NOESY) 
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with a mixing time 1 s, at 296 K. Rates were calculated using the program D2DNMR 
kindly supplied by Dr. K.G. One!!. 2 ' Inputs for each calculation consisted of volume 
integrals from diagonal- and cross-peaks together with population estimates based on 
1D 1 H NMR spectra. 
All samples were in 90%H20/10%D20 (0.6 ml). The reactions of complexes 
1 or 2 (3 mM) with 5'-GMP were conducted at a 1:2 molar ratio. Samples contained 
0.1 M NaCI04 to maintain a constant ionic strength. Buffer was not used in the 
reactions of complexes 1 and 2 with 5'-GMP in order to avoid possible interference 
with the reactions, and the pH values were adjusted to 6.85 and 6.55 (for complexes 
1 and 2, respectively) at the beginning of the reaction. The pH value for the reaction 
of cis-[Pt(NH3)(2-picoline)(H20)2I 2  with 5'-GMP (1:2) was adjusted to 6.47. In the 
reactions of complex 1 or 2 with GSH (3 mM, 1:1 molar ratio), 100 mM phosphate 
buffer (pH = 7) was used. Competitive reactions between 5'-GMP and GSH with 
complexes 1 or 2 (2 mM) were carried out at 2:2:1 molar ratios, with 100 mlvi 
phosphate buffer present to maintain neutral pH. After mixing, argon was bubbled 
through the solution to minimise GSH oxidation and the NMR samples were 
carefully sealed. 
pH measurements 
These were made using a Coming 145 pH meter equipped with an Aldrich micro 
combination electrode calibrated with Aldrich buffer solutions of pH 4, 7 and 10. 
Values of pH were adjusted with 1 M HCI04 or NaOH as appropriate. 
Kinetic measurements 
For kinetic analysis of NMR spectra, peak volumes were measured and the relative 
concentrations of each species were calculated at each time point. The appropriate 
differential equations were integrated numerically, and the rate constants were 
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determined by a non-linear optimization procedure using the program SCIENTIST 
(version 2.01, MicroMath Inc.). The errors represent one standard deviation. 
For reaction of complexes 1 or 2 with 5'-GMP (shown in Scheme 5.1), and 
assuming that at time t, the concentrations of species a, b, c, d, e, f, g, h are A, B, C, 
D, E, F, U and H, respectively. Then the corresponding reaction rates are: 
A'= -k1A 42A + k' 1 .B.(B+C+Di-Ei-2F+2G+2H) + k2•C(B+C+D+E+2F+2G+2H) 
B'= k1•A - k3•B(2A0-D-E-F-G-2H) - k'1.B.(B+C+D+E+2F+2G+2H) 
C'= k2A - k4•C(2A0-D-E-F-G-2H) - k'2.C(B+C+D+E+2F+2G+2H) 
D'=  k3 B(2A0-D-E-F-G-2H) - k5D + k5F(B+C+D+E+2F+2G+2H) 
E'=  k4C(2A0-D-E-F-G-2H) - k6E + k'6G(B+C+D+E+2F+2G+2H) 
F'= k5•D - k7F(2A0-D-E-F-G-2H) - k'5•F(B+C+D+E+2F+2G+2H) 
G'= k5E - k8•G(2A0-D-E-F-G-2H) - k'6.G.(B+C+D+E+2F+2G+2H) 
H'= k7 .F.(2A0-D-E-F-G-2H) + k8G.(2A0-D-E-F-G-2H) 
A0 is the starting concentration of complex 1 or 2, and k' 1 , k'2, k'5, k'6 are the rate 
constants for back reactions corresponding to k1, k2, k5 and 1c5 (Scheme 5.1). 
5.4 Results 
Labelling the anilnine ligand with 15N allowed investigation of the specificity and 
rates of substitution of the chloride ligands in complexes 1 and 2 by Y-GMP and 
GSH to be made for the first time using 2D [ 1 H, ' 5N] NMR spectroscopy. The 15N 
chemical shift is diagnostic of the coordinating atom of the ligand in the position 
trans to the ammine. 22 For an ammine ligand trans to an oxygen donor in a Pt(II) 
complex, the 15N shift lies between -75 and -90 ppm, for an ammine trans to 
nitrogen/chloride, between -55 and -70 ppm, and for ammine trans to sulfur, between 
-40 and -50 ppm. 
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Both 1D 'H and 2D [ 1 H, ' 5N] HSQC NMR spectroscopy were used to monitor the 
reactions between complex 1 or 2 (3 mM) and 5'-GMP in a 1:2 molar ratio at 296 K 
and pH 6.85 or 6.55, respectively. 2D ['H, 15N] HSQC NMR spectra recorded 40 It 
after mixing for complex 1 and 20 It for complex 2 are shown in Figures 5. 1A and 
5.1B, respectively. For the 3-picoline complex 2, the peak assignable to 2 at 4.26/-
62.68 ppm (peak 2a) was accompanied by two new peaks (21b and 2c) with chemical 
shifts of 4.12/-79.62 and 4.33/-61.31 ppm after one hour. The ' 5N shift of former 
peak is typical of NH3 trans to 0 and is consistent with assignment to 
{PtC1(' 5NH3)(3-picoline)(H20)1' (2b), 5 and the latter peak to the aqua complex 2c 
with 15NH3 trans to Cl, Table 5.1 (for the structures of complexes, see Scheme 5.1). 
The intensity of the cross-peak from the monoaqua complex 2b, in which the H20 is 
trans to NH3, is much stronger than that of complex 2c with H20 trans to 3-picoline. 
After 2 h, two other new peaks (2d and 2e) appeared at 4.27/-64.21 and 4.53/-60.81 
ppm, which are both in the region of 15NH3 trans to N or Cl. By comparing the 
intensities of these two peaks with those for the two monoaqua species (2b, 2c), the 
stronger cross-peak 2d can be assigned to [PtC](' 5NH3)(3-picoline)(5'-GMP-N7)1' 
(2d, GMP trans to NH3), and cross-peak 2e to [PtCl( 15NH3)(3-picoline)(5'-GMP-
N7)] (2e, GMP trans to 3-picoline). These two peaks reached a maximum intensity 
after 5 to 6 h and then gradually decreased in intensity. Cross-peaks 2f at 4.44/-60.93 
(NH3 trans to N) and 2g at 4.47/-75.92 ppm (NH3 trans to 0) differ greatly in 
intensity, comparable to the difference observed for cross-peaks 2d and 2e (Fig. 
5.1B). Therefore, cross-peak 2f is assignable to [Pt( 15NH3)(3-picoline)(5'-GMP-
N7)(H20)] 2 (GMP trans to NH3) (2f), and cross-peak 2g to [Pt(' 5NH3)(3-
pico1ine)(5'-GMP-N7)(H20)] 2 (OMP trans to 3-picoline) (2g). Cross-peak 2h at 
4.63/-62.60 ppm, which was observable from soon after the beginning of the 
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Figure 5.1 2D ['H, 15N] HSQC NMR spectra from reactions of 2 mol equiv. of 5'-
OMP (0.1 M NaC104, 296 K) with (A) (15  NH,)-1, pH = 6.85, after 40 h and (B) 
(' 5NH3)-2 pH = 6.55, after 20 h. Peak assignments are given in Table 5.1. 
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reaction, increased in intensity with time, and became the major cross-peak after 24 
h. This is assignable to the final his 5'-GMP product cis- [Pt(' 5NH3)(3-picoline)(5'-
GMP-N?)2] 2 (2h). An unassigned cross-peak 2i at 4.33/-59.55 ppm, appeared after 8 
h of reaction, but accounted for only a very small amount of the total Pt-NH3 species 
present (<4%), and disappeared after 1 week. The assignments and chemical shifts 
of all peaks are listed in Table 5.1. The reaction pathway is summarised in Scheme 
5.1. 
The reaction of the 2-picoline complex 1 with 5'-GMP was much slower in 
comparison with complex 2. Only peaks for complex 1 (peak la) (4.19/66.75 ppm) 
and two monoaqua hydrolysis adducts (peaks lb and ic) with similar intensity 
(3.99/-82.61, 4.22/-65.34 ppm, respectively) were observed after two hours at 296 K. 
The chemical shift distribution of the cross-peaks for the 2-picoline complexes in 
Figure 5.1A is very similar to that for the 3-picoline complexes in Figure 5.113, 
except that all the 15N chemical shifts of the signals in Figure SiB are shifted to low 
frequency by ca 3 ppm. However, the relative intensities of the cross-peaks for the 
intermediates in the reaction of complex 1 with 5'-GMP are different from those for 
complex 2. Cross-peaks le at 4.47/-64.51 ppm and lg at 4.36/-78.60 ppm are 
stronger than the peaks Id at 4.22/-67.43 ppm and lf at 4.35/-64.18 ppm, 
respectively. Whereas, for complex 2, cross-peaks 2d and 2f are much stronger than 
2e and 2g. The two cross-peaks lb and lc for the monoaqua adducts of complex 1 
had similar intensities during the reaction. The final bisGMP adduct is formed much 
more slowly for complex 1 compared to complex 2. The broad cross-peak (lh) for 
the bisGMP adduct of complex 1 appeared to be composed of two overlapping cross-
peaks at 4.59/-65.96 and 4.58/-66.05 ppm. The peak intensity versus time profiles 
(Figure 5.2) allowed similar assignments to be made for the cross-peaks obtained 
from reactions between complexes land 2 with 5'-GMP (Table 5.1). Cross-peaks ig, 
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Table 5.1 1 H and 15N NMR Pt-NH3 chemical shifts at 296 K for cis-{Pt( 15NH3)(2-
picoline) 124  and cis- { Pt( '5NH3)(3-picoline) 12,  complexes. 
S( ' 5N) 
Compound 	 Peak* 	o( ' M) 	( 15NH3 trans to) 
a 
[PtCl 2( 15NH3)(2-pico}ine)] la 4.19 -66.75 (Cl) 
[PtCl(' 5NH3)(2-picoline)(H20)] lb 3.99 -82.61 (0) 
[PtCI( 5 NH3)(2-picoline)(H20)f' lc 4.23 -65.34 (Cl) 
[PtC1( 5NH3)(2-pico1ine)(5'-GMP-N7)] +  id 4.22 -67.43 (N) 
[PtC1( 5NH3)(2-picoline)(5'-GMP-N7)1 le 4.47 -64.51 (Cl) 
[Pt( 5NH3)(2-pico1ine)(5'-GMP-N7)(H20)] 2 if 4.35 -64.18 (N) 
[Pt( 5NH3)(2-pico1ine)(5'-GMP-N7)(H20)] 2 ig 4.36 -78.60(0) 
[Pt( 5NH3 )(2-pico1ine)(5'-GMP-N7)2] 2 lh 4.59 -65.87 (N) 
4.58 -66.15 (N) 
[PtCl2( 15  NH3)(3-picoline)]  2a 4.26 -62.68 (Cl) 
[PtC1(' 5NH3)(3-picoline)(H20)f' 2b 4.12 -79.62(0) 
[PtC1(' 5NH3)(3-picoline)(H20)f' 2c 4.33 -61.31 (Cl) 
[PtCl(' 5NH3)(3-pico1ine)(5'-GMP-N7)] 2d 4.27 -64.21(N) 
[PtC1( ' 5NH3)(3-picoline)(5'-GMP-N7)] 2e 4.53 -60.81 (Cl) 
[Pt( 15NH3 )(3-pico1ine)(5'-GMP-N7)(H20)] 2 2f 4.44 -60.93 (N) 
[Pt(' 5NH3 )(3-picoline)(5'-GMP-N7)(H2O)j 2 2g 4.47 -75.92(0) 
[Pt(' 5NH3 )(3-picoline)(5'-GMP-N7)2] 2 2h 4.63 -62.60 (N) 
unassigned 21 4.33 -59.55 (N) 
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Figure 5.2 Plots of the relative concentrations of species a to h (based on Pt-NH 3 
peak integrals) versus time for the reactions shown in Fig. 5.1. (A) 2-Picoline 
complex 1, (B) 3-picoline complex 2. Peak labels: (a) •, (b) 0, (c) A, (d) X, (e) +, 
(f) N, (g) •, (h) A. The curves are the computer best fits for the rate constants given 
in Table 5.2. 
123 

































Chapter 5 Reactions with GMP and GSa 
Table 5.2 Rate constants for reactions of cis-[PtC12(NH3)(picoline)] with 5'-GMP at 




Rate constants 	2-picoline 	 3-picoline 	k31 0 / k21 0 
k1 (1) 6.87 (± 0.18) x 10- 
5.87 (±0.18)x 10' 
k3 (M' 1 •s') 7.97 (± 0.33) x 10' 
k4 (M"•s 1 ) 6.67 (± 0.37) x 1'3 
/c 	(s') 8.53 (± 1.11) x 10-5 
k6 ('1) 2.77 (± 0.31) x 1'5 
k7 (M*s") 4.2 (± 0.6) x 10 2 
ks (M*s") 5.92 (± 0.74)x 10-3 
2.60 (± 0.03) x io- 4 
1.17 (± 0.03)x 10 -' 2 
1.60 (± 0.03)x 102 2 
1.87 (± 0.08) x 102 3 
1.78 (± 0.04)x io' 0.2 
1.48 (± 0.14) x 10 4 5 
3.2 (± 0.1) x 102 0.8 
6.85 (± 0.75) x 1112 12 
if and ih were also observed during reaction of the diaqua complex cis-
[Pt(' 5NH3)(2-picoline)(H20)2] 2" (3 mIvi) with 5'-GMP (1:2) at 296 K and pH 6.47. 
Kinetic fits to the reaction profile in Scheme 5.1 for complexes 1 and 2 are 
shown in Figures 5.2A and 5.213, and the rate constants for each step are listed in 
Table 5.2. Most of the rate constants for the reaction steps of complex 2 with 5'-GMP 
are more than twice as large as those for complex 1, except k5 and k7. The largest 
differences are for k5 and k8 (substitution of Cl' cis to picoline by H20, and then by 
5'-GMP in the second stage), which are five and twelve times larger for complex 2. 
Rotation of 5'-GMP and 2-picoline in cis -[Pt(2-picoline)(NH3)(5'-GMP)2] 2 
1 H NMR spectra for the reactions between complex 1 or 2 and 5'-GMP (1:2 reaction 
ratio) at 296 K recorded after 2 hours and 1 week are shown in Fig. 5.3. For complex 
i, after I week of reaction, the H8 resonance of free 5'-GMP at 8.19 ppm and the 
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methyl signal of complex 1 at 3.15 ppm have completely disappeared (Fig. 53A). 
Four major H8 signals were observed in two sets of two singlets between 8.7 and 8.3 
ppm, and two methyl-signals appeared at 3.30 and 3.27 ppm. The Hi' signals of 
bound 5'-GMP were also observed in two sets of two doublets, with vicinal coupling 
constants 3J(Hl'-H2') = 4.8, 4.4 and 5.1, 4.9 ± 0.1 Hz. However, for complex 2 after 
one week of reaction, only two H8 signals at 8.66 and 8.52 ppm were observed 
together with one methyl signal at 2.37 ppm and two HI' doublets ( 3J(H1 '-H2') = 
4.6 and 4.9 ± 0.1 Hz ) for bound 5'-GMP (Fig. 5.3B). 'H NMR data for cis-[Pt(2-
picoline)(NH3)(5'-GMP)2] 2 (lh) and cis-[Pt(3-picoline)(NH3)(5'-GMP)2] 2 (2h) are 
listed in Table 5.3. 
Table 5.3 'H NMR Chemical shifts and coupling constants (Hz) for his 5'-GMP 
adducts of 1 (pH = 6.85) and 2 (pH = 6.55) at 296 K. (Pie = picoline) 
Complex 	 8H8 	8CH3 	SHY 	3J(Hl -H2) 
cis-[PtCl2(NH3)(2-Pic)] (1) 	 3.15 
[Pt(NH3)(2-Pic)(5'-GMP)2] 2 	8.66, 8.63 	3.30, 3.27 	5.93, 5.92 	4.8, 4.4 
	
8.42, 8.40 	 5.80, 5.78 	5.1,4.9 
cis- [PtCl2(NH3)(3-Pic)] (2) 	 2.37 
[Pt(NH3)(3-Pic)(5'-GMP)2] 2 	8.66, 8.52 	2.36 	5.93, 5.82 	4.6, 4.9 
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* 	* * 
 
9.0 8.5 8.0 7.5 7.0 6.5 	ppm 	3.0 ppm 
Figure 5.3 'H NMR spectra recorded after 2 h and I week of reactions at 296 K of 5'-GMP (2 mol equiv) with (A) complex 1, and (B) 
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Figure 5.4 The temperature dependence of the H8 'H NMR signals of cis-
[Pt(NH3)(2-pico1ine)(5'-GMP)2] 2 
129 









3.4 	3.3 	3.2 	3.1 	3.0 
Figure 5.5 2D EXSY spectrum (mixing time = 1 s) for cis- [Pt(NH 3 )(2-picoline)(5'-
GMP)2] 2 showing exchange cross-peaks between the two methyl signals, indicative 
of the slow rotation of coordinated 2-picoline. 
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The temperature dependence of the H8 signals of [Pt(2-pico1ine)(NH3)(5'-GMP)2] 2 
is shown in Fig. 5.4. The four H8 singlets coalesced into two singlets when the 
temperature was raised to 338 K. Based on the coalescence temperature (Tc) and the 
chemical shift differences (Ay in Hz) between the two signals in the slow exchange 
limit, the rate constant ic and activation free energy AG' for the exchange process at 
338 K were calculated 23: 
/c = 2.22 •Av = 25.5 51 
AG c+ = 19.14 T (10.32 + log 	J moL 1 = 73.2 kJ • mol' 
At 338 K, the two 'H, ' 5N cross-peaks which constituted peak lh (Fig. 5.1A) for bis-
GMP adducts of complex 1 merged into one cross-peak. The two methyl signals at 6 
3.30 and 3.27 ppm also became closer when the temperature was raised to over 333 
K. Because of the temperature limitation of the NMR probe, the spectrum was 
recorded at a maximum temperature of 348 K, where no coalescence of the two 
methyl signals was observed. When the spectra were recorded at 250 MHz, the two 
methyl signals were observed to coalescence at 343 K, from which similar Ic (25.6 
S-1 ) and AG+  (75.15 kJ • moF) values were obtained. A 2D EXSY experiment with a 
mixing time of 1 s (Fig. 5.5) showed clear exchange cross-peaks between the two 
methyl signals at 296 K. An average rate constant for the exchange process of 0.62 s 
at this temperature was determined. Interestingly, one of the four H8 signals at 8.42 
ppm for the bisUMP adduct of complex 1 became broader when the temperature was 
below 296 K (Fig. 5.3A), as did one of the -CH3 signals at 3.30 ppm. 
Reactions of complexes 1 and 2 with glutathione (1:1, pH 7) 
Reactions of complexes 1 and 2 with GSH were followed by 2D ['H, ' 5N] HSQC 
NMR spectroscopy. Spectra recorded after 3.5 h are shown in Fig. 5.6. In both cases, 
peaks assignable to hydrolysis products (ib, lc and 2b, 2c) were observed before the 
appearance of peaks for GSH adducts. For complex 2, cross-peaks from GSH adducts 
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Figure 5.6 Two-dimensional [ 1 H, 15N] HSQC NMR spectra for reactions of GSH (1 
mol equiv.) with (A) complex 1, and (B) complex 2, recorded at 296 K, pH 7 (100 
mM phosphate buffer) after 3.5 h. Peaks (la to ic, and 2a to 2c) are assigned 
according to Table 5.1; the others are unassigned. Satellites ( 195Pt) of peaks la and 
2a are labelled with *• Peaks with 15N chemical shifts near -40 ppm are characteristic 
of NH3-Pt trans to sulfur. 
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Table 5.4 'H and 15N NMR Pt-NH3 chemical shifts at 296 K for the major peaks 
observed during the reactions of 1 and 2 with GSH (1:1 molar ratio, pH 7). 
Peak a 	 6('H) 	 5(' 5N) ("NI-13 trans to) 
la 4.21 -66.84 (Cl) 
lb 3.89 -81.27(0) 
ic 4.23 -65.49 (Cl) 
lj 4.27 -62.64 (N or Cl) 
ip 3.60 -40.85(S) 
lq 3.97, 3.95 -65.84, -65.95 (Nor CI) 
* 4.29 -62.52 (N or CI) 
* 4.25 -62.89 (N or Cl) 
* 3.96 -43.24(S) 
* 4.05 -42.76(S) 
* 3.69 -42.12(S) 
2a 4.27 -62.82 (Cl) 
2b 3.93 -76.77(0) 
2c 4.30 -61.74 (Cl) 
2j 4.32 -58.14(NorCl) 
2k 4.10 -40.09(S) 
2m 4.05 -39.01 (S) 
2n 3.97 -39.37(S) 
3.68 -36.70(S) 
a For peak labels, see Fig. 5.6. Peaks labelled * were not observed in the same 
spectrum as the other peaks but appeared at later times. 
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Figure 5.7 Time dependence of the concentrations of the starting complex 1 (, its 
monoaquachloro adducts (lb + ic) (A), and complex 2 (0), its monoaquachioro 
adducts (2b + 2c) (X), during reactions with GSH (1:1 molar ratio, pH 7,296K). 
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began to appear after 45 minutes in the 8( 5N) region of -35 to -40 ppm which 
corresponds to NH3 trans to S, while for complex 1, new peaks were observed only 
after 2 h and in the 8( 5N) region of -62 to -67 ppm which corresponds to NH3 trans 
to N or Cl. Therefore, the first binding site for 0S is trans to 2-picoline for complex 
1, but cis to 3-picoline for complex 2. Due to the complicated nature of the reactions 
(Table 5.4), no specific assignments for the products of the reactions between 
complex 1 and 2 and GSH have been made. Time dependences of the concentrations 
of complexes 1 and 2 and their monoaquachloro adducts during the reactions with 
GSH are shown in Fig. 5.7. The rate of reaction of complex 2 is about 3 times as fast 
as that of complex 1. After two weeks' standing at ambient temperature, yellow 
precipitates formed in both reactions, and all the signals had disappeared from the 2D 
['H, ' 5N1 HSQC NMR spectra. 
Competitive reactions of 1 or 2 with GSH and 5-GMP 
The reaction of complex 1 with GSH in the presence of 5'-GMP (1:2:2) was 
followed by 2D [ 1 11, 15N] NMR spectroscopy at 296 K, pH 7 (100 mM phosphate 
buffer). A spectrum recorded after 14.5 h of reaction is shown in Figure 5.8. Only the 
peaks for the starting complex 1 (peak la) and hydrolysis products (peaks ib, ic) 
were present after 0.5 h. Peak lq, which was also observed during the reaction with 
GSH (Fig. 5.6a), began to appear after 1 h of reaction. The mono-GMP adduct (peak 
le) began to form after 2.5 h, and the bis-OMP adduct (peak lh) was present after 8 
h of reaction. Peaks due to both 5'-GMP adducts (id, le, if and lh) and GSH 
adducts (peaks lq, lj, ir and those in dashed box) are present in Fig. 5.8. Due to the 
complicated nature of GSH reactions, no attempt was made to assign the peaks iq, lj 
or those in the region for NH3-Pt trans to S (dashed box, Fig. 5.8). Most of these 
peaks for GSH adducts were also observed in the reaction of complex 1 with GSH in 
the absence of 5'-GMP. Peak ir has an ' 5N chemical shift in the region of NH3-Pt 
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Figure 5.8 2D ['H, ' 5N] HSQC NMR spectrum for the competitive reaction of OSH 
and 5'-GMP with complex 1 (molar ratio: 2:2:1) at 296 K, pH 7.0 (100 mM 
phosphate buffer) recorded after 14.5 h. Peaks of 5'-GMP adducts (id, le, lh) and 
GSH adducts (lj, lq) are labelled according to those in Table 5.1 and Table 5.4. 
Satellites of peak la are labelled with . The peaks in the dashed box are due to the 
formation of GSH adducts (' 5N chemical shifts near -40 ppm are characteristic of 
NH3 -Pt trans to sulfur), but no specific assignments were made. Peak ir is 
tentatively assigned to an adduct with one GMP and one GSH ligand in the cis 
position (NH3-Pt trans to N7). 
-60 
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trans to N or Cl, and was not observed in the reactions of 1 with 5'-GMP or with 
GSH. It can be tentatively assigned to a mixed-ligand adduct containing GMP trans 
to NH3 and a 0S ligand. Spectra recorded after 3 days of reaction at 296 K showed 
that only one major peak (lh) in the region of NH3-Pt trans to N or Cl (8 15N: -60 to - 
70 ppm) together with some other peaks ( 15N: -40 to -45 ppm) in the region of NH3-
Pt trans to S. The presence of a strong H8 signal at 8.13 ppm due to free 5'-GMP in 
1D spectra recorded after 3 days showed that most of the 5'-GMP was still unreacted 
at this stage, while signals for free GSH had nearly disappeared. The 2-methyl signal 
at 3.15 ppm from coordinated 2-picoline had shifted to 2.57 ppm, which implied that 
the 2-picoline ligand had been mostly displaced. Signals for the bisGMP adduct were 
only just visible in 1D spectra because of their low intensity and overlap with broad 
signals. Compared with 1, the competitive reaction of 2 with GSH and 5'-GMP 
(1:2:2) was much faster and peaks assignable to GSH adducts were detectable after 
0.5 h. Mono and bisGMP products started to appear after 1.5 and 5 h of reaction, 
respectively. Much less of the bisGMP adduct of complex 2 was formed in the 
competative reaction with GSH compared to complex 1. 
5.5 Discussion 
Cis-[PtC12(NH3)(2-picoline)I (1) is a new anticancer drug which has a different 
spectrum of biological activity compared to cisplatin. In particular it is active against 
cisplatin-resistant cell lines and xenographs. 2 ' 3 ' 4 In order to shed light on the chemical 
reactivity of 1, and to elucidate the potential role of steric hindrance, 5 kinetic studies 
of reactions of complex 1 with 5'-GMP and OSH have been made in comparison to 
the isomeric 3-picoline complex 2. By labelling complexes with 15NH3, it was 
possible to determine for the first time the specificity of substitution of the chloride 
ligands by 5'-GMP and GSH using 2D ['H, 15N] HSQC NMR spectroscopy. Because 
of the sensitivity of the 15N chemical shifts to the ligand trans to H3N-Pt, and of 'H 
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NH3 shifts to cis effects, it has been possible to resolve peaks for a variety of 
intermediates in the reactions, detect them at micromolar concentrations, and make 
reasonable assignments. 
Reactions with 5'-GMP 
Concentration versus time profiles for reactions of complexes 1 and 2 with 5'-GMP 
fitted well to the kinetic scheme shown in Scheme 5.1, showing that they are two-
step and two stage: initial hydrolysis followed by 5'-GMP substitution to give the 1:1 
Pt-5'GMP adduct, and then further hydrolysis and 5'-GMP substitution to give the 
final product, the bis 5'-GMP complex. For each complex there are two routes to the 
final product, depending on whether initial substitution is trans to picoline or trans to 
NH3. From the rate constants listed in Table 5.2, the following conclusions can be 
drawn: 
The rates of ligand substitution (Cl - by 1120, or H20 by 5'-GMP) cis to picoline 
(k1, k3, /co, k8) are 2-12 times slower for the 2-picoline complexes compared to 3-
picoline. 
The rates of substitution trans to picoline are also slower for the 2-picoline 
complex (2-3 times slower) except when 5'-GMP is present as the cis ligand 
(compare 1c5 and k7 values for complexes 1 and 2, Table 5.2). However, it should 
be noted that the errors for some of the rate constants determined for the second 
stage of the reaction are rather large on account of the low concentrations of the 
intermediates. 
The relative rates of the first step of the GMP reactions are similar to those we 
determined previously for hydrolysis of the complexes, and for complex 2 these 
follow the order expected from the higher trans influence of NH3 (pK a 9.29) 
compared to 3-picoline (pKa 6.0),24 which is the weaker a donor. Since 2-picoline 
has a similar pKa value (6.1) to that of 3-picoline, the similarity in the hydrolysis 
138 
Chapter 5 Reactions with GMP and CS!.! 
rates for CF trans to NH3 and trans to 2-picoline in complex 1 can be attributed to 
steric hindrance provided by the 2-methyl group. In the X-ray structure of complex 1, 
the 2-picoline ligand is almost perpendicular to the Pt square plane (102.7) and the 
methyl group is close to Pt (113ç• "Pt: 3.224 A). 5 
Such steric hindrance is well known to slow down the rates of ligand 
substitution reactions in square-planar metal complexes. 25 For example, the rate 
constants (s') for the hydrolysis of cis-[PtC1(L)(PEt3)2] complexes (the replacement 
of Cl- by H20) decrease in the order of (L): pyridine (800 x 10) > 2-methylpyridine 
(2.0 x 10-4) > 2,6-dimethylpyridine (0.01 x 10j. 26 In the latter case the methyl 
groups block entry of incoming nucleophiles both above and below the square-plane. 
The steric effect is more prominent in the position 'cis to 2-picoline which is 
consistent with the CH3 group being further from the entering and leaving groups in 
the trigonal bipyramidal transition state if the pyridyl ligand is in the trigonal 
plane. 26,27  The plane of the 3-picoline ring in complex 2 is tilted by 48.9° with respect 
to the Pt square plane, and the rates of substitution for (2) are determined mainly by 
the trans effect. 
The rate of binding of the second 5'-GMP ligand in the position cis to picoline 
is much slower for complex 1 compared with 2, which gives rise to a long-lived 
monofunctional adduct for the 2-picoline complex. This may explain the brief report 
that complex 1 forms DNA cross-links extremely slowly. 7 There appears to be no 
comparable kinetic data available in the literature for reactions of 5-GMP with 
cisplatin. Compared to the rate constants for the second stage of binding of 5'-GMP 
to [Pt(NH3)2(5'-GMP)(H20)] 2 (298 K, 0.24 M' -I)28  those for complexes 1 and 2 
are an order of magnitude smaller. The rates of reactions of aquachloro cisplatin with 
DNA oligonucleotides 29'30 are also about two orders of magnitude faster in 
comparison to those for reaction of the chloroaqua species of the picoline complexes 
1 and 2 with 5'-GMP. 
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Figure 5.9 Schematic representations of the possible isomers in a C2-symmetrical 
cis-PtA2G2 complex and their interconversion. Arrow represent an N7-bound 0, with 
the head of the arrow denoting H8. (based on Ref. 31) 
Restricted rotation about the Pt-N7 bonds can potentially lead to three different 
bisGMP stereoisomers for square-planar complexes having two cis ligands with C2 
local symmetry: two head-to-tail (HT) and one head-to-head (HH) species (Fig. 5.9), 
with the H8s of 5'-GMP on the opposite side or on the same side of the Pt 
coordination plane, respectively. Because of the chiral ribose of 5'-GMP, the FIJI' 
enantiomers become diastereomers and should be distinguishable by NMR. Each FIT 
is C2-symmetrical and has one H8 signal, but the FIR with two nonequivalent 118s 
has two 118 signals. So four 118 signals in total are expected for the three 
stereoisomers. If the cis-PtA2 moiety lacks local C2 symmetry (e.g., two different A 
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(A, A') or an unsymmetrical chelate), four different stereoisomers (two HT and two 
HH) are possible when there is restricted rotation about the Pt-N7 bonds in bis-GMP 
complexes." Normally only HT conformations are expected to be 
thermodynamically favoured and detectable in solution, as is found in most solid-
state crystallographic studies. ' ° '32 '33 Each H8 is non-equivalent for both HT 
stereoisomers,' 3 '34 '35  giving a total of four H8 signals for the HT stereoisomers. 36 For 
the 2-picoline complex 1, the 2-methyl group can be on the upper side or the lower 
side of the platinum plane for each HT stereoisomer, so theoretically eight H8 signals 
should be observed for the two HT isomers together with four methyl signals (Fig. 
5.10) when there is slow rotation (on the NMR timescale) about both the Pt-N7 GMP 
and Pt-N-picoline bonds. Usually fast rotation of bound OMP about Pt-N7 bond in 
cis-[PtA2(GMP)21 (where A2 are two unidentate or one bidentate amine ligands) is 
expected if the substituents on the two cis amine ligands are not very bulky. 
34,36  In 
our NMR experiments, only four H8 signals in two sets of two singlets were 
	
- slow - 	CH3 \ _NH3  
fast 	 fast 
fl—CH3 
NH3 	slow - 	CH3 
Figure 5.10 Diastereomers of cis- [Pt(' 5NH,)(2-picoline)(5'-GMP-N7)21 2t The 
arrows (-*) represent 5'-GMP molecules, with the head of the arrow denoting H8. 
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observed for complex 1, together with two methyl signals. This suggests that rotation 
of 5 '-GMP about the Pt-N7 bond is fast on the NMR timescale but slow about the Pt-
N bond for 2-picoline. This slowness of the rotation was evident from the exchange 
rate (0.62 sI,  296 K) determined by 2D EXSY spectrum. The activation free energy 
(AG+) measured from the coalescence temperature of the H8 signals represents the 
barrier for rotation about the Pt-N-(2-picoline) bond. The coalescence of the two 
close cross-peaks comprising peak lh in the 2D ['H, 15N] HSQC NMR spectrum of 
the bisGMP adduct of complex 1 at 65°C can also be attributed to faster rotation 
about the Pt-N-(2-picoline) bond at higher temperature. The broadening of one H8 
signal and one -CH3 signal at low temperature (< 296 K) suggests that one of the 
bound GMP ligands (probably that cis to 2-picoline) in a HT stereoisomer is more 
affected by the rotation of Pt-N-(2-picoline) than the other. Compared with complex 
1, the rotation of 3-picoline in complex 2 is facile, there being little steric hindrance 
from the methyl group in this case. Slow rotation about Pt-N-(2-picoline) bonds has 
been reported previously for cis- [Pt(2-picoline)2(Guo)2] 2 (Guo = guanosine) at room 
temperature, whilst the rotation about Pt-N7-Guo was still fast on the NMR time 
scale. 37 
Hydrogen-bond interactions between ammine hydrogens and 0(6) or the 5'-
phosphate of GMP can give rise to high-frequency 'H chemical shifts of Pt-NH3 
groups in bisGMP adducts (lh and 2h). Platinum coordination to nucleotides is 
known to induce a change in the sugar-ring conformation from S-type (C2'-endo) to 
N-type (C3-endo), which changes the Hl'—H2' coupling constant, 38  consistent with 
the small decrease observed in the present work. 
The facile rotation of guanine about the Pt-N7 bond is thought to be important in 
the binding of cisplatin to DNA. From the results obtained here, several isomers 
would be expected when complex 1 reacts with G bases of DNA because of the steric 
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effect of 2-picoline and the non-C2-symmetrical structure, which is similar to cis-
[Pt(NH3)(C5H 11 NH2)C12]. 39 These isomers may be stabilized by different H-bonding 
patterns and have contrasting reactivities. Such studies may allow the further 
development of strategies for the systematic design of platinum antitumor complexes. 
Reactions with GSH 
The reactions of cisplatin and related Pt complexes with S-containing nucleophiles 
usually occur via direct substitution without prior aquation, 4° as been observed for 
substitution of Cl - by methionine, GSH and metal lothionein.4l42W  However, in the 
reactions described here, aqua adducts were the first species observed during 
reactions of both complexes 1 and 2 with OSH. There could be two reasons for this: 
(1) reactions of complexes 1 and 2 with GSH do proceed via hydrolysis, or (2) 
because of the steric effect of the picoline ligands, binding of GSH is slowed down 
and hydrolysis is fast enough to compete with direct substitution. Unfortunately the 
reactions were too complicated to allow a kinetic analysis to be carried out. 
The thiolate sulfur of OSH has a high trans effect and this can lead to 
labilization and release of the ammine ligand in the trans position. 43  However, 
despite an overall loss of general signal intensity, no cross-peak for free 15NH4 was 
observed in the 2D spectra, probably because of fast proton exchange with H20 at pH 
7. The yellow solids formed during reactions of thiots with platinum complexes are 
usually thought to be sulfur-bridged polymers. 43''45 From the 2D [ 1 H, ' 5N] HSQC 
NMR spectrum (Fig. 5.6), the initial binding site for GSH on complex 1 is in the 
position trans to 2-picoline, and attributable to the steric effect in cis position, which 
is similar to the situation of GMP binding. 
No rate constants were determined for the reactions of complexes 1 and 2 with 
GSH due to their complicated nature, but, the time-dependent plots (Fig. 5.7) showed 
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that complex 1 reacted much more slowly than complex 2. The half life 4112) of 
complex 1 was about three times longer than that of complex 2. 
Competitive binding of GSH and 5'-GMP 
At neutral pH, GMP cannot usually compete with thiols for binding to Pt(II) when 
both ligands are present at equal concentrations.' 7 The kinetic preference of 
[Pt(dien)(H20)] 2 at neutral pH is exclusively toward thiols when in competition with 
5'-GMP. 17 Complex 1 increases steric crowding in the square-plane and circumvents 
resistance caused by reactions with glutathione and other cellular thiols, but still 
maintains the ability to form cytotoxic lesions with DNA .4  From the experimental 
results obtained above, the rate of binding of the thiol ligand GSH to complex 1 is 
greatly slowed down but is still faster than that of 5'-GMP. Substitution of CF by the 
thiol ligand appeared to proceed via prior aquation because of the steric hindrance by 
2-methylpyridine ligand. The presence of hydrolysis products in the system provides 
a pathway for the formation of mono- and bis-GMP adducts which are formed via 
hydrolysis steps. The bisGMP adduct was stable in the presence of free USH even 
after 3 days, but was present in only small amounts. 
5.6 Conclusion 
Labelling of the new anticancer drug cis-[PtC]2(' 5NH3)(2-picoline)] has allowed 
detailed insight to be gained into the kinetics and mechanisms of its reactions with 
5'-GMP and glutathione. The steric effect of 2-picoline reduces the reactivity of 
complex 1 towards 5'-GMP compared to its 3-picoline analogue, especially towards 
substitution in the position cis to 2-picoline. The low reactivity of complex 1 towards 
5'-GMP may explain why it forms interstrand DNA cross-links much more slowly 
than cisplatin. 2 Two HT isomers were observed for cis-[Pt( 15NH3)(2-picoline)(5'-
GMP-N7)2] 2 due to the slow rotation of 2-picoline and non-C2-symmetrical 
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structure. Reactions of GSH with complex 1 were Ca. three times slower than those 
with 2, and appeared to proceed via aquated intermediates, with initial binding of GS 
trans to 2-picoline for 1 and trans to NH3 for 2. The bisGMP adduct of complex 1 
was able to form in the presence of GSH at neutral pH in a competitive reaction. The 
steric effect of 2-picoline and asymmetric structure of 1 may give rise to several 
isomers when it binds to DNA. This, together with its low reactivity towards GSH 
may play an important role in its high activity against cisplatin-resistant cell lines. 
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6.1 Abstract 
The intrastrand d(GpG) cross-link is the major adduct for cisplatin binding to DNA. I 
present here NMR solution structural studies of a DNA 14-mer duplex, 
d(ATACATG*G 9TACATA)d(TATGTACCATGTAT) intrastrand cross-linked at 
the d(G*pG*)  site by cis-{Pt(NH3)2} 2t This DNA duplex is longer in length and 
richer in A-T base pairs compared with the platinated DNA duplexes reported in 
previously studies. The binding of cisplatin cause the adjacent guanine bases to roll 
toward each other by 43°, leading to an overall helix bending angle of 47°. The minor 
groove opposite the platinum binding lesion is widened and flattened with geometric 
parameters similar to those of A-form DNA. The unwinding of the helix at the 
platinated site is 26°. The structural differences between the results of the current 
study and those of other studies are discussed based on the differences of DNA 
sequence and length. 
6.2. Introduction 
The complex cis-[PtC12(NH3)2], clinically known as 'cisplatin', is the most 
widely used antitumor drug! Its antitumor activity is believed to result from covalent 
binding to DNA and subsequent modification of the structure of DNA. Cisplatin 
forms many kinds of DNA adducts in cells, including major intrastrand d(GpG) 
(70%) and d(ApG) (15%) cross-links, where platinum binds to two adjacent guanine 
residues or an adjacent adenine and guanine.' Other minor adducts include 1,3-
intrastrand and interstrand cross-links. The major intrastrand crosslink adducts 
formed at the d(GpG) and d(ApG) sites have been suggested to be responsible for the 
biological activity of cisplatin, because their presence in cancer patients correlates 
with a positive response to treatment with the drug. 2 Such lesions have deleterious 
effects on DNA replication and transcription, 3 and cause mutations. 4 Recent studies 
show that proteins containing one or more high-mobility group (HMG) domains can 
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recognise and bind to these intrastrand cis-[Pt(NH3)2{d(GpG)}] and cis-
[Pt(NH3)2{d(ApG)}I adducts. 5,6,7  The shielding of excision repair caused by binding 
of the HMG proteins on DNA has been confirmed by in vitro and vivo experiments. 8,9 
Such biological effects are clearly correlated with the structures of the cisplatin-DNA 
adducts, and it is therefore very important to understand the structural details of these 
DNA duplex adducts. 
Sei'eral studies have been reported on the structural distortions of cisplatin-
DNA adducts. An X-ray crystal structure of cis- [Pt(NH3)2-{d(GpG-N7(l),N7(2))}I 
shows that cisplatin forms bidentate adducts with the two adjacent guanines joined 
together in a "head-to-head" configuration, with the dihedral angles between the two 
Gs ranging from 72° to 82°. The deoxyribose rings of the 5'- and 3'-dG nucleotides 
have C3'-endo (N-type) and the C2'-endo (S-type) pucker, respectively.' () More 
recently, the crystal structure of a duplex dodecamer d(5'CCTCTG*G*TCTCC 
3')d(5'-GGAGACCAGAGG-3') (2), where G*G*  represents the 1,2-intrastrand 
cisplatin adduct, was solved to a resolution of 2.6 A. 11 " 2 The triclinic crystals 
contained two independent molecules which have similar structures for the platinum-
modified duplex. Two different bending angles were observed, one of 39° and the 
other of 55°. The bend is largely due to a roll of 26° toward the major groove at the 
G*G* site of the platinum intrastrand cross-link. The binding of the platinum atom to 
the N7 atoms of adjacent guanine residues, caused the major groove to become 
compacted and the minor groove widened and flattened. In particular, the Pt atom 
was displaced from the plane of each guanine base by approximately 1 A. The overall 
structure of the cisplatin-modified duplex contains an unusual A413-form junction 
situated just to the 3' side of the platinum adduct, most likely to be due to crystal 
packing force. An analysis of the unit cell packing revealed end-to-end and end-to-
groove interactions between the platinated duplexes. 
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The effects of crystal packing are known to influence structures and for this 
reason there is much interest in solving solution structures of platinated DNA 
duplexes. NMR spectroscopy has played an important role in structural studies of 
platinum-DNA adducts. Early attempts to elucidate the solution structure of the 
cisplatin 1 ,2-intrastrand cross-link in double-stranded DNA indicated that the duplex 
formed a kink towards the major groove at the platinum coordination site) 3 With the 
aid of molecular mechanics and dynamics calculations to build models consistent 
with observed NMR data, the kink was estimated to be about 600  and the remainder 
of the helix was in an undistorted B-form. More recently, the NMR structure of a 
short octameric duplex d(CCTG*G*TCC) was reported. 14  The NOE-restraint refined 
duplex is unwound (--21°) and kinked (-58°) towards the major groove at the G*G* 
site, and the minor groove is significantly widened. In order to detect the structural 
consequences of the major cisplatin adduct over at least one turn of DNA duplex and 
compare differences between the solution and solid state structures, the solution 
structure of a platinated DNA duplex dodecamer, with the same DNA sequence used 
in X-ray crystal structure studies d(CCTCTG*G*TCTCC),  was recently reported 
from the group of Lippard.' 5 Although the unwinding and flattening of the minor 
groove opposite the platinum adduct is similar in both the solution and crystal 
structures, some of the features are more exaggerated in the solution structure 
compared with the X-ray crystal structure. The cis- [Pt(NH3)2-(d(GpG-
N7(1),N7(2))J] lesion causes the adjacent guanine bases to roll toward one another by 
49°, leading to an overall helix bend angle of 78°. This deformation is especially 
noteworthy for the solution structure, because the DNA sugar puckers are primarily 
those of B-form DNA. Unwinding of the helix at the site of platination is 25° and the 
Pt atom is displaced from each base plane by -0.8 A. The greater helix deformation 
may have been prevented in the crystal structure due to helix packing interactions at 
the site of platination. Of total 12 possible imino resonances, only that from G6*  was 
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not observed indicating fast exchange with H20 and disruption of base pairing at 5'- 
as reported for other studies. 14  The imino protons for terminal bases can only be 
observed at low temperature without any NOEs to other protons. Using a nitroxide 
spin-labeled platinum complex cis-[Pt(NH3)(4-aminoTEMPO)ClI], the same group 
also determined the NMR solution structure of an undecamer DNA duplex 
d(CTCTCG*G*TCTC). The structure was determined from conventional NOE 
studies of the reduced, diamagnetic undecamer and long-range (10-20 A) electron-
proton restraints from the paramagnetic duplex. 16  Refinements of the structure with 
either conventional interproton restraints or a combination of the electron-proton and 
interproton restraints afforded the same local but different global structures. 
Significant similarity was found for the later structure to the tertiary structure of a 
cisplatin-modified dodecamer duplex solved by X-ray crystallography, although their 
bending angles determined by the programme CURVES are quite different.'' 
Comparing the results of previous studies, differences appear to show 
between the solution structures of the cisplatin d(G*pG*)  cross-linked DNA duplexes 
depending on the methods used to solve the structures, and, more importantly, on the 
sequence and length of DNA duplex used for the study. A rearrangement from an 
intrastrand to a more stable interstrand cross-link was observed in the study of 
d(CCTG*G*TCC), while this was not observed for the dodecamer 
d(CCTCTG*G*TCTCC).' 4 'S The differences observed in the studies were attributed 
to the short length and instability of the duplex, which is responsible for the reactivity 
of its strained Pt-N7 bonds. 
The 14-mer DNA duplex, d(ATACATG*G*TACATA),  has been used in kinetic 
studies of DNA platination. 17 Remarkably long-lived monofunctional adducts, which 
could have important biological significance, were observed during the course of the 
formation of the GpG bifunctional adducts. The sequence of this DNA 14-mer is 
more rich in AT base pairs compared with the other reported DNA sequences used in 
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structural studies of DNA intrastrand platination. In duplex DNA, major and minor 
grooves provide the topology and there are sequence-dependent variations in the 
patterns of hydrogen bonding with relatively significant variations in the minor 
groove. Features which vary according to DNA sequence range from relatively gross 
changes in bending, to effects of groove width, and finally to local variations in the 
disposition of contact points with bound ligand. Usually DNA or RNA duplexes rich 
in AT base pairs exhibit slightly different structural characteristics compared with 
those rich in GC base pairs.' 8 Knowledge about sequence-dependent variations in 
platinated DNA duplex geometry may be essential to protein recognition. Besides the 
sequence, the length of d(G*pG*)  platinated DNA duplex may also have an 
important influence on the structure. To my knowledge, the length of the DNA used 
in this study (14-mer), which is over one turn, is the longest used in the structural 
studies of interactions between cisplatin and DNA. 
In this work, the solution structure of the platinated DNA 14-mer duplex has 
been determined by NMR spectroscopy and restrained Molecular Dynamics (rMD). 
The observed structural features are compared to those reports previously for crystal 
and NMR-derived platinated DNA structures, and the results are discussed. 
5' d(A l T2 A3 C4 A5 T6 G7 G8T9 A10C 11 Al2T13A14) I 
1+11=111 
3' d(T28A27T26G25T24A23C22C21A20T19G13T,7A16T15) II 
6.3. Experimental 
Materials 
cis-[PtCl2(' 5NH3)2] and cis- [Pt(' 5NH3)2(H2O)2] 2 were prepared as previously 
described. 19 The sodium salts of HPLC-purified 14-mer oligonucleotides 
d(ATACATG*G*TACATA) (strand I) and its complement strand 
d(TATGTACCATGTAT) (strand II) were supplied by Oswel (Southampton, U. K.). 
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Platination of single strand I with cis-[Pt(' 5NH3)2(H20)2] 2 
The platinated DNA adduct (1*)  of the GG 14-mer single strand I was prepared by 
reaction of 0.1 mM GO single strand I with 1.2 mole equiv. of prepared cis-
[Pt(' 5NH3)2(H20)2] 2 in water at 298 K in the dark. The reaction was monitored by 
HPLC using a Nucleosil C3 300 A stainless steel column. After a total of one week of 
incubation, the reaction was judged to be complete and the separation was carried out 
using Biocad perfusion chromatography with a Poros RV Column (100 mm x 4.5 
mm). Operating conditions: mobile phase ammonium acetate 5mM, 50 % acetonitrile 
(gradient: 5% acetonitrile for 5 mins; from 5 min to 19 mm 5% to 25%, from 19 mm 
to 22 min 25%), flow rate I mlmin 1 , 298 K. The retention time of unplatinated 
single strand was 7.7 min compared with the platinated adduct of 14.9 mm. The 
platinated adduct was collected and freeze-dried to remove the volatile salts. The 
final yield of platinated single strand was less than 50%. The purity of the separated 
0*0* adduct was checked by both HPLC, 1D 'H and 2D ['H, ' 5N] HSQC NMR 
spectroscopy. The method development for HPLC separation was carried out with 
the assistance of Dr. P. del. S. Murdoch. 
Preparation of Platinated DNA 14-mer Duplex 
The NMR sample was prepared by adding one mole equivalent amount of the 
complementary CC strand II to the purified platinated GO strand I to give a final 
platinated DNA duplex concentration of 0.9 mM in 100 mM NaCI04 and 90% 
H20/10% DO. The concentrations of the DNA single strands I and II were 
measured by UV spectroscopy (extinction coefficients at 260 nm for GO strand: 149 
M 1 cm 1 ; CC strand: 137.2 M'cm'). The precise ratio of the two strands was also 
monitored by 1D 'H-NMR spectra. The platinated DNA duplex (111*)  was annealed 
by heating briefly to 343 K followed by slow cooling of the solution to room 
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temperature. The extent of duplex formation was verified by the 1D 'H-NMR and 2D 
['H, ' 5N] ITISQC NMR spectra. The pH of the solution was raised from 4.3 to 6.2 
using 0.5 M NaOH solution. Dioxane (3.767 ppm, 25 °C) was added as an internal 
reference for 'H NMR. The D20 sample was prepared by freeze-drying the DNA 
sample twice from 99.9% D20 and finally dissolving it in 99.9% D20 to afford a 
concentration of 0.9 mM DNA duplex. 
NMR Data Acquisition and Analysis 
One-dimensional (1D) 'H and two-dimensional (2D) NOESY and DQF-COSY NMR 
spectra were acquired both at 500 MHz on a Bruker DMX500 NMR spectrometer 
using a TBI ['H, "C, XI probe-head equipped with a z-field gradient coil, and at 600 
MHz on a Varian unttYll.4OVA spectrometer using a triple resonance probe-head ['H, 
13C, ' 5N] equipped with z-field gradients. 500 MHz 2D NOESY experiments on 
exchangeable imino protons were carried out at 5 °C using a 90% H20/10% D20 
sample. Data were acquired over a 'H spectral width of 21 ppm (10.5 kHz) into 4096 
data points with 64 transients for each of 512 t, increments (TPPI). The mixing times 
were 150 and 300 ms, and the recycle delay was 2.0 s. The solvent signal is on 
resonance and water suppression was achieved by using the WATERGATE 20  pulse 
sequence prior to data collection. One-dimensional (ID) NMR spectra were acquired 
with 128 transients into 32 K data points over a spectral width of 10.5 kHz using a 
double pulsed field gradient spin echo pulse sequence. 2 ' Other acquisition parameters 
were: relaxation delay, 1.8 s; dummy scans, 4; solvent selective pulse length, 1.954 
ms. Data were apodized using a line broadening function of 0.5 Hz prior to Fourier 
transformation into 32 K data points. Chemical shifts were internally referenced to 
dioxane calibrated at different temperatures according to the expression: ö = 3.8415 - 
(0.25 x 10' x TIK). 
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High resolution 600 MHz 2D NOESY data sets were acquired at 5 °C using 
the 99.9% D20 sample with 40 transients acquired over a 'H spectral width of 9 ppm 
(5.4 kHz) into 4096 data points for each of 2x256 t, increments (States). The mixing 
times were 150 and 300 ms and the recycle relay was 3.5 s. The 512 data increments 
were zero filled to 1024 points and apodized using a it12.5 shifted sine-squared 
function before Fourier transformation. Automatic baseline corrections were carried 
out in both dimensions. 600 MHz 2D DQF-COSY spectrum was acquired at the 
same temperature (5 °C) with 96 transients for each of 2x512 t, increments (States) 
over a spectral width of 10 ppm (6.0 kHz). Water suppression was achieved by 
presaturation using a 1.5 s pulse during the pre-acquisition delay. 
Two-dimensional (2D) ['H, ' 5N] HSQC NMR data sets were acquired on the 
500 MHz at a calibrated probe temperature of 25 °C. All data acquisitions were 
carried out using 8 transients into 1024 data points over a 'H (F2) spectral width of 2 
kHz (4 ppm, centred at the water resonance) for each of 128 t, increments (TPPI), 
and over a ' 5N (Fl) spectral width of 1.52 kHz (30 ppm, centred at -75 ppm). A 
GARP decoupling scheme, centred at ' 5N chemical shift of -75 ppm, was applied 
during the acquisition time. A relaxation delay of 2.0 s was used for all experiments. 
Coherence pathways were selected via the use of z-field gradients, 22  and the 'H 
solvent resonance was eliminated as part of this procedure. Data were zero-filled to 
1024 data points in both dimensions prior to apodization with Gaussian weighting 
functions and Fourier transformation. Data were referenced internally ('H) to dioxane 
at 3.767 ppm and externally (' 5N) to the 15  N resonance of 15NH4CI at 0 ppm. A post-
acquisition filter was applied at the solvent signal position to remove the residual 
solvent resonance. Typically 2D ['H, ' 5N] HSQC spectra were acquired over a 33 
minute period. 
All spectra were processed using XWIN-NMR version 1.3 (Bruker U. K. 
Ltd.). Processed data were imported into the TRIAD NMR module of Sybyl (version 
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6.3, Tripos Inc.) for data reduction. NOESY data were assigned for the platinated-
DNA 14-mer duplex using well established assignment strategies for right-handed 13- 
form DNA .21,24  DQF-COSY data were used to confirm the assignments of 2' and 
2"H resonances of sugar rings. 
Generation of Experimental Restraints 
Initial structures for canonical A- and B-DNA conformations were generated using 
the Sybyl 6.3 software. The atom charges for DNA were calculated using the 
Pullman method . 25 The backbone charges were reduced to 0.5 to implicitly 
incorporate counter-ion effects. The cis-diammineplatinum(ll) residue was docked 
onto the N7 atoms of G7*  and  G8*.  The bond lengths and angles of docked cis-
diammineplatinum(ll) residue were set according to the crystal structure data with the 
chloride ligands removed.' 1 Charges for the cis-diammineplatinum(ll) residue and 
the bound guanine bases were modified according to a molecular mechanics 
calculation by Herman et a]. 13  The platinated A- and B-DNA structures were energy-
minimized, and subsequently used as starting structures in the restrained molecular 
dynamics calculations. 
2D NOE intensities were measured using peak-picking in NMR Triad module 
of Sybyl 6.3. Final intensities were obtained by averaging corresponding cross-peaks 
on both sides of the diagonal. Proton-proton distances were calculated from 2D NOE 
cross-peak intensities using the complete relaxation matrix approach implemented in 
the program MARDIGRAS 26 repeated with randomly assigned correlation times ; 
(2, 3, 4 ns) and noise levels (0.002, 0.003, 0.004). An isotropic tumbling motion was 
assumed for the molecule, with an overall correlation time of 2.0 ns. 27 MARDIGRAS 
calculations were carried out on both A- and B-form starting structures from NOESY 
data acquired at two different mixing times (150, 300 ms). A final distance restraint 
set was pooled using Windows 95 EXCEL from all the results calculated by 
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MARDIGRAS.25 The distances involving exchangeable protons were calculated 
quantitatively by classifying the intensity of NOE cross-peaks as strong, medium and 
weak using a single set of intensities acquired with 150 ms mixing time. 
Deoxyribose sugar puckers were deduced for those sugar rings displaying 
clearly resolved DQF-COSY cross-peaks between 2', 2"H and 1'H using the 
programs SPHINX and LINSHA. 29 A six component spin-system (Hi', H2', 1 ­12', H3', 
H4 and P) was used for all simulations with strong coupling only between geminal 
protons (H2' and H2"). The conformations of the sugar rings were estimated by 
matching the experimental coupling constants to values calculated assuming a two-
state model with rapid N-S interconversion for the sugar pucker, which reflects the 
dynamics of sugar rings.  30  Coupling constants and resonance linewidths were 
systematically varied until the best match between simulated and experimental data 
was observed. Simulations were compared for cross-peaks from both sides of the 
diagonal. Other simulation variables such as digital resolution, acquisition time and 
window functions were also set to match. This analysis yielded five torsion angle 
restraints per sugar residue for the subsequent rMD structure refinement. The torsion 
angle restraints were inputted manually according to the simulation results. 
In addition to the NMR-derived sugar torsion angles and interproton 
distances, hydrogen bond distances and angles were also included in the restraint data 
set to maintain Watson-Crick hydrogen bonding during the simulations. These 
restraints were taken from crystallographic data. Target distances between proton 
donor and acceptor in GC base pairs were set to 2.81 d(006, CN4) ! ~ 3.01 A, 
2.84 A !~ d(GN1, CN3) !~ 3.05 A, and 2.76 A !~ d(GN2, CO2)!5 2.96 A; for AT base 
pair, lower and upper limits were 2.72 A !~ d(AN1, TN3) !~ 2.92 A and 2.85 A < 
d(AN6, T04) !~ 3.05 A. 3 ' The force constants for Watson-Crick hydrogen bonding 
distance restraints were always lower than that for experimental NOE distance 
restraints throughout the simulations. 
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Overall, the restraint set consisted of 120 torsion angle restraints, 665 distance 
restraints and an additional 76 restraints (distance and angle) defining the Watson-
Crick hydrogen bonds of the DNA duplex. The angles of the cis- [ Pt(NH3)2 12+  residue 
was also defined so as to maintain square-planar geometry. 
Restrained Molecular Dynamics 
The Molecular Dynamics module in Sybyl 6.3 enables energy refinements on 
structures to be performed using NMR-derived distance and torsion angle restraints. 
Restraint energy violations are calculated for each distance restraints using a flat-well 
potential, where the lower and the upper bounds derived from MARDIGRAS define 
the size of the flat-well width. The force constants (kcalmor'k 2) for NOE distance 
restraints were defined according to the difference between the calculated upper and 
lower bounds from MARDIGRAS: below 1 A (20), 1 t 2 A (15), 2 to 3 A (10), 3 to 
5 A (5), 5 to 10 A (1), over 10 A (0). All the calculations were carried out on a 
Silicon Graphics Indigo2 workstation. 
Different rMD strategies were applied to platinated A-form and B-form 
starting DNA structures. For B-DNA, all the rMD runs were kept at the same 
temperature of 300 K. While for A-DNA, a strategy similar to simulated annealing 
techniques for proteins (elevated temperature with high force-constants) was used to 
overcome energy barriers associated with larger conformational changes. 32  Typical 
molecular dynamics simulations were carried out in vacuo with a time step of 1 fs. 
Snapshots were taken every 100 fs. All atoms within 30 A radius were included in 
non-bonded interactions, and the non-bonded pair list was updated every 25 steps. 
The Tripos force field was used in all the calculations. The snapshots from the last 3-
5 ps of the rMD trajectory were averaged and energy-minimized with restraints to 
remove averaging artifacts. During all restrained energy minimization, force 
constants were the same as those employed during the final rMD equilibrium period. 
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The structures were energy-minimized by steepest descent first, followed by 200 
steps of Powell minimization. 
The NMR experiments and final structural calculations were carried out with 
the assistance of Dr. J. A. Parkinson. 
pH Measurements 
These were made using a Coming 145 pH meter equipped with an Aldrich micro-
combination electrode calibrated with Aldrich buffer solutions of pH 4, 7 and 10. 
Values of pH were adjusted with 1 lvi HCI04 or NaOH as appropriate. 
6.4. Results 
Preparation ofpurified G*G*  platinated single strand and DNA duplex Platinated 
G*G* single strand 1*  was prepared by incubation of GG single strand I (0.1 mM) 
with 1.2 molar equivalents of cis- [Pt( 5NH3)2(H2O)2] 2 at 25 °C. After one week, the 
reaction was judged to reach equilibrium and the separation of platinated single 
strand 1*  was carried out by HPLC. Figure 6.1 (A, B) shows RPLC chromatograms 
corresponding to the samples before and after HPLC separation. The separated 
samples of the free and platinated single strand were re-injected into HPLC using the 
elution conditions reported before. 33  From the retention time, the two separated peaks 
are confirmed to be free and G*G*  platinated single strand. The purified platinated 
single strand 1*  and double strand 111*,  which was prepared by annealing with 
complementary CC strand II, were also checked by 2D ['H, 15N] HSQC NMR and 
spectra are shown in Figure 6.2. In both cases, two cross-peaks were observed for 
platinated single strand (8 1 H/' 5N, 4.581-65.19, 4.511-66.49) and double strand (8 
'H115N, 4.431-70.45, 4.201-70.26). Comparing the spectra with reported shifts for the 
same adducts '33  these two pairs of cross-peaks correspond to the platinated G*G*  14-
mer single strand and platinated DNA duplex (Figure 6.2A and 6.213, respectively). 
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Figure 6.1 HPLC chromatograms for the reaction of cis- [Pt(NH3)2(H2O) 2 J 2 with 
DNA 14-mer single strand 1(100 pM, 1:1.2 molar ratio, 298K). (A) one week after 
incubation; (B) re-injection of purified sample corresponding to "bound" fraction in 
A, the unpiatinated single strand with retention time Ca. 7 min has disappeared. 
162 













Chapter 6 Structure of Platinated DNA' 74-nter Duplex 
4.7 4.6 4.5 4.4 4.3 	3(1 H) 
Figure 6.2 2D ['H, ' 5N] NMR spectra recorded at 298 K of (A) the HPLC purified 
platinated G*G*  14-mer single strand 1*;  (B) platinated 14-mer DNA duplex 111* 
formed by annealing the purified G*G*  single strand }* with its complementary CC 
strand 11(0.1 M NaCI04 , pH 6.0, 9 mM phosphate buffer, 90% 1 ­120/10% D,O). 
Only one pair of cross-peaks was observed in each spectrum which suggests that the 
purity of the platinated single strand and duplex samples is high. 
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NMR Spectroscopy of Platinated 14-mer DNA duplex 	Assignments of the base 
and sugar protons were made through analysis of the 150 and 300 ms NOESY 
spectra using established methods. 24,29 Contour plots of the Hg/H6/H2-to-Hl ' region 
of the 300 ms NOESY spectrum are shown in Figure 6.3. The H6/H8 resonances of 
the 5'-terminal residues (Al and T15 for strands I and II respectively) are NOE 
connected only to the Hl ' of their own sugars and therefore only one cross-peak is 
exhibited for each. These NOEs were used as starting points for the sequential 
assignment of both strands. The sequential connectivities from nH8/H6 to nHV and 
from nHl - to (n+I)H81H6 for Al to A14 in the platinated (top) strand 1*  and for T15 
to T28 in the complementary (bottom) strand II were all identified and are shown in 
Figures 6.3A and 6.3B. The assignment walks are fundamentally consistent with 
right-handed duplex DNA. The H8 signals of the two platinated bases 07*  (8.64 
ppm) and 08* (8.08 ppm) are downfield (high frequency) shifted from their normal 
positions (07: 7.75 ppm; 08: 7.56 ppm) 34 for a free B-DNA duplex. Strong NOE 
connectivities were observed between these two protons, which is similar to the 
previously reported NMR studies of DNA duplexes platinated at GG  sites by 
cisplatin. 14" 5  NOESY spectra recorded at different temperatures were used to clarify 
assignments for some of the overlapped cross-peaks. Besides H8/H6 to Hl' cross-
peaks, relatively weak NOE signals were observed for most of the adenosine H2 
protons (except AlO and A20) to interstrand, intra- and inter-nucleotide Hl' sugar 
protons. Strong intranucleotide NOEs were observed between cytosine H6 to H5 
protons, which also show internucleotide NOE connectivities to H8 of nearby 5-
adenosine. 
An analogous NOESY walk between the base and sugar protons was used to 
assign Hi', H2' and H2" protons. A significantly high-field shifted resonance was 
observed for T6 H2 (from 1.92 ppm 34 to 1.37 ppm). A contour plot of the 
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Figure 6.3 Contour plots of the 2D NOESY spectrum (300 ms mixing time, 99.9% D20, 278 K) of 111* showing the aromatic 
H8/H6/H2 to HI 7H5 region. The sequential NOESY walks are shown in (A) for the platinated 0*0*  top strand 1*  and (B) for the 
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shown in Figure 6.4. A combination of NOESY and DQF-COSY data were used to 
complete and confirm the assignments of the sugar protons including the H4' and 
some of the H5 '1H5" protons. The chemical shifts of the assigned non-exchangeable 
protons are listed in Table 6.1. 
Assignments for important exchangeable protons for the platinated 14-mer 
DNA duplex were made through analysis of the 150 ms NOESY spectra recorded in 
90% H20/10% D20 at 5 °C. The imino-to-imino contour plot region is shown in 
Figure 6.5. The assignment of these protons was achieved via a chain of 
connectivities involving Watson-Crick hydrogen bonding, only interrupted at the G7* 
site. The resonances for the imino protons of the pairs A1-T28, T2-A27, T13-A16 
and A14-T14 present at the 5' and 3' ends were missing. The imino proton of G7* 
was assigned by comparing ID 'H NMR spectra recorded at different temperatures 
(Figure 6.6). On lowering the temperature, an imino proton signal at 13.49 ppm 
gradually increased in intensity and became clearly visible at 5 °C, but no NOE 
connectivities were observable between this proton and other imino protons in Figure 
6.5. The assignments for imino proton resonances were further confirmed by cross-
peaks from thymidine imino protons to adenosine H2 protons within AT base pairs 
and guanosine imino protons to cytidine H4 amino protons within GC base pairs. It 
is interesting to note that the NOE connectivities remain intact between G7*  1-NH 
and C22 4-NH 2 (both the hydrogen-bonded amino proton in the G•C base pair and the 
non-hydrogen-bonded amino proton), but relatively weaker than the NOE between 
G8* NH and C21 4-NH2. Similarly, strong NOEs were observed between the imino 
protons of GI 8 and G25 and 4-NH2 of Cli and C4, respectively. Both the imino 
proton chemical shifts of G7*  (13.49 ppm) and G8*  (13.06 ppm) appear downfield 
shifted compared with G18 (12.46 ppm) and G25 (12.42 ppm). This is also true for 
the imino protons of T6 (13.96 ppm) and T9 (13.80 ppm). The chemical shifts for the 
exchangeable protons are listed in Table 6.1. 
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Table 6.1 'H chemical shift assignments (ppm) for the DNA 14-mer duplex 111* in 0.1 M NaCI0 4 at pH 6.2 and 278 K. 
base H6/H8 a H5/CH3/H2 b HI' H2'/H2" 1-13' 1-14' H5'/H5" GHI/TH3 	CH4b/H4f 
Al 8.20 7.94 6.21 2.69/2.85 4.87 4.27 3.81 
T2 7.41 1.37 5.61 2.20/2.48 4.91 4.23 4.12 
A3 8.31 7.54 6.24 2.73/2.90 5.06 4.46 
C4 7.36 5.29 5.50 2.12/2.39 4.84 4.23* 8.12/6.59 
AS 8.25 7.58 6.18 2.63/2.83 
T6 7.14 1.41 5.86 1.37/2.37 4.79 4.29 4.11/4.06 13.96 
G7 8.64 6.08 2.50/2.72 5.09 4.23 4.15/4.07 13.50 
G8 8.08 5.58 2.23/2.55 4.64 4.18 4.08 13.06 
T9 7.48 1.31 5.83 2.27/2.63 4.91 4.24 13.80 
AlO 8.28 6.21 2.67/2.90 5.03 4.41 
CII 7.32 5.30 5.51 2.05/2.37* 4.84 4.19 8.17/6.63 
Al2 8.28 7.63 6.18 2.59/2.84 
T13 7.18 1.48 5.80 1.90/2.27 4,81 4.11 4.11/4.08 
A14 8.22 7.47 6.28 2.67/2.43 4.70 4.20 
base H6/148 a H5/CH3/H2 b HI' H2'/H2" H3' H4' H5'/H5" GH1IfH3 	CH4bJH4f 
T15 7.37 1.56 5.78 185/2.25 4.68 4.02 3.65 
A16 8.50 7.80 6.37 2.88/3.05 5.05 4.47 4.14/4.05 
T17 7.27 1.42 5.77 2.22/2.50 4.90 4.27 13.39 
G18 7.85 5.99 2.63/2.78 4.94 4.41 4.23/4.19 12.46 
T19 7.32 1.42 5.81 2.22/2.56 4.91 13.53 
A20 8.29 6.21 2.62/2.83 4.38 
C21 7.40 5.46 5.88 1.97/2.36 4.73 4.09* 4.28 8.39/6.92 
C22 7.47 5.47 5.52 2.02/2.36 4.79 4.06* 3.93 7.87/6.80 
A23 8.34 7.81 6.24 2.77/2.93 5.02 4.37 
T24 7.20 1.38 5.73 2.17/2.45 4.89 4.21 13.36 
G25 7.85 5.94 2.61/2.76 4.95 4.39 4.21/4.14 12.42 
T26 7.25 1.45 5.74 2.06/2.45 4.88 4.21 13.55 
A27 8.31 7.56 6.29 2.74/2.90 4.42 
T28 7.25 1.48 6.09 2.14 4.52 4.02 4.31/4.08 
a H6: TH6 or CH6; H8: AH8 or GH8. bH5:  CH5; CH: TCH 3 ; H2: AH2. ccH4h  is the cytosine amino proton involved in H-bonding in 
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Figure 6.4 A contour plot of 300 rns NOESY spectrum of DNA duplex 111*  at 278 K showing the H27H27thymidine Me-to-aromatic 
region NOE connectivities. 
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Figure 6.5 A contour plot of the 150 ms NOESY spectrum of DNA duplex 111* 
recorded in 90% H 20/10% D 20 at 278 K showing the imino-to-imino region. A 
sequential walk was made between the imino protons involved in Watson-Crick 
hydrogen bonding in the platinated 14-mer DNA duplex, which is only interrupted at 
G7* site. The imino protons of the two base-pairs at each of the 5 and 3 ends are 
not observed. The 1D 1 H spectrum of the same region is plotted on the top. 
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Figure 6.6 Temperature dependent 1D 'H spectrum of DNA duplex III in the imino 
proton region showing the appearance of G7* imino proton at low temperature. 
Assignments are indicated on the top of the peaks. 
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The intensity of the strong intra-nucleotide Q7*  H8-H3 NOE cross-peak 
compared with that of the modest G8*  H8-H3' NOE cross-peak suggests that the 
deoxyribose rings of the G7*  and  G8*  nucleotides are of the N-type (C3'-endo) and 
S-type (C2'-endo) conformations, respectively. From the 2D DQF-COSY data, it is 
clear that the coupling patterns of Hl'-to-H2/H2" of G7 and A14 are different to the 
other nucleotides. By using SPHINX and LINSHA programs to simulate the DQF-
COSY cross-peak patterns, the proton homonuclear 3J1 -2 -, 3Ji-2-, 3J2 -3 ', 3J-3 -, and 
3J22 '- coupling constants were extracted. To obtain pseudorotational parameters, 
which describe the geometry of the sugar moiety, experimental J coupling constants 
were compared with theoretical values using a graphical method. A two-state model 
with rapid N-S interconversion was assumed to match experimental values. Figure 
6.7 shows the final simulated DQF-COSY cross-peaks compared with the actual 
cross-peaks in spectra. From the result, only G7*  and 3-end A14 in strand 1*  are 
predominantly C3-endo conformations, while the others, including T6 and G8 are 
all in C2-endo or related C3'-exo conformations. 
All together 574 and 662 NOE cross-peak integrals were measured from the 
NOESY spectra at mixing times of 150 ms and 300 ms respectively. 
Structure Determination of Cisplatin-Modifled DNA 14-mer Duplex. Both the 
energy-minimized B- and A-form DNA duplexes modified by cisplatin were used as 
starting models for rMD calculations (Figure 6.8). Starting from energy-minimized 
B-DNA, the force constants for the distance restraints were gradually increased to a 
final value of 20 kcal.mol'. 2 k in the first three rMD runs (20 Ps each). The system 
was strongly coupled to a heat bath and kept at 300 K. The initial velocity for rMD 
was assigned to a Boltzmann default value. After the final constraints were set up, a 
long rMD run (100 ps) was performed. Coordinates of the final 5 ps of the dynamics 
trajectory were averaged and subjected to 200 cycles of Powell minimization to 
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Figure 6.7 Simulated (A) and observed (B) cross-peaks for A14 H1-to-H2' and H2"in 2D DQF-COSY spectra of DNA duplex 111*. 
The simulation was carried out using SPHINX and LINSHA programs, The simulation indicates the presence of only the C3-endo 
conformation for A 14 deoxyribose. 
OT 
A-form B-form 
Figure 6.8 Standard A- and B-form 14-mer DNA duplexes built in Sybyl 6.3 and used as starting models for structural calculations. 
Colour code: C (white), H (cyan), N (blue), 0 (red), P (orange). 
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achieve a single coordinate set expected to reflect the averaged conformational 
characteristics. The structure obtained after this calculation is called B- 1. 
With energy-minimized A-DNA as the starting structure, the system had to be 
brought up to high temperature utilising high force constants in order to pass over 
energy barriers to achieve successful convergence. Initially the temperature was set 
to 100 K, with the model being gradually heated to 900 K. The force constant was 
increased with temperature and finally reached 100 kcal.mol'k 2 at 900 K. After a 
10 Ps rMD run at 900 K, the system was slowly cooled down to 300 K in 5 ps steps 
and the force constant was reduced to 20 kcalmoV A ' 2 . The slow cooling process 
can avoid the system being trapped in local energy minima. Large conformational 
changes were observed during the rMD run at 900 K. A further 30 ps rMD run was 
carried out at 300 K and the coordinates for the last 3ps of the rMD trajectory were 
averaged. The average was subsequently subjected to restrained energy minimization. 
The structure obtained at the end of this procedure is called A-I. Comparing A- 1 and 
B-I, the two structures exhibited an average root-mean-square deviation (RMSD) of 
1.5 A for best-fit backbone of the central base-pairs or 2.0 A for heavy atoms (all 
atoms except for hydrogen), which means a convergence has been achieved from 
starting A- and B-form standard duplex (RMSD for heavy atoms, 6.7 A). Due to the 
limited amount of experimental NMR data directly related to the backbone geometry, 
the two ends of this distorted DNA duplex are relatively flexible during the rMD 
runs, which affects the whole backbone RMSD value. 
To cover more conformational space, a series of short molecular dynamics 
runs (20 ps each) were carried out with randomly assigned initial atom velocities for 
both A-1 and B-i structures (five each). The final 3 Ps (31) structures of each run 
were averaged and restrained-minimized. This resulted in families of structures with 
very similar energy and similar overall geometry. Average atom RMSDs for five 
structures of B-form DNA family were between 0.85 to 1.26 A, and for A-form DNA 
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family is between 0.50 to 0.71 A. The structures in each of the two sets were further 
averaged and restrained-minimized to extract the average features of each set. This 
gives two subfinal structures, rMD-A and rMD-B. These two structures exhibited an 
average RMSD of 1.3 A for best fit backbone or 1.8 A for heavy atoms. The 
coordinates of all ten structures from the two sets were superimposed, averaged and 
restrained-minimized to achieve a single final structure which is called rMD-final, as 
shown in Figure 6.9. The RMSD values between rMD-A, rMD-B and rMD-final are 
listed in Table 6.2. 
Table 6.2 RMSD values (A) calculated from structures of rMD-A, rMD-B and rMD-
final. 
RMSD rMD-A rMD-B rMD-final Average-RMSD 
rMD-A' 1.3 0.9 1.1 
rMD_Ba 1.3 1.1 1.2 
rMD-finaI' 0.9 1.1 1.0 
rMDAb 1.8 1.0 1.4 
rMD-B' 1.8 1.1 1.5 
rMD_fina lh 1.0 1.1 1.1 
a  RMSD of best-fit backbone; b  RMSD of heavy atoms (all the atoms except protons). 
Structure of the Platinated 14-mer DNA Duplex. 
The sharp 1D 'H NMR signals of the Pt-DNA sample 111*, together with the 
single set of detectable proton resonances in the 2D NOESY spectra, suggest that the 
duplex exists predominantly as a single structure in solution on the NMR time scale. 
The detection of a nearly complete set of sequential connectivities for the base 
H8/H6 to sugar Hl', H2'/H2" and H3' provides evidence for a stable right-handed 
double-helical structure, with all bases orientated in an anti-conformation. 
177 
Figure 6.9 A capped stick model of the rMD calculated 14-mer DNA duplex 111*, 
where the G 7 *G8 * site is modified by cis-{Pt(NH3)2} 2 . Colour code: C (white), H 
(cyan), N (blue), 0 (red), P (orange), Pt (purple). 
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The NOE constraints used in the structure calculation proved to be sufficient 
to reach the final converged structure from either A- or B-form starting models. The 
final calculated structure of platinated 14-mer DNA duplex is quite distorted 
compared to standard A- or B-form models, but it is still primarily a B-form structure 
according to sugar puckers and phosphate-phosphate distances (6.28 A). Only the 
G7* and A14 deoxyribose rings of the final calculated structure have C3'-endo sugar 
puckers, consistent with the 2D NOESY and DQF COSY data. The other sugar 
puckers are all S-type, with either a C2'-endo or the related C3'-exo conformation. 
The program CURVES 5.2 was used to calculate the helical base-base and 
base-step parameters which describe the duplex. Those parameters are defined 
according to the EMBO workshop on DNA curvature and bending. 35  The binding of 
cis-diammineplatinum(ll) to the N7 atoms of the adjacent guanine bases G7*  and 
G8* causes a roll of 43° toward the major groove, resulting in a global bend of the 
duplex of 23.6°. This calculated bending angle is much smaller than the overall 
appearance of the structure. The global helix axis, as determined in the CURVES 
program, passes through the center of the duplex at the 5' end but through the base 
pairs in the 3' end, shown in Figure 6.10. It has been shown that the bending angle 
obtained from CURVES has a large associated error due to the difficulty of making 
such rigorous calculations for the distorted structures." 16 A manual method was used 
to measure the bend angle of helix axis, and the final value was 47°. The bending 
point of the helix axis is located at T9 on the 3' side of G7*G8*,  rather than at the 
platinated G7*G8*  base step. The roll and the geometric distortion at the G7*G8* 
base step are consistent with the 2D NOESY data, which shows an intense cross-
peak between G7*H8  and  G8*H8  protons. 
An expanded view of the structure at the platinum-binding site is shown in 
Figure 6.11. The two guanosine residues coordinate to the N7 atoms of G7*G8*  in a 
head-to-head configuration. The H-bonding of 5"G7*.C22  base pair is most affected 
IVDJ 
Figure 6.10 Helical axes calculated by the program CURVES for the final structure. 
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Figure 6.11 Extended view of the central four base pairs T 6G* 7G* 8T9/A23 C22C21 A20 
of the platinated 14-mer DNA duplex 111*.  The duplex is unwound and the base pairs 
are destacked at the G*G*  site. Colour code: C (white), H (cyan), N (blue), 0 (red), 
P (orange), Pt (purple). 
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and consistent with the weak NOE cross-peaks between G7*  1-NH and C22 4-NH 2 . 
The Pt atom is displaced from the planes of the coordinated guanine bases by 0.8 A 
(5'G) and 0.3 A (3'G). The purine ring of G7*  does not stack with G8*,  neither does 
the pyrimidine ring of A23 with C22 in strand II, but the cytosine residues which pair 
with G7*  and  G8*  still stack on one another. The distortions caused by the platinum 
lesion also include a large positive stretch and buckle at the G7*C22  base pair and 
significant opening and stagger at the G8*C2I  base pair. 
In the 2D NOESY spectrum, both the chemical shifts of G7*  H8 (8.64 ppm) 
and G8*  H8 (8.08 ppm) are very much low field shifted from the normal chemical 
shift region of guanosine H8 (7.8 ppm), 34 and the H8 chemical shift of 5'G7* is 
more downfield shifted than that of 3'G8*.  This is consistent with the R-
conformation, which is usually observed for G*G*  intrastrand platinated DNA 
duplexes. 36  In the final structure, the G8*  H8 proton remains underneath the 
imidazole ring of the G7*  base, therefore sensing the ring-current shielding effect of 
the G7*  base. This and the inductive effect of platinum binding causes the chemical 
shift of 5G*  H8 to be more downfield shifted than that of 3'G*  H8. The T6 
deoxyribose is also affected by the platinum crosslink at the G7*G8*  site, which 
induces characteristic chemical shift changes for T6 HI' (from 5.71 to 5.86 ppm) and 
H2' (from 1.92 to 1.37 ppm), compared with unplatinated, normal DNA duplex with 
the same sequence. Similar shifts for the Hl ' and H2' of 5'-deoxyribose are observed 
in the other reported structural analyses of intrastrand cross-linked DNA 
duplexes. 14,15,37  It indicates that T6 H2 is located in the shielding zone of the G7* 
purine ring. 
The minor groove opposite the site of platination is widened and shallow 
compared with normal B-form DNA which has an average width of 6.0 A and a 
depth of 8.2 A. 38 It is opened from 8 to 11 A over the region of G7*  to AlO, with a 
depth ranging from 3.9 to 1.3 A. Both the width and shallowness of minor groove 
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Figure 6.12 Graphic plots of the variation of the minor groove width with the base 
pair step. The minor groove width of standard A- and B-forms of DNA are plotted 
with dashed lines for comparison. (.) for the platinated 14-mer DNA duplex. 
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reach their biggest values at the T9-A1O step. The variation of minor groove width 
with the base pair step is graphically depicted in Figure 6.12. The platinated DNA 
structure shows significant unwinding by approximately 26 0 twist. All the structural 
data are listed in Table 6.3, and compared with other published results. 
Table 6.3 Maior structural parameters for G*G*  platinated DNA structures. 39 
DNA 14-mer (1) 12-mer (2)11 	12-mer 
(3) 15 1 1-mer (4) 16 
Method NMRa X-ray' 	NMRa NMRb 
DNA form primarily B A/B junction 	primarily B primarily B 
Minor groove width(A) 8.0-11.0 9.5-11.0 	9.4-12.5 9.0-12.0 
depth (A) 1.3 3.0 	1.4 2.1 
P-P distance (A) 6.3 5.5 	6.9 6.8 
Roll at G*G*  bases (°) 43 26 	49 59 
Pt atom displacement 0.8 A, 5' 1.3 A, 5' 	0.8 A, 5' 0.5 A, 5' 
from guanine ring 0.3 A, 3' 0.8 A, 3' 	0.8 A, 3' 0.65 A, 3' 
Average helix twist (°) 26 32 	25 26 
DNA bend (°) —47 39 and 55C 78 —81 
d 
S'-ATACATGGTACATA 5'.CCTCTGGTCTCC 5-CTCTCGGTCTC 
Sequence 3'-TATGTACCATGTAT 3.GGAGACCAGAGG 3'-GAGAGCCAGAG 
(14mer) (12mer) (11-mer) 
a cis-[Pt(NH 3 ) 2C1 2] adduct. b  Spin-labelled compound cis-[Pt(NH 3 )(4-amino-
TEMPO)C!IJ was used in this study. C  Two independent molecules. d  The same 
sequence was used in structural studies of DNA 12-mer by X-ray (2) and NMR (3). 
6.5. Discussion 
Structures determined via rMD have two major determinants: the 
experimental restraints and the force field applied. The role of the force field is to 
provide an energetically feasible structural framework for the molecule as the rMD 
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protocol is utilised to search conformational space for a structure most consistent 
with the experimental constraints . 40 The results of these studies have shown that a 
successful convergence to the final structure has been achieved from the starting 
standard A- and B-form DNA duplexes (RMSD, 6.7 A). The heavy atom RMSD 
value is reduced to 1.8 A between rMD-A and rMD-B. 
Due to the lack of long distance constraints (>5 A) from 2D NOESY data and 
flexible nature of this highly distorted structure, the two ends of this platinated DNA 
duplex are distorted and less well defined, which affects the final RMSD value. The 
superimposed 10 structures calculated from A-1 and B-1 with randomly assigned 
initial atom velocities (five each) are shown in Figure 6.13. The flexibility of the 5 
and 3'-ends can be clearly seen. During the rMD runs, the bending angle of the 
duplex fluctuated with time and the longer molecular dynamics (100 ps) runs proved 
to be very important for defining this highly distorted duplex. The fluctuation of this 
DNA duplex during the rMD runs also reflects the possible existence of multiple 
exchanging conformations in solution and rapid internal motions, which affects the 
time-averaged N OE distance constraints. 
Compared with the two ends, the conformation of central four base pairs is 
very well defined in all the final rMD runs. When the cisplatin was replaced by 
another anticancer active complex cis-[PtC12(NH3)(2-picoline)J in the reaction with 
14-mer DNA duplex, which is reported in Chapter 7, it was surprising to find that 
little rearrangement of the conformations for those base pairs was needed to satisfy 
all the NOE connectivities between the 2-picoline ligand and nearby T6 and G7* 
protons as well as the ring current effect of pyridine on the chemical shift of T6 H2' 
(see Figure 7.8 in Chapter 7). This is impossible if the cis-{Pt(NH3)(2-pico1ine)} 2 is 
docked onto the reported 12-mer G*G*  platinated DNA structures (2 and 3), 
although the sequences of the central four base pairs TG*G*T  are the same. 
Figure 6. 13 Superimposed 10 structures calculated from A-I and B-I with randomly 
assigned initial atom velocities (five each), showing the flexibility of the 5' and 3'-
ends. Colour code: C (white), N (blue), 0 (red), P (orange), Pt (purple). 
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The major structural difference between structure 1 and previously reported 
structures (2, 3, 4 in Table 6.3) of intrastrand platinated DNA duplex is the bending 
position of the duplex. In structure 1, both the widest and most shallow position of 
the minor groove occurs at the T9 site, resulting in the 3' side of the 14-mer DNA 
duplex being much more bent towards the major groove. This contrasts to the 
previous reports, in which the widest positions of the minor groove occurs on the 5' 
side of the XG*  (X: T or C) base step and in consequence the 5' side of the duplex is 
more bent towards the major groove. 12,15,16  This structural difference could be due to 
the different sequences chosen for the studies. The sequence of the 14-mer DNA 
duplex is richer in AT base pairs compared with all the previously reported Pt-DNA 
structures. It has only one G•C base pair on each side of G7*G8*,  separated by two 
AT base pairs. The data from CURVES analysis shows that both the G7*G8*  step 
and T9-AlO step have large positive rolls, which causes the helix to bend towards the 
major groove. The large positive roll on the G7*G8*  step is due to the binding of 
cisplatin, while the positive roll on T9-AlO is a feature reported to be typical for 
pyrimidine-purine steps including C-A (= T-G), T-A, or less frequently C-G.' 8 ' 4 ' This 
extra T-A step, adjacent to G*G*  on the 3' side, is unique in this 14-mer DNA 
duplex. Bending of DNA is sequence-dependent. Pyrimidine-purine steps have a 
tendency toward positive roll bending because of the relatively limited overlap 
between base pairs, but in a given setting, not every pyrimidine-purine step is 
necessarily bent. It is analogous to a flexible hinge which can only bend under proper 
stress. Previous studies have shown that there are positions where a C-A step or a T-
G step exists but is not bent .41  In the 14-mer DNA duplex, there are two hinges on 
either side of the G7*G8*  platination site, e.g. 5' side T6G7*  and 3' side T9-AlO 
steps which can both cause roll bending. The final structural analysis reveals that the 
most bent position occurs at G8*T9A10 steps, which causes the 3' side of the DNA 
to bend towards the major groove. In the other reported Pt-DNA structures (2, 3, 4 in 
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Tables 6.3), there is only one hinge (TG*  or CG*) on the 5' side of G*G*.  The 
positive roll on both T.G*  (or  C-G*)  and  G*.G*  steps causes the 5'-side of the DNA 
duplex to bend towards the major groove and the opposite minor groove to open. 
This sequence-dependent differential bending of G*G*  intrastrand cross-linked DNA 
could have important implications for the recognition of DNA-binding proteins. 
Besides the sequence, the length of the current 14-mer DNA duplex might also have 
some influence on the bending position. It has been reported that short DNA 
sequences can destabilize the binding of cisplatin, causing migration from intrastrand 
to interstrand cross-links. 14,15 
Recent X-ray crystal structure studies of HMG domain A protein complex 
with cisplatin-modified DNA has shown that HMG1-A binds to the widened minor 
groove of G*G* platinated DNA duplex and protein binding extends exclusively to 
the 3' side of the platinated strand . 42 Both domains (A and B) of HMGI protein bind 
preferentially to DNA having AlT flanking sequences, with slightly different base 
pair preference. 43  HMG1-A binds much more tightly than 11MG 1-B to any of the 
platinated DNAs, having typically a 10- to 100-fold lower Kd value. The more 
flexible A-T base pairs flanking the platinum lesion would facilitate further bending 
of the DNA duplex caused by HMG protein binding. The tighter binding of HMG 1-A 
is also accompanied by a much more distinct flanking sequence specificity, with the 
3'-flanking nucleotide of G*G* determining the sequence preference. The slightly 
different binding abilities of the two domains in a full-length protein suggests a 
mechanism for sequence recognition. 39 
The bending angle (470)  of this platinated DNA 14-mer duplex 111* is less 
than those of the reported for the solution structures of 3 (78°)' and 4 (810)16,  but 
close to that of a reported 8-mer (58') 14 and X-ray crystal structure of a platinated 12-
mer (39° and 55') 12 From the previous reports and this study, it is difficult to 
calculate rigorously the bending angle of a highly distorted DNA structure with the 
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programme CURVES and use it to compare with other structures. The overall shape 
of the platinated DNA 14-mer duplex 111*  is very similar to that of the reported X-
ray crystal structure (2) and structure (4) determined by combining long-range 
electron-proton and short-range interproton distance restraints. For comparison, the 
bending angles analysed by gel mobility assays which reflect macroscopic duplex 
shape are between 32-34° and the bending angle of platinated DNA in HMG1-A-
DNA complex is 61 °t'42 
In all the previously reported NMR structural studies of intrastrand G*G* 
cross-linked DNA duplex, 14,15,16  the imino proton of the 5'G*  is not observable even 
at low temperature. This is because of the distortion of 5' G*.0  base pair by the 
Q*G* bischelate, which causes fast exchange of 5'G*  HI proton with water. But for 
the platinated DNA 14-mer duplex 111*,  the intensity of the 5'G7*  imino proton 
resonance was quite strong at low temperature and showed clear NOE connectivities 
with the opposite C22 4-NH2 (both the hydrogen-bonded and non-hydrogen-bonded 
proton). This implies that the Watson-Crick base-pair between 07 and C22 still 
remains, although the hydrogen-bonding is much weaker compared with the other 
GC base pairs. This observation is consistent with the calculated final structure. The 
different bending position in our structure (at T9-A10 step, 3' side of 07*08*) 
compared with the other reported structures (at T-G*  or  CG*  step) causes the 
hydrogen-bonding of G7*C22  to be relatively less distorted. No NOE connectivities 
were found between the imino proton of 07*  and the nearby T6 and 08*  bases, 
which suggests that the base-stacking is disordered at the G7*G8* site. The absence 
of Watson-Crick base-paired imino protons at both ends of the DNA duplex indicates 
flexibility at the two ends, which is a common feature of DNA NMR studies. 
6.6. Conclusion 
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By combining NMR spectroscopy and restrained Molecular Dynamics, a 
successfully converged structure of G*G* platinated DNA 14-mer duplex has been 
obtained. The platinum atom is coordinated to the N7 positions of adjacent guanines. 
The binding of cisplatin causes the DNA duplex to be bent towards the major groove 
and unwind. The minor groove opposite the platinated site is significantly widened. 
The final refined structure is a distorted B-form DNA. The major structural 
difference between this platinated 14-mer DNA duplex and the other previous studies 
is the bending position of the DNA. The 14-mer DNA duplex 111*  is bent at the 3 
side of G*G*  (T9 position), which causes the 3' side of DNA duplex to be much 
more bent towards the major groove, while the other reported DNA structures are all 
bent at the other side of G*G*  and the 5' side of the DNA is more bent towards the 
major groove. The structural difference is most likely due to the different DNA 
sequence chosen in the studies. Platinated DNA duplexes with different structural 
characteristics, for example either with the 3' side or 5' side of the platination lesion 
more bent, may be recognized differently by DNA-binding proteins. 
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7.1 Abstract 
The new anticancer drug cis-[PtCl2(NH3)(2-picoline)] (1) forms a highly 
stereoselective GG intrastrand bischelate with a 14-mer DNA duplex (2-picoline cis 
to 5'G and 2-methyl group pointing to the major groove). This is in contrast with the 
reactions between complex 1 and d(GpG) or a 14mer single strand, in which four 
stereoisomers were observed in each of the cases, with the 2-picoline ligand in the 
position either cis to 5'G or 3'G and the rotation about the Pt-N picoline bond. From 
NMR data and molecular modelling, several factors are found to contribute this high 
stereoselectivity: favourable steric interactions between the 2-picoline ring and the 
nearby nucleotides, hydrogen-bonding between the NH3 ligand and 06 of G8, and 
together with van der Waals interactions between the 2-picoline CH3 and the CH3 of 
nearby T6. In addition, kinetic factors may also play a role. The result of these studies 
provides a structural basis for optimising the design of the substituted pyridine ligand 
as a way of controlling the rate of formation, stability of GG-intrastrand crosslinks 
and DNA duplex sequence selectivity of platination. The highly stereoselective 
formation and stability of this adduct could play an important role in the unique 
anticancer activity of 1, especially for the activity against cisplatin-resistant cell lines. 
7.2 Introduction 
Much attention is currently focused on the design of new generations of 
platinum anticancer complexes which circumvent cisplatin resistance. Such 
resistance often involves the recognition of platinated DNA adducts by proteins and 
enzymes in the nucleotide excision-repair, mismatch repair and post-replication 
repair systems in cells.' Recent study shows that the carrier ligands of Pt anticancer 
agents, including oxaliplatin and JM216, appear to play an important role in 
determining their efficacy against tumours with both intrinsic and acquired resistance 
to cisplatin. 2 Both the mismatch repair and post-replication repair pathways have 
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shown carrier ligand specificity. The use of chiral ligand in DWA21 14R provides the 
interesting observation that the R-isomer is not toxic while the S-isomer is, 3 which 
suggests different interactions that occur following DNA binding. It is therefore vital 
to understand how ligand design influences the nature of platinated DNA lesions. 
A complex with high activity against cisplatin-resistant cell lines is the 2-
picoline (2-Pie, 2-methylpyridine) complex cis-[PtC12(NH3)(2-Pic)] 1 (ZD0473). 4 ' 5 
As described in Chapter 4 and 5, the steric effect of 2-picoline plays an important 
role in determining the rates of hydrolysis and substitution reactions with the 
nucleotide 5'-GMP. 6 ' 7 Due to slow rotation about the Pt-N 2-picoline bond (0.62 s, 
296 K), together with the non-C 2-symmetrical structure of complex 1, four isomers 
of the bis(GMP) adduct are possible, and these are formed in equal amounts .7 
In all previous reports of the stereoselective formation of platinated GG adducts 
by unsymmetrically substituted cisplatin derivatives (general formula cis-
[PtC12(LL')]), 8 ' 9 the selectivity has been low and with the orientation of NH3 cis to 
5 'G preferred. In the case of cis-[PtC] 2(NH3)(C5H1 1NH2)j, a metabolite of the orally-
active Pt(IV) drug JM2 16, the most abundant platinated G*G*  stereoisomer (isomer 
ratio 2:1) has the cyclohexylamine ligand directed towards the 3 'G of both calf 
thymus DNA and shorter single strand 12-mer oligonucleotides.' ° This preference 
was attributed partly to Pt-NH3 H-bonding with the 5-phosphate, which was a 
structural feature identified as being important in the major cisplatin adducts with 
DNA. Opposite selectivity was observed in the platination of the dinucleoside mono-
phosphate d(GpG), which contains no 5'-phosphate. 10 The same ratio (2:1) and 
preference of orientational isomers (NH3 cis to 5'G) have also been observed for an 
1 1-mer DNA duplex platinated at G*G*  with cis-{Pt(NH3)(4-aminoTEMPO)} 2 , 
which has a spin-labelled ligand." 
In dramatic contrast, the reactions of 1 with the 14mer DNA duplex III give 
predominantly a single stereoisomer, whereas relatively little stereoselectivity is 
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observed for reactions with d(GpG) or the 14-mer single strand I. The structural basis 
for this unusually high stereoselectivity has been revealed by NMR studies and 
molecular modelling in this report. 
5' d(A1 T2 A3 C4 A5 T6 G7 G8 T9 A10C11Al2T13A 14) I 
I + II = III 
3' d(T28A27T26G25T24A23C22C21A20T19G13T17A16T15) II 
7.3. Experimental 
2-Picoline was purchased from Aldrich. The sodium salts of 14-mer 
oligonucleotides were prepared by Oswel (Southampton, U. K.). Cis-
[PtC1 2( 5NH,)(2-Pic)] 1 was prepared from cis-[PtC12( 15NH3)21 by the procedure 
described in Chapter 4. 12 
The concentrations of GG 14mer single strand and its complementary CC 
strand were determined by UV according to their E values at 260 nm (GG strand: 149 
M'cm'; CC strand: 137.2 M'cm'). The DNA 14-mer duplex III was annealed by 
slow cooling the solution containing equivalent of GG and CC 14mer single strands 
from 70 °C. The reaction of 1 with HI was conducted at a 1:1 molar ratio (1 mM) in 
90% H20110% D20 (0.5 ml). Samples contained 0.1 M NaC104 to maintain a 
constant ionic strength. Phosphate buffer (9 mlvi) was used in the reactions to 
maintain the pH at 6.0. For experiments in D20, the sample was freeze-dried twice 
from 99.9% D20 and finally dissolved in 99.9% D20. 
NMR spectra were acquired, as previously described '6,7  on both Broker 
DMX500 and Varian UUItYII4OVA600  NMR spectrometers operating at 'H resonance 
frequencies of 500.13 and 599.842 MHz respectively. 2D 'H NOESY data sets were 
acquired for both the 90% H20/10% D20 sample and the 99.9% D20 sample using a 
200 ms mixing time at 278 K. 2D DQFCOSY data were acquired only on the 99.9% 
D20 sample. 
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Measurements of pH were made using a Coming 145 pH meter equipped 
with an Aldrich micro combination electrode calibrated with Aldrich buffer solutions 
of pH 4,7 and 10. 
Molecular modelling was carried out using Sybyl version 6.3 (Tripos Inc.). 
DNA duplex structures were based on an energy minimised model of a cisplatin-
DNA duplex with the same sequence calculated from NMR data (Chapter 6). The X-
ray crystal structure coordinates of 16  were used to construct the fragment 
{Pt(NH 3)(2-Pic)J 2 for docking onto the G*G*  site of DNA 14mer duplex. Distances 
(2.0 A) between GN7 and Pt were based on the crystal coordinates of the 12-mer 
DNA duplex-cisplatin adduct. 13  Four different models reflecting the possible 
geometry of the final DNA adduct were built. Inter-proton distance constraints were 
built into each model based on an assessment of the distances calculated from the 
NOE data. Distance bounds were set for strong, medium and weak NOEs in the 
ranges 2.5-4.5 A, 3.0-5.0 A and 4.0-5.0 A, respectively, with force constants of 20 
kcal mol' A-2 each. A total of 8 identifiable NOE distance constraints between the 2-
picoline ring and the DNA duplex were incorporated into the models. Substructures 
of each model (T6G7 *G8 *T9  + {Pt(NH3)(2-Pic)} 2 ') were subjected to 200 steps 
conjugate gradient energy minimisation to allow each model to satisfy the distance 
constraints. The molecular modelling was done with Dr. J. A. Parkinson. 
7.4 Results and Discussion 
Reactions of complex 1 with both d(GpG) and 14-mer single strand I at a 1:1 molar 
ratio (1 mM, pH 6.0, 9 mM phosphate, 100 mM NaC104, 90% H20/10% D20, 298 
K) were followed by 1D 'H and 2D [ 1 H, ' 5N] HSQC NMR spectroscopy. In each 
case the GG chelate finally gave rise to four cross-peaks of similar intensities 
corresponding to similar populations of the four possible stereoisomers (Figure. 
7.1A): 2-picoline orientated towards 5'G or 3D, and slow rotation about Pt-N(2-Pic) 
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bond. The chemical shifts ('H/' 5N) for the adducts of d(G*pG*)  were 4.61/-65.68, 
4.571-65.73, 4.481-65.63 and 4.461-65.31 (relative intensities: 2:2:3:3), and for the 
adducts of 1*  were 4.841-65.12, 4.821-65.03, 4.691-65.12 and 4.65/-65.25 (partially 
overlapped with water, relative intensities: Ca. 2:2:3:3). When the temperature was 
increased, the two pairs of 'H/ 15N cross-peaks for the d(G*pG*)  adducts began to 
merge into two (Figure. 7.113), as observed for the bis(GMP) adducts because of the 
faster rotation of Pt-N(2-Pic) bond at higher temperature. 7 
The reaction of 1 with duplex III at a 1:1 molar ratio was studied under the 
same conditions, and followed in the same way. A 2D HSQC spectrum recorded after 
15 hours of reaction is shown in Figure 7.2A, in which the peak of one of the 
monoaqua hydrolysis species (peak b, 5 'H/' 5N: 4.161-84.57, H20 trans to NH3) is 
much stronger (1.7:1) than the other one (peak c, S 1 HI 15N: 4.31/-65.02, H20 trans to 
2-Pic), in contrast to the two monoaqua species observed with similar intensity 
during the hydrolysis experiment in Chapter 4 and reactions with 5-GMP in Chapter 
6 After one week, one major cross-peak was observed (Figure 7.213, S 'H/' 5N: 
4.51/-67.46) which accounted for 90% of the total quantity of platinated adducts. In 
the ID 'H spectrum, peaks for the H6 (8.88 ppm) and 2-methyl (3.15 ppm) protons 
of the 2-Pic ligand of unreacted 1 were replaced by two new signals at 9.205 and 3.19 
ppm, respectively (Figure 7.3). A feature of the new 2-picoline signals was their 
broadness relative to free 1, due to the 2-picoline complex taking on the T2 relaxation 
characteristics of a macromolecule via irreversible binding to DNA. New NMR 
resonances were also observed outside the usual windows expected for both aromatic 
and methyl protons of DNA (peaks at 8.55, 1.16, 0.43 ppm). These signals enabled 
further assignments to be made. 
The use of NMR methods was explored to determine the structure around the 
platination site of the major adduct even though the NMR spectra were complicated 
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4.95 4.90 4.85 	ö ( 1 .H) 
Figure 7.1 The 2D ['H, ' 5N] HSQC NMR spectrum recorded after 1 week of 
reaction of cis-[PtCl 2(' 5NH3)(2-Pic)] 1 with d(GpG) dimer at (A) 298 K (1 MM, 1:1 
molar ratio, 100 mlvi NaC104, pH 6.0, 9 mM phosphate buffer, 90% H,0/10% D 20). 
The two pairs of peaks are shown in two dotted boxes and their relative intensities 
are 2:2:3:3 (from left to right). (B) 338 K, one pair of peaks becomes closer and the 
other pair has merged. 
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	 Minor Adducts 
4.6 4.5 4.4 4.3 4.2 6 ( 1 H 
Figure 7.2 The 2D ['H, ' 5N] HSQC NMR spectrum of reaction of cis-
[PtCl 2(' 5 NH3)(2-Pic)] 1 (1 mel equiv.) with 14-mer DNA duplex HI at 298 K (1 
mM, 100 mM NaCI04, pH 6.0, 9 mlvi phosphate buffer, 90% H20/10% D 20) 
recorded after (A) 15 hours. Peak assignments: a is the starting complex 1; b and c 
are the two monoaqua species (in dashed boxes for intensity comparison with those 
in hydrolysis experiment in Chapter 4); d is the final major adduct; those 
intermediates unassigned are labelled as * (B) Recorded after 1 week. The integral 
percentages of the major peak and the two minor peaks are indicated. 
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3.0 2.5 2.0 1.5 1.0 
Figure 7.3 'H N]\4R spectrum recorded after (A) 0.5 hand (B) I week of reaction of cis-[PtCl 2 (' 5NH3 )(2-Pic)] 1(1 mol equiv.) with 14-
mer DNA duplex 2 at 298 K for the same sample in Fig. 7.2. The assignments of peaks in (B) are listed in Table 7.1. Broad peak for T6 
H2' at 0.43 ppm is scaled up on top. 
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Table 7.1 Assignments of key 'H resonances for the G*G*  ehelate of duplex Ill with 
cis- {Pt(5NH3)(2-Pic) }2+ 
Assignment (2-Pie) S Assignment (DNA) S 
116 9.20 T6CH3 1.16 
115 7.67 T6 Hi' 5.82 
114 8.18 T6 112' 0.43 
H3 7.59 T6 1-12- 1.91 
2-CH3 3.19 T6 113' 4.69 
T6 1-14' 4.00 
G7 H8 8.55 
G8 H8 8.18 
Table 7.2 Key NOE signals observed between 2-picoline and DNA protons after 
platination of DNA duplex III with the platinum anticancer drug 1. The 
corresponding distances in the four models are listed for comparison. Distances over 
5 A are beyond the limit for NOEs, and are labelled (-). 
NOE Observed 
1 .......... III 3a 
Distances (A) in Models 
3b 	 3c 3d 
H6..... G7 118 4.45 3.47 5.70(-) 5.15(-) 
H6..... T6 113' 4.88 4.53 7.21(-) 7.06(-) 
116.... T6 112" 4.98 4.50 7.08(-) 7.02(-) 
116..... T6 112' 3.33 3.52 5.57(-) 5.88(-) 
H5..... T6 112' 3.78 3.85 7.86(-) 8.09(-) 
CH, ..... T6 CH, 8.22(-) 4.03 9.07(-) 5.31(-) 
113..... T6 CH3 7.26(-) 2.73 9.66(-) 7.35(-) 
H4..... T6 CH3 5.42(-) 4.70 9.02(-) 9.15(-) 
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by the presence of peaks for the minor adducts and free duplex Ill. A 'H 2D NOESY 
NMR spectrum (mixing time 200 ms) was acquired for the same sample and 
compared to that for the cisplatin GG bischelated adduct of the same DNA duplex 
(Chapter 6). The key 'H NMR assignments derived from these data are listed in Table 
7.1. They are based on the following observations: a clear strong NOE between G7 
118 and G8 118 with chemical shifts similar to those observed for the cisplatin-DNA 
adduct of DNA duplex which indicates bischelate at G7G8 site by {Pt(NH3)(2-Pic)j 2 
(Figure 7•4),14  an NOE between 2-picoline H6 and G7 H8, a cross-peak between a 
resonance in the usual 112! H2" region and a resonance at 0.42 ppm assignable to T6 
142' (which is significantly low-frequency-shifted compared to that for DNA 
platinated by cisplatin, 1.37 ppm for duplex Ill, c.f. 1.40 ppm for a reported I 2-mer 
duplex ' 4), a strong cross-peak between 2-picoline CH, and T6 CH3 which also 
showed NOEs to T6 HI 'and T6 H2'. The assignments of resonances for T6 were 
further confirmed by the NOE observed between T6 112' and 07 118. Figure 7.5 
shows slices taken through the NOESY data at the chemical shifts of T6 CH,, T6 112' 
and 2-picoline 116. Key assignments of NOEs around the platination site are listed in 
Table 7.2. Confirmation of assignments for the 2-picoline ring protons were made 
from a 'H 2D DQFCOSY NMR spectrum, shown in Figure 7.6. 
Four molecular models of the GO adduct of duplex III were built by docking 
{Pt(NH3)(2-Pic) } 2 onto the G?*Gg*  site of the 14-mer DNA duplex III. The structure 
of the latter was based on that of the cisplatin adduct in Chapter 6. The models 
differed as follows (Figure 7.7): 2-picoline trans to G8 (3'-G) with the 2-methyl 
group orientated either towards the phosphate backbone (Methyl-Out) (3a) or 
towards the centre of the major groove (Methyl-In) (3b); 2-picoline trans to 5'-G 
also with either Methyl-Out (3c) or Methyl-In (3d) orientations. Distance restraints 
were applied to each case, based on the NOE data shown in Table 7.2, and the 
models minimised in the region of the bischelate site in order to satisfy the data. Of 
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o( 1 H) 
Figure 7.4 Expansion of the aromatic region of the 200 ms 2D NOESY NMR 
spectrum for the same sample of platinated DNA duplex as used for Fig. 7.2 in 
99.9% D20. Assignments are shown on the right-hand side (Pic refers to the 2-
methylpyridine ligand), and the dashed line shows the connectivity from Pic-H6 to 
G7 H8 and G7 H8 to G8 H8. 
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(c) 
Plc Me 
Plc H4" H3 T6-11' 
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Figure 7.5 Slices taken through the 2D NOESY spectrum at the chemical shifts of 
(a) 2-picoline H6. (b) T6 H2 and (c) T6 CH 3 , showing NOE connectivities to other 
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7.5 
8.0 
( 1 H) 
8.5 
9.0 
Figure 7.6 2D DQFCOSY NMR spectrum for the same sample as Fig. 7.2 in 99.9% 
D20. The assignments of protons on picoline ring are shown on the right-hand side 
(Pic refers to the 2-methylpyridine ligand), and the dashed lines show connectivities 
between Pic-H6, H5, H4 and H3. 
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Figure 7.7 Stereoview of four molecular models for the G*G*  adduct of duplex III: 
2-picoline trans to G8 (3 '-G) with the 2-methyl group orientated either (A) towards 
the phosphate backbone (Methyl-Out) or (B) towards the centre of the major groove 




Figure 7.7 (C) and (D) 
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the 4 models, only that with 2-picoline trans to 3'-G with the Methyl-In orientation 
(model 3b) satisfied all of the observed NOE constraints, as shown in Table 7.2 and 
Figure 7.8. The first notable feature of model 3b is that the picoline ring fits perfectly 
into the major groove of the DNA duplex and lies along the phosphate backbone, as 
shown in Figure 7.8A. Models 3c and 3d, in which the 2-picoline is trans to 5'-G 
with Methyl-Out or Methyl-In, have the 2-picoline ring in an almost perpendicular 
orientation with respect to the planes of the nearby nucleotide bases (Fig. 7.7). This 
steric clash causes models 3c and 3d to be far less stable than those with 2-picoline 
trans to 3 '-G. The other notable feature is the orientation of the 2-picoline ring, 
which lies almost perpendicular to the Pt square plane (angle 1000),  as in the crystal 
structure of 1 (1030).6  Model 3b satisfies several other features of the NMR data. As 
shown in Table 7. 1, the T6 H2' resonance at 0.44 ppm is significantly low-frequency-
shifted from its normal position for a G*G*  DNA duplex/cisplatin adduct (usually 
near 1.39 ppm). It can be seen in Figure 7.8B, that T6 H2' for molecule 3b lies 
directly beneath, and within 3 A of, the centre of the 2-picoline ring. This is 
consistent with strong aromatic ring current shielding 5,16  The 'H chemical 
shift of the NH3 signal of the platinated duplex is shifted to high frequency by 0.4 
ppm compared with that for 1 itself. This is consistent with the presence of hydrogen-
bonding in model 3b between the NH3 of {Pt(NH3)(2-Pic) }2+  and 06 of DNA 
residue G8. Additional stabilisation of complex 3h may arise from van der Waals 
contact between the 2-picoline 2-methyl group and the T6 methyl of DNA (C C: 
3.78 A).' 7 This contact is not observed in the Methyl-Out model 3a (closest distance 
between 2-CH3 and T9 CH3: 5.13 A) and appears to be important in distinguishing 
between the Methyl-In and Methyl-Out models. 
In the case of cis-[PtC12(NH3)(C6H11NH2)} and cis-{Pt(N113)(4-
aminoTEMPO) }2+,  the preferred orientational isomers are NH3 cis to the 5'-  
nucleotide. '°" This is probably because the bulky groups in those two complexes are 
210 
Figure 7.8 (A) Space-filling model of cis- { Pt(NH3 )(2-Pic) } -d(ATACATG * G * TACATA) d(TATGTACCATGTAT), with cis-
{Pt(NH3)(2-Pic)} 2  shown in green. The perfect fit and alignment of the 2-picoline ligand along the major groove can be seen. (B) Close-
up view of the Pt binding site showing NOE connectivities (yellow dashed lines, listed in Table 7.2) between 2-picoline and DNA. H-
bonding between Pt-NH3 and 06 of G8 is shown as a yellow dotted line. Colour code: C (white), H (cyan), N (blue), 0 (red), P (orange), 
Pt (purple). 
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Scheme 7.1 Pathways for reactions of anticancer complex 1 with DNA duplex III 
(only G7 and G8 are shown). Charges on complexes are not shown. A possible 
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further away from Pt atom compared with 1, and both of the ligands C6H11NH2 and 
4-aminoTEMPO are relatively flexible so that they could easily fit into the distorted 
DNA duplex structure. The H-bonding between Pt-NH3 and 5'-phosphate instead of 
steric effect in the two complexes therefore appears to be more significant in 
determining the preference for orientational isomers. Considering the sequence-
dependent structures of G*G*  platinated DNA duplexes discussed in Chapter 6, 
either the 5- or 3'-side of the DNA can be more bent towards the major groove. It is 
also possible that the preference for orientation of a bulky group (cis- to 5' or 3'-G) 
in platinated DNA duplexes is sequence-dependent. 
Preliminary kinetic studies of the reaction of complex 1 with duplex Ill show 
that the monoaqua species with 2-picoline trans to water reacts faster with DNA 
(Fig. 7.2A), from comparing the hydrolysis rates of the two chloride ligands in 
complex i. Therefore monofunctional adducts with GJV7 trans to 2-picoline are 
formed in preference to those with NH3 trans to GIV7 (Scheme 7.1), which is 
probably due to unfavourable steric interactions when 2-picoline is cis to GIV7. This 
contrasts with the formation of monofunctional adducts of cis- and trans-
[PtCI(NH3)2(4-Me-Py)f' where the methyl substituent is further away from the 
coordination plane, 18  and emphasises further the important role played by the 2-
methyl group of 1 which is close to Pt. Monofunctional 3'G platinated adducts of 
DNA duplexes with cisplatin usually form faster and ring-close faster than 5'G 
monofunctional adducts. 19 If this is also the case for adducts of 1, then this, together 
with the preference for substitution trans to 2-picoline, would explain why the 
bifunctional adduct with 2-picoline cis to 5'G is the preferred product. 
Studies have shown that the anticancer active complex, cis-[PtC1(NH3)2(4-
Me-Py)jt forms monofunctional adduct with DNA duplex and destabilise the DNA 
significantly. 18 The base pairs located on the 5' side of the oligonucleotide, beyond 
the platinum lesion site, are disrupted in order to accommodate the pyridine ring. The 
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presence of bulky aromatic amine ligand, such as methyl-pyridine and N-Me-2-
diazapyrenium,20 is apparently important for the anticancer activity of these 
monofunctional platinum complexes. The monofunctional adducts formed during the 
reaction of complex 1 with DNA duplex can also play a role in its anticancer activity. 
7.5 Conclusion 
This work has shown that a number of factors appear to drive the high 
stereoselectivity in reactions of the anticancer drug cis-[PtC12(NH3)(2-Pic)I with 
DNA duplex III. These include: unfavourable steric interactions between the 2-
picoline ring and the nearby nucleotide bases in models 3c and 3d, favourable 
hydrogen-bonding between the NH3 ligand and 06 of 08 in model 3b, and together 
with van der Waals interactions between the 2-picoline CH3 and the CH3 of nearby 
T6, which is absent in model 3a. Both thermodynamic and kinetic factors seem to 
favour the formation of complex 3b. The high stability of 3b may be important in 
determining the lack of cross-resistance between 1 and cisplatin. Such a lesion may 
be recognised differently from cisplatin-DNA adducts by the excision repair systems 
in cells. 3,21 
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